²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --]

¿¼²©ÂÛ̳ -> SCI -> ʲôÊÇSCIÆÚ¿¯ [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

kaobook 2011-08-17 22:27

ʲôÊÇSCIÆÚ¿¯

µÚÒ»Õ ʲôÊÇSCIÆÚ¿¯ eo@:@O+bm  
1£®SCI vbSz&+52;  
SCIÊÇÃÀ¹úEugene Garfield´´½¨µÄ¿ÆÑ§Ç鱨Ñо¿Ëù£¨Institute for Scientific Information,ISI£©ÓÚ1960Äê±à¼­³ö°æµÄ¿ÆÑ§ÒýÎÄË÷ÒýÊý¾Ý¿â¡£1992Ä꣬ISI¹éÊôÓÚThomson Scientific and Healthcare,²¢¸ÄΪThomson ISI£¬ÏÖÊôÓÚÌÀÄ·É­¹«Ë¾£¨The Thomson Corporation£©µÄÌÀÄ·É­¿Æ¼¼ÐÅÏ¢¼¯ÍÅ£¨Thomson Scientific£©ÆìÏ¡£ÏêÇé¿É¼û¸Ã¼¯ÍÅÍøÕ¾£ºhttp://scientific.thomson.com. SCIÓбðÓÚ¡¶»¯Ñ§ÎÄÕª¡·£¨Chemical Abstract,CA£©¡¢¡¶ÉúÎïѧÎÄÕª¡·£¨Biological Abstract,BA£©¡¢¡¶¹¤³ÌË÷Òý¡·£¨Engineering Index,EI£©¡¢¡¶¿ÆÑ§ÎÄÕª¡·£¨Scientific Abstract,SA£©¡£Í¨¹ý¼ìË÷SCI¾Í¿ÉÒÔ»ñµÃÒÔÏÂÐÅÏ¢£º &Z f@vD  
£¨1£©Ïà¹ØÂÛÎÄÊÇ·ñ±»ÒýÓùý£¿ QJv,@@mu  
£¨2£©ÂÛÎĵÄÖ÷ÒªÄÚÈÝÊÇʲô£¿ v+\E%H  
£¨3£©Ïà¹Ø¿ÎÌâµÄ×ÛÊöÒÔ¼°×îнøÕ¹ºÍÑÓÉ죿 M]6=Rxq1:E  
£¨4£©Ä³Ò»ÀíÂÛÓÐûÓеõ½½øÒ»²½µÄ֤ʵ£¿ [rQ#skf  
£¨5£©Ä³·½·¨ÓÐûÓеõ½¸Ä½ø£¿ *{C)o0D  
£¨6£©Ä³¸ÅÄîÊÇʲô£¿ÓÉË­Ìá³öÀ´µÄ£¿ C~l5D4D#  
£¨7£©Ä³ÎÊÌâÓÐûÓнøÒ»²½¿±ÎóºÍÐÞÕý£¿ |o+vpy  
£¨8£©»¹ÓÐË­ÔÚ´ÓÊÂÕâ·½ÃæµÄÑо¿£¿ (US8Sc  
£¨9£©Ä³Ñо¿»ú¹¹»òÕß´óѧ×î½ü·¢±íÁËÄÄЩÎÄÕ£¿ )>=`[$D1t  
£¨10£©Ä³ÀíÂÛ»ò¸ÅÄîÓÐûÓÐÓ¦Óõ½ÐµÄÁìÓòÖÐÈ¥£¿ ,x_g|J _Y  
£¨11£©Ïà¹ØÑо¿ÈËÔ±·¢±í¹ýÄÄЩÂÛÎÄ£¿ g :O.$  
SCIµÄ¼Ç¼°üÀ¨ÂÛÎÄÓëÒýÎÄ£¬ÆäÒýÎļǼËùÉæ¼°µÄ·¶Î§Ê®·Ö¹ã·º£¬°üÀ¨Êé¼®£¬ÆÚ¿¯ÂÛÎÄ£¬»áÒéÂÛÎÄ£¬×¨ÀûºÍÆäËû¸÷ÖÖÀàÐ͵ÄÎÄÏס£Ëùº­¸ÇµÄѧ¿Æ³¬¹ý100¸ö£¬ËüÊÕ¼ȫÊÀ½ç³ö°æµÄÊýѧ£¬ÎïÀí£¬»¯Ñ§£¬Å©Òµ£¬ÁÖÒµ£¬Ò½Ñ§£¬ÉúÎ»·¾³£¬²ÄÁÏ£¬¹¤³Ì¼¼Êõ£¬ÐÐΪ¿ÆÑ§µÈ×ÔÈ»¿ÆÑ§ÁìÓòµÄºËÐÄÆÚ¿¯¡£¾­¹ý40¶àÄêµÄ·¢Õ¹ÍêÉÆ£¬ÒÑ´Ó¿ªÊ¼Ê±µÄµ¥Ò»Ó¡Ë¢ÐÍ·¢Õ¹³ÉΪ¹¦ÄÜÇ¿´óµÄµç×Ó»¯£¬¼¯³É»¯£¬ÍøÂ绯µÄ´óÐͶàѧ¿Æ£¬×ÛºÏÐÔ¼ìË÷ϵͳ¡£ |R+=Yk&u  
SCI¸ù¾ÝÆÚ¿¯À´Ô´ÖÖÀà»®·ÖΪSCIºÍSCI-E¡£Web of ScientificµÄÍøÕ¾Îªhttp://scientific.thomson.com/products/wos/¡£ ~)( )PO  
2.Ñ¡¿¯¹ý³Ì  f(9w FT  
£¨1£©Ñ¡¿¯ TsR20P@  
ISIÿÖÜ´ÓÊý¾Ý¿âÖÐÔö¼Ó»òɾ³ýÆÚ¿¯£¬Ã¿ÄêISI±à¼­²¿ÆÀÉó½ü2000ÖÖÐÂÆÚ¿¯¡£±»ÆÀÉóµÄÆÚ¿¯Ö»ÓÐ10%----12%±»Ñ¡Óã¬ÍË»ØÂÊ´ï88%¡£´ËÍ⣬ÿÄêÉÐÓÐ150--200ÖÖÒѽøÈëµÄÆÚ¿¯±»ÖÐ;ÌÔÌ­£¬ISIÊý¾Ý¿âµÄÏÖÓÐÆÚ¿¯Ò²ÔÚ²»¶Ïɸѡ¸üС£ J,E&Uz95%  
¼ÆÁ¿Ö¸±ê¸ù¾ÝÖÊÁ¿ÓëÊýÁ¿ÅÅÁУ¬·Ö±ð°üÀ¨ÆÚ¿¯µÄ¸²¸ÇÂÊ¡¢ÆÚ¿¯µÄ»ù±¾³ö°æ±ê×¼¡¢Ñ§ÊõÄÚÈÝ¡¢ÆÚ¿¯×÷ÕߵĹú¼Ê»¯³Ì¶ÈÒÔ¼°Éæ¼°µÄÒýÎÄÊý¾Ý¡£ C@KYg/nYw  
£¨2£©ÌÔÌ­ &qo'ge8p  
ISI¶Ôÿһѧ¿ÆµÄÆÀÉóÁ½Äê½øÐÐÒ»´Î¡£ISI»áÁªÂç³ö°æÈ˼ì²éÆÚ¿¯µÄ³ö°æÇé¿ö¡£Ä³Ð©ÆÚ¿¯µÄ¶ÁÕßȺ»áÒòΪ³ö°æÊ±¼ä²»¼°Ê±¶ø²»ÔÙÒýÓøÿ¯£¬Ê¹Ó°ÏìÒò×Ó½µµÍ¡£±»ÌÔÌ­ÆÚ¿¯ÉêÇ븴ÒéÒ»°ãÔÚÆÀÉóºó12----18Öܺ󱻿¼ÂÇ£¬´Ó±»ÌÔÌ­ÆÚ¿¯ÖÐÖØÐÂɸѡ³öSCIÆÚ¿¯»¹ÐèÒª3Äêʱ¼ä¡£ NMOTWA }2  
£¨3£©ÒýÎÄ·ÖÎö @GGyiK@  
ISIʹÓõļ¸ÖÖÒýÎÄ×ÊÁÏ£¬°üÀ¨ÒýÎÄÂÊ¡¢Ó°ÏìÒò×Ó¡¢¼°Ê±Ö¸±ê¡£¶ÔÐÂÆÚ¿¯ISIÒª¼ìË÷ÆÚ¿¯×÷ÕßÓë±àί»á³ÉÔ±µÄ³ö°æ¼Ç¼¡£ISIÕªÒýµÄÎÄÏ×À´×Ô8000ÖÖºËÐÄÆÚ¿¯£¬×î¾ßÓдú±íÐÔ¡£ Phx/9Kk  
£¨4£©ÏÖ¿¯Ä¿Â¼ tl#hCy  
¸ÃÊý¾Ý¿âÆÀÑ¡±ê×¼ÓëÒýÎÄË÷ÒýÏàËÆ£¬ÒýÎÄÁ¿±ÈSCIÉÙ£¬µ«Æä¸²¸ÇÂÊÏ൱¿É¹Û¡£ bG\1<:6B  
£¨5£©µç×Ó°æÆÚ¿¯ "i#!   
1994Äê7ÔÂISIÑ¡ÓÃÁ˵ÚÒ»·Ýµç×ÓÆÚ¿¯£¨The Online Journal of Knowledge Synthesis for Nursing£©¡£1998Äê4ÔÂISIÑ¡ÓÃÁË17ÖÖµç×ÓÆÚ¿¯×÷ΪÆÚ¿¯Ô´¡£´«Í³ÆÚ¿¯ÖÐÊ®·ÖÖØÒªµÄÐÅÏ¢£¬ÈçѧÊõÄÚÈÝ¡¢±àÅŸñʽ¡¢»ù½ð×ÊÖú¡¢Éó¸å»úÖÆ¡¢±à¼­²¿Óë×÷ÕßµÄÏêϸÐÅÏ¢¡¢¹ú¼Ê»¯Ç÷ÊÆµÈ£¬ÔÚµç×ÓÆÚ¿¯ÖÐͬÑùÖØÒª¡£ F@?QVdY1q7  
3.ÈçºÎÍÆ¼öÆÚ¿¯ÆÀÉó½ü ,E/vHI8  
ISI¾­³£½øÐÐÓû§µ÷²éºÍÊг¡Ñо¿¡£Èç¹ûÒª¸øISIÍÆ¼öÆÚ¿¯×öÆÀÑ¡£¬¿ÉÒÔÓëEditorial Development DepartmentÁªÏµ£¨Fax£º215--386--6362¡£E-mail£ºJournals@isinet.com£©£¬²¢ÌṩÆÚ¿¯µÄÈ«³Æ¡¢ISSNºÅÂë¡¢Ö÷±àµÄÐÕÃû¡¢µØÖ·ºÍÆÚ¿¯µÄ³ö°æÕß¡£Èç¹û¿ÉÄÜ£¬½«×îÐÂÒ»ÆÚÆÚ¿¯¼ÄÈ¥£¬ËæºóµÄµÚ2°æ¡¢µÚ3°æÒ»µ©³ö°æÒ²ÂíÉϼÄÈ¥¡£Í¬Ê±¸½Ò»·Ý¶ÌÐÅ£¬ËµÃ÷Õâ¸öÆÚ¿¯µÄ¶ÀÌØÖ®´¦ÒÔ¼°ÓëÆäËûÆÚ¿¯µÄ²»Í¬Ö®´¦¡£½«Æä¿¯Ñù±¾¼ÄÖÁ£º o2%"Luf<  
Publication Processing Department W[YcYa_tQ  
Institute for Scientific Information I</Nmgf  
3501 Market Street {\ .2h  
Philadelphia,PA 19104 4u:{PN  
USA ay4|N!ExO  
4.SSCI¼ò½é C?b Mj[$  
SSCIÊÇSocial Scientific Citation Index<<Éç»á¿ÆÑ§ÒýÎÄË÷Òý>>µÄËõд¡£SSCI´´¿¯ÓÚ1956Ä꣬ÊÇISI´Ó50¶à¸öÁìÓòµÄ3300¶à¸öÖØÒªµÄ¹ú¼ÊÆÚ¿¯ÖУ¬Í¨¹ý¼ÆËã¼°¼ìË÷ÎÄÕÂÖ÷ÌâºÍÒýÎĺó½¨Á¢ÆðµÄ×ÛºÏÐÔÉç¿ÆÎÄÏ×Êý¾Ý¿â£¬ÄÚÈÝÉæ¼°¾­¼Ã¡¢·¨ÂÉ¡¢¹ÜÀí¡¢ÐÄÀíѧ¡¢ÇøÓòÑо¿¡¢Éç»áѧ¡¢ÐÅÏ¢¿ÆÑ§µÈ50¸öÁìÓò¡£ÊÕ¼ÎÄÏ×ÀàÐͰüÀ¨Ñо¿ÂÛÎÄ¡¢ÊéÆÀ¡¢×¨ÌâÌÖÂÛ¡¢ÉçÂÛ¡¢ÈËÎï×Ô´«ºÍÊéÐŵȡ£µ±È»£¬SSCIµÄÊÕ¼ÆÚ¿¯ÓÐÒ»²¿·ÖÄÚÈÝÓëSCIÖØ¸´¡£2005ÄêµÄSSCIÏÂÔØÍøÖ·Îªhttp://scientific.thomson.com/media/pdfs/sourcepub--journals/wos_ssci_a5022_final.pdf¡£ÄϾ©´óѧÒѾ­½¨Á¢¡°ÖÐÎÄÉç»á¿ÆÑ§ÒýÎÄË÷Òý¡±£¨CSSCI£©£¬µÇÂ½ÍøÖ·http:www.cssci.com.cn²éѯ¡£ {x-g?HB  
5.ISTP¼ò½é K)^.96{/@  
ISTPÊÇIndex to Scientific and Technical Proceedings<<¿ÆÑ§»áÒé¼Ë÷Òý>>µÄËõд£¬´´¿¯ÓÚ1978Äê¡£¸ÃË÷ÒýÊÕ¼ÁËÉúÃü¿ÆÑ§¡¢ÎïÀíÓ뻯ѧ¿ÆÑ§¡¢Å©Òµ¡¢ÉúÎïºÍ»·¾³¿ÆÑ§¡¢¹¤³Ì¼¼ÊõÓ¦ÓÃÓëÓ¦ÓÿÆÑ§µÈѧ¿ÆµÄ»áÒéÎÄÏס£°üÀ¨Ò»°ãÐÔ»áÒé¡¢×ù̸»á¡¢Ñо¿»á¡¢ÌÖÂۻᡢ·¢±í»áµÈµÄ»áÒéÎÄÏס£ÏêÇé²éÑ¯ÍøÖ·http://scientific.thomson.com/products/istp¡£ FS H6C2  
6.ISR¼ò½é sba0Q[IY  
ISRÊÇIndex to Scientific Reviews<<¿ÆÑ§ÆÀÂÛË÷Òý>>µÄËõд£¬´´¿¯ÓÚ1974Äê¡£ÊÕ¼ÊÀ½ç¼°¸÷¹ú2700ÓàÖֿƼ¼ÆÚ¿¯¼°300ÓàÖÖ׍ָ¡¢´Ô¿¯ÖÐÓмÛÖµµÄÆÀÊöÂÛÎÄ¡£ÏêÇé¿É¼ûÍøÕ¾ i++ F&r[  
d[ {=/~0  
http://scientific.thomson.com/products/isr¡£ tMupX-V  
7.ÆäËû KxiZ x I  
PCIÊÇPatent Citation Index<<רÀûÒýÓÃË÷Òý>>µÄËõд£¬ÊÕ¼·¢Ã÷רÀû¡£ÏêÇé¿É¼ûÍøÖ·£ºhttp://scientific.thomson.com/products/pci¡£ t6LTGWs/_o  
<<ÒÕÊõÓëÈËÎÄÒýÎÄË÷Òý>>£¨Arts and Humanities Citation Index,A and HCI£©ÊÕ¼ÓëÒÕÊõ¡¢ÈËÎÄѧ¿ÆÓÐ¹ØµÄÆÚ¿¯Ä¿Â¼¡£ÏêÇé¿É¼û£º c?wFEADn  
~lQ]PKJ"  
http://scientific.thomson.com/products/ahci¡£

kaobook 2011-08-17 22:27
µÚ¶þÕ SCIÆÚ¿¯Ó°ÏìÒò×Ó g l00$}C  
l--xq^,`o]  
SCIÆÚ¿¯Ó°ÏìÒò×Ó Bxz{rR0XV  
SCIÆÚ¿¯Ó°ÏìÒò×Ó£¨impact factor, IF£©ÊÇÖ¸ÎÄÕÂÔÚÌØ¶¨Äê·Ý»òʱÆÚ±»ÒýÓÃµÄÆµÂÊ£¬ÊǺâÁ¿Ò»¸öѧÊõÆÚ¿¯Ó°ÏìÁ¦µÄÖØÒªÖ¸±êºÍѧÊõ¿¯ÎïµØÎ»µÄÖ÷ÒªÒòËØ£¬ÓÉEugene Garfield ÔÚ20ÊÀ¼Í60Äê´ú´´Á¢£¬ËüµÄ½¨Á¢ÊÇÔÚSCI»ù´¡ÉϵÄÒ»ÖÖͳ¼Æ½á¹û¡£Ä¿Ç°Ëù˵µÄÓ°ÏìÒò×ÓÊÇ´Ó1975Ä꿪ʼ¡£ {hVSVx8ZL  
Ó°ÏìÒò×Ó=£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄÔÚͳ¼Æµ±Äê±»ÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸Ã¿¯Ç°Á½Äê·¢±íÂÛÎÄ×ÜÊý£© ])0&el3-  
ʾÀý1. b abDLaC@  
2007ÄêÓ°ÏìÒò×Ó¼ÆËã p5>TL!4M  
Ó°ÏìÒò×Ó£¨2007£©=A¡ÂB ;Mw9}Reh@  
ÆäÖУ¬AΪ¸ÃÆÚ¿¯2005-2006ÄêÂÛÎÄÔÚ2007Äê±»ÒýÓõÄ×Ü´ÎÊý£»BΪ¸ÃÆÚ¿¯2005-2006ÄêËùÓÐÂÛÎÄ×ÜÊý¡£ 6lsU/`.  
ÀýÈ磬2007ÄêNature GeneticsµÄÓ°ÏìÒò×Ó¼ÆËã·½·¨ÈçÏ£º O^|,Cbon6  
2005Äê³ö°æµÄÎÄÏ×ÔÚ2006Äê±»ÒýÓõĴÎÊý=5789£¨´Î£© Mm|HA@W^  
2006Äê³ö°æµÄÎÄÏ×ÔÚ2007Äê±»ÒýÓõĴÎÊý=4193£¨´Î£© ^#XxqVdPk  
2005Äê³ö°æµÄÎÄÏ×Êý=203£¨Æª£© mqwN<:  
2006Äê³ö°æµÄÎÄÏ×Êý=210£¨Æª£© ,O $F`0>9A  
¸Ã¿¯2007ÄêµÄÓ°ÏìÒò×Ó=£¨5789+4193£©¡Â£¨203+210£©=24.17£¨´Î/ƪ£©¡£ G;wv.|\  
Òò´Ë£¬2007ÄêNature GeneticsµÄÓ°ÏìÒò×ÓÊÇ24.17¡£±íÃ÷¸ÃÆÚ¿¯ÔÚ¹ýÈ¥Á½Äê·¢±íµÄÂÛÎÄÔÚ2007ÄêÆ½¾ùÊÕµ½24ÌõÒýÎÄ¡£ Hq6VwQu?  
2.ÆäËû³£ÓÃµÄÆÚ¿¯ÆÀ¹ÀÖ¸±ê ^:LF  
£¨1£©¼°Ê±Ö¸Êý£¨immediacy index£©ÊǼÆËãijһÆÚ¿¯ÂÛÎĵÄÂÛÎÄÔÚ¸ÃÄê¶È±»ÒýÓõÄËÙ¶È¡£ B% BO  
¼°Ê±Ö¸Êý¼ÆËãµÄ·½·¨£º nvgo6*  
¼°Ê±Ö¸Êý=£¨¸ÃÆÚ¿¯ÎÄÏ×±»µ±ÄêÒýÓõÄ×Ü´ÎÊý£©¡Â£¨¸ÃÆÚ¿¯µ±ÄêÎÄÏ××ÜÊý£© $kkdB,y  
ʾÀý < _c84,[V  
2005Ä꼰ʱָÊý¼ÆËã @q[-,EA9  
¼°Ê±Ö¸Êý£¨2005Ä꣩=A¡ÂB j&[63XSe  
ÆäÖУ¬AΪ2005Äê³ö°æµÄÎÄÏ×ÔÚ2005Äê±»ÒýÓõĴÎÊý£»BΪ2005Äê³ö°æµÄÎÄÏ×Êý¡£ u;1#eP\;  
£¨2£©±»ÒýÓðëË¥ÆÚ£¨cited halflife£©ÊǼÆËãijһÆÚ¿¯ËùµÇµÄÂÛÎÄÆ½¾ù¾­¹ý¶à³¤Ê±¼ä£¬ÈÔÈ»»¹»á±»ÒýÓ᣼ÆËãµÄ·½·¨ÊÇ´Óµ±ÄêÍùǰÀۼƣ¬µ±Äê±»ÒýÓõÄÂÛÎÄÆªÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄ±»ÒýÓðëË¥ÆÚ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±»ÒýÓÃ×÷Ϊ²Î¿¼ÎÄÏ×µÄʱЧÐÔÔ½¸ß¡£ g oWD~'\  
£¨3£©ÒýÓðëË¥ÆÚ£¨citing halflife£©ÊǼÆËãijһÆÚ¿¯Æ½¾ùÒýÓöà¾ÃÒÔǰµÄÂÛÎÄ¡£¼ÆËã·½·¨ÊÇ´Óµ±ÄêÍùǰÀۼƣ¬µ±ÒýÓõÄÂÛÎÄÆªÊý´ïµ½È«²¿µÄ50%ʱ£¬¸ÃƪÂÛÎĵijö°æÄêµ½µ±ÄêµÄ¼ä¸ôÄêÊý¼´Îª´ËÆÚ¿¯µÄÒýÓðëË¥ÆÚ¡£Èô10ÄêÄÚÒýÓôÎÊýδ´ïµ½50%£¬ÆäÒýÓðëË¥ÆÚÖµÒÔ£¾10.0À´±íʾ¡£µ«¸ÃÆÚ¿¯±ØÐëÒýÓÃÆäËûÂÛÎÄ×ÜÊýÁ¿´ïµ½100´ÎÒÔÉϲÅÁÐÈ룬·ñÔòÔòÒÔ¿Õ°×±íʾ¡£°ëË¥ÆÚµÄÖµÔ½µÍ£¬±íÃ÷¸ÃÆÚ¿¯ËùÒýÓõIJο¼ÎÄÏ×ʵЧÐÔÔ½¸ß¡£ )QFT$rmX  
ͨ¹ýJCR£¨Journal Citation Reports£¬ÆÚ¿¯ÒýÓñ¨µÀ£©¿ÉÒÔµÃÖª£º OjyS ?YY)b  
ÄÄЩÊÇ×îÓÐÓ°ÏìÁ¦µÄÆÚ¿¯¡£ Z/:( *FC  
ÄÄЩÊÇ×î³£ÓÃµÄÆÚ¿¯¡£ 3l<)|!f]g  
ÄÄЩÊÇ×îÈÈÃÅµÄÆÚ¿¯¡£ g 9>p?XY  
ÄÇЩÆÚ¿¯³ö°æÁ¿×î´ó¡£ 2|w(d  
ÄÇЩÆÚ¿¯×î³£±»ÒýÓᣠAY,6Ddw  
ÄÇЩÆÚ¿¯µÄÓ°ÏìÒò×Ӹ߻òµÍ¡£ N~Ax78TX  
ÄÇЩÆÚ¿¯µÄ¡°Á¢¼´ÒýÓÃÂÊ¡±×î¸ß¡£ JnV$)EYi  
ÄÄЩÆÚ¿¯ÒýÓü°±»ÒýÓõÄÇé¿ö¡£ SS(jjpe&,  
ÊÕ¼ÆÚ¿¯µÄÏêϸ³ö°æÐÅÏ¢¡£ K xh)'aal  
3.ÆÚ¿¯Ó°ÏìÒò×ӵIJéÕÒ ,Sghi&Ky  
·½·¨Ò»£ºµã»÷Á´½Ó£ºhttp://isi3.isiknowledge.comºóÔÙµã»÷Journal Citation Reports£¬½øÈëJCRÊý¾Ý¿â£¬¼´¿É²éÕÒµ±ÄêÆÚ¿¯µÄÓ°ÏìÒò×ÓµÈÖ¸±ê¡£È±µãÊÇÐèÒª¶©¹º²ÅÄܽøÈëJCRÊý¾Ý¿â¡£ y)Ip\.KV\  
·½·¨¶þ£º´ò¿ªÓ¢ÎÄÍøÖ·http://www.google.com,ÊäÈëimpact factor,»òÕß´ò¿ªÖÐÎÄÁ´½ÓÍøÖ·http://www.google.com.cn£¬ÊäÈëÆÚ¿¯Ó°ÏìÒò×Ó¡£È±µãÊDz»Äܼ°Ê±²éµ½×îÐÂÐÅÏ¢£¬°üÀ¨ÆÚ¿¯Ó°ÏìÒò×Ó¡£ S#2 'Jw  
2005Äê£Ó£Ã£ÉÊÕ¼ÆÚ¿¯Ó°ÏìÒò×Ó£º£¯£¯£º£÷£÷£÷£®£ì£é£â£®£å£ã£î£õ£®£å£ä£õ£®£ã£î£¯£ó£ã£é£ê£ï£õ£ò£î£á£ì£²£°£°£µ£®£ø£ì£ó izmL8U ?t  
200£³ÄêÖйúÆÚ¿¯Ó°ÏìÒò×Ó£º C @hnT<e  
www.lib.ecnu.edu.cn/sci/jcr.doc .Uha%~%  
4.ÆÚ¿¯Ó°ÏìÒò×ÓµÄÓ¦ÓüÛÖµ ag[yM  
Ö÷Òª°üÀ¨ÒÔÏÂÄÚÈÝ£º h, +2Mc<  
¡òͼÊé¹ÝÈËÔ± g7_ a8_  
kf&id/|  
¶¨ÆÚ¿¯Òý½øÕþ²ß£¬Ïò¶ÁÕßÍÆ¼öÓÅÐãÆÚ¿¯¡£ 1B,RRHXn6  
¿ª·¢ºÍ¹ÜÀíÆÚ¿¯¹Ý²Ø£¬Ð­Öú×ö³ö¿¯´æµµ¾ö¶¨¡£ ~)sb\o  
¡ò±à¼­ O#cXvv]Z*  
¡îÁ˽âºÍÕÆÎÕ×Ô¼ºÕÆÎÕµÄÆÚ¿¯Çé¿ö£¬Öƶ¨ÓÐЧµÄµÄ±à¼­¹æ»®ºÍÄ¿±ê¡£ VUagZ 7 p  
¡ò³ö°æÉÌ w}oH]jVKL6  
¡î²â¶¨ÆÚ¿¯µÄÊг¡Ó°ÏìÁ¦¡£ DV{Qbe#In  
¡òÂÛÎÄ×÷Õß -%%2Pz0I  
¡îѰÕÒºÍÈ·¶¨Óë×Ô¼º×¨ÒµÏà¹ØµÄÆÚ¿¯¡£ /of,4aaK7  
¡îѰÕÒ×îÇ¡µ±×îÓÐÓ°ÏìÁ¦µÄµÄÆÚ¿¯·¢±íÆäÎÄÕ¡£ jO!!. w  
¡îÈ·ÈÏÆÚ¿¯µÄѧÊõµØÎ»¡£ 1fEV^5I  
¡òÐÅÏ¢Ñо¿·ÖÎöÈËÔ± y Bs  
¡î¸ú×ÙÎÄÏ×¼ÆÁ¿Ñ§µÄ·¢Õ¹Ç÷ÊÆ¡£ {jggiMwo.v  
¡îѧϰÑо¿ÒýÎÄģʽ¡£ k@KX=mG<  
¡îÑо¿×¨ÒµÑ§¿ÆµÄ·¢Õ¹±ä»¯Ç÷ÊÆ¡£ sE-"TNONZ  
5.ÆÚ¿¯Ó°ÏìÒò×ӵľÖÏÞÐÔ p A1Tod  
£¨1£©ÓÉÓÚѧ¿ÆµÄ²îÒìµ¼ÖÂÁËÆÚ¿¯Ó°ÏìÒò×ӵĴóСÏà²îÊýÊ®±¶¡£Ä³Ò»Ñ§¿ÆÆÚ¿¯µÄ×ÜÌåˮƽֻÄÜÕë¶Ô×ÔÉíµÄѧ¿ÆÁìÓò£¬ÒòΪÎÞÂÛÓ°ÏìÒò×Ó»¹ÊÇ×ÜÒýÓÃÊýÔÚѧ¿ÆÖ®¼ä¶¼Ã»ÓпɱÈÐÔ¡£ =GFlaGD  
£¨2£©Ó°ÏìÒò×ÓÊÇÒ»ÖÖͳ¼ÆÑ§ÉϵĸÅÄÊÇ´óÁ¿ÂÛÎIJúÉúµÄ½á¹û¡£Òò´Ë£¬Ó°ÏìÒò×ÓÓÃÓÚÆÀ¼ÛÆÚ¿¯µÄÕûÌåˮƽÊÇ¿ÉÐеġ£ F0Rk[GM  
£¨3£©ÆÚ¿¯µÄ·¢Ðмä¸ô¡¢Ã¿ÆÚÊÕ¼µÄÂÛÎÄÆªÊý¸÷Óв»Í¬¡£Ã¿ÆÚÊÕ¼ÂÛÎĽ϶àµÄÆÚ¿¯¿ÉÄÜÒòΪ½ÏÈÝÒ×»ñµÃÒýÓôÎÊý£¬¶øÔÚͳ¼Æ×ÜÒýÓôÎÊýÉϾßÓÐÓÅÊÆ¡£ khW3z*e#  
£¨4£©Â©ÒýºÍÎÄÏ××÷ÕßÒýÓõIJ»¹æ·¶£¬ÖîÈ硰תÒý¡±£¨¶Ô×Ô¼ºÃ»ÓÐÇ××Ô²éÔ½¹ýµÄÎÄÏ×´Ó±ðÈËÂÛÎĵÄÒýÎÄÖмÓÒÔÒýÓã©£»¡°³çÒý¡±£¨Îª×°µãÃÅÃæ£¬Ã¤Ä¿°áÓá°È¨ÍþÃûÖø¡±£¬»ò¹ÊÒâʹÓÃһЩʱ÷ÖµÄÊõÓïÃû´Ê£©£»²»Ç¡µ±µÄ¡°×ÔÒý¡±£¨×÷ÕßÒýÓÃ×Ô¼ºµÄÎÄÏ×±íÃ÷Ñо¿¹¤×÷µÄÁ¬ÐøÐÔ£¬µ«ÓеÄ×÷ÕßÒýÓÃ×Ô¼ºÒѾ­·¢±íµÄÓëÖøÎÄÖ÷Ìâ¹ØÁª²»´ó»òºÁ²»Ïà¹ØµÄÎÄÕ£¬ÒÔÀ©´ó×Ô¼ºµÄѧÊõÓ°Ï죩¡£ UO>p-M  
Òò´Ë£¬ËäÈ»ÆÚ¿¯µÄÓ°ÏìÒò×ÓÊÇÆÚ¿¯ÆÀ¹À·Ç³£ÓÐÓõŤ¾ß£¬µ«ÓÐÒ»¶¨µÄ¾ÖÏÞÐÔ£¬±ØÐëÕýÈ·¶Ô´ý¡£ H }</a%y  
6.ÈçºÎ²é¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý£¬ÒÔ¼°¶¼±»ÄÇЩÂÛÎÄÒýÓà 6M259*ME  
·½·¨Ò»£ºÔÚSCIÎÄÏ×¼ìË÷½çÃæhttp:/www.isiknowledge.com£¬µã»÷×ó²à¡¾web of science¡¿,½øÈëÂÛÎļìË÷½çÃæ¡£ÒÔÒ³ÃæÖС¾general search¡¿ÎªÀý£¬Í¨¹ý±êÌâ×÷ÕßÄê·Ý×÷Õßµ¥Î»µÄ²éѯ»òÕß×éºÏ²éѯ¡£ 0&c12W|B<L  
·½·¨¶þ£º´ò¿ªhttp://scholar.google.com,ÍøÒ³£¬ÊäÈëÎÄÏ×µÄÌâÄ¿»ò×÷Õߣ¬È»ºóµã»÷¡¾ËÑË÷¡¿¿ÉÒÔ¿´Ä³ÆªÎÄÏ×±»ÒýÓõĴÎÊý¡£µã»÷¡¾±»ÒýÓôÎÊý¡¿¿ÉÒÔ¿´µ½¸ÃÎÄÏ×±»ÄÇЩÂÛÎÄÒýÓá£

kaobook 2011-08-17 22:28
µÚÈýÕ SCIÂÛÎĵĻù±¾ÒªÇó qL UbRp  
1.¿Æ¼¼ÂÛÎĵ͍Òå :a[L-lr`e  
ÃÀ¹úÉúÎïѧ±à¼­Ð­»á°Ñ¿Æ¼¼ÂÛÎ͍ÒåΪ£ºÒ»ÆªÄܱ»½ÓÊܵÄԭʼ¿ÆÑ§³ö°æÎï±ØÐëÊÇÊ×´ÎÅû¶£¬²¢Ìṩ×ã¹»µÄ×ÊÁÏ£¬ÊÇͬÐÐÄܹ»£º¢ÙÆÀ¶¨Ëù¹Û²ìµ½µÄ×ÊÁϵļÛÖµ£»¢ÚÖØ¸´ÊµÑé½á¹û£»¢ÛÆÀ¼ÛÕû¸öÑо¿¹ý³ÌµÄѧÊõ¡£´ËÍ⣬Ëü±ØÐëÊÇÒ×ÓÚÈËÃǵĸйٽÓÊÜ¡¢±¾ÖÊÉϳ־ᢲ»¼ÓÏÞÖÆµØÎª¿ÆÑ§½çËùʹÓ㬲¢ÇÒÄÜΪһÖÖ»ò¶àÖÖ¹«ÈϵĶþ¼¶Ç鱨ԴËùÑ¡Óá£Öйú¹ú¼Ò±ê×¼GB7713-87ËùÖ¸µÄѧÊõÂÛÎÄÊÇ£º¡°Ä³Ò»Ñ§Êõ¿ÎÌâÔÚʵÑéÐÔ¡¢ÀíÂÛÐÔ»ò¹Û²âÐÔÉϾßÓÐеĿÆÑ§Ñо¿³É¹û»ò´´Ð¼û½âºÍ֪ʶµÄ¿ÆÑ§¼Ç¼£¬»òÊÇijÖÖÒÑÖªÔ­ÀíÓ¦ÓÃÓÚʵ¼ÊÖÐÈ¡µÃ×îнøÕ¹µÄ¿ÆÑ§×ܽᡱ¡£ $iupzVrro  
2.SCIÂÛÎĵÄÌØµã yA \C3r'  
¡òѧÊõÐÔ ^)D[ W(*  
SCIÂÛÎIJ»Í¬Óڽ̲ģ¬Ò²²»Í¬ÓÚ¶ÁÊé±Ê¼Ç£¬ËüÊÇÒ»ÖÖѧÊõÐÔµÄÎÄÕ¡£ËùνѧÊõÊÇָϵͳºÍרÃŵÄѧÎÊ£¬ÊÇÓнÏÉîºñµÄʵ¼ù»ù´¡ºÍÒ»¶¨ÀíÂÛÌåϵµÄ֪ʶ¡£¿Æ¼¼ÂÛÎĵÄѧÊõÐÔÊÇָһƬ¿Æ¼¼ÂÛÎÄÓ¦¾ß±¸Ò»¶¨µÄѧÊõ¼ÛÖµ£¨ÀíÂÛ¼ÛÖµ£©¡£ÔËÓÿÆÑ§µÄÔ­ÀíºÍ·½·¨£¬Í¨¹ý˼¿¼·ÖÎö»òʵÑ飬×÷³öÅжϣ¬×îºóµÃ³öеļû½â»ò½áÂÛ¡£ÕâÖÖеļû½â»ò½áÂÛ£¬¿ÉÒÔÊÇÍÆ·­¾ÉµÄÀíÂÛ£¬Ò²¿ÉÒÔÊÇÓÃеĹ۵㽫һЩ·ÖÉ¢µÄ²ÄÁÏϵͳ¹á´©ÆðÀ´£¬¾­¹ýÌáÁ¶¼Ó¹¤£¬´ÓÀíÂÛÉϽøÐзûºÏÂß¼­µÄÂÛÖ¤Óë·ÖÎö»ò×÷³ö˵Ã÷¡£Òò´Ë£¬Ñ§ÊõÐÔÊǿƼ¼ÂÛÎĵÄÌØÕ÷¡£ ixE72bX  
¡ò´´ÔìÐÔ£¨Ô­´´ÐÔÓë´´ÐÂÐÔ£© AEe*A+  
SCIÂÛÎÄÊǶԿÆÑй¤×÷µÄÎÄ×ÖÐÔ×ܽᣬǿµ÷Ô­´´ÐÔÓë´´ÐÂÐÔ¡£Ô­´´ÐÔ²»µÈͬÓë´´ÐÂÐÔ£¬´´ÐÂÐÔ¿ÉÒÔÊDZðÈËÑо¿µÄÑÓÐø£¬¶øÔ­´´ÐÔÒâζ×ÅÒ»¸öÐÂÊÂÎï¡¢ÐÂÁìÓò¡¢ÐÂÎÊÌâµÄ¿ª´´¡£¿ÆÑ§Ñо¿µÄÄ¿µÄÔÚÓÚ´´Ô죬Òò´ËºâÁ¿SCIÂÛÎļÛÖµµÄ¸ù±¾±ê×¼¾ÍÔÚÓÚËûµÄ´´ÔìÐÔ¡£ i|)<#Ywl  
¡ò¹æ·¶ÐÔ (7;}F~?h  
SCIÂÛÎıØÐë°´Ò»¶¨µÄ¸ñʽºÍÒªÇó½øÐй淶Êéд¡£ÀýÈ磬SCIÂÛÎĵIJο¼ÎÄÏ×ÖøÂ¼Ó¦¹æ·¶£¬ÎÄ×Ö±í´ïÓ¦¹æ·¶£¬ÓïÑԺͼ¼Êõϸ½ÚÓ¦²ÉÓùú¼Ê·¨¶¨µÄÃû´ÊÊõÓï¡¢Êý×Ö¡¢·ûºÅ¡¢¼ÆÁ¿µ¥Î»µÈ¡£SCIÂÛÎÄÒªÇó׼ȷ¡¢¼ò½à¡¢Í¨Ë³¡¢ÌõÀíÇå³þ¡£ ]fnc.^{  
¡ò¿ÆÑ§ÐÔºÍ׼ȷÐÔ nO,<`}pV  
¿ÆÑ§ÐÔÊÇÖ¸SCIÂÛÎÄͬһ°ãÂÛÎÄÒÔ¼°Ò»ÇзǿƼ¼ÎÄÌåµÄ»ù±¾Çø±ð¡£¿ÆÑ§ÐÔÖ÷Òª°üÀ¨Á½·½Ã棺һ·½ÃæÊÇÖ¸ÂÛÎĵÄÄÚÈÝÊÇ¿ÆÑ§¼¼ÊõÑо¿µÄ³É¹û£»ÁíÒ»·½ÃæÊÇÖ¸ÂÛÎĵıí´ïÐÎʽ½á¹¹ÑϽ÷£¬Ë¼Î¬·ûºÏÂß¼­¹æÂÉ£¬²ÄÁÏÕæÊµ£¬·½·¨×¼È·¿É¿¿£¬¹Ûµã׼ȷÎÞÎó¡£×¼È·ÐÔÖ÷ÒªÊÇÖ¸SCIÂÛÎĵÄʵÑé¹ý³Ì¡¢ÊµÑé½á¹û¾ßÓпÉÖØ¸´ÐÔ¡£ 7rbl+:y2  
3.SCIÂÛÎĵĻù±¾ÒªÇó ~OAST  
¡òÏȽøÐÔ ÏȽøÐÔÖ÷ÒªÌåÏÖÔÚ %q`_vtUT  
¨SÀíÂÛ·½ÃæµÄ´´Ð¼û½â£¬ÈçijЩÀíÂÛ·½ÃæµÄ¶ÀÌØ¼û½âºÍÕâЩ¼û½âµÄÒÀ¾Ý¡£ v<HhB.t.  
¨SÓ¦Ó÷½ÃæµÄ´´Ð¼û½âµÈ£¬Èçз¢Ã÷¡¢Ð¼¼Êõ¡¢Ð²úÆ·¡¢ÐÂÉ豸»ò½ÒʾԭÓм¼Êõ×ªÒÆµ½ÐµĿÆÑ§ÁìÓòÖеÄЧ¹û¡£ .FtW $Y~y  
¨SÑо¿·½·¨·½ÃæµÄ´´ÐÂÐÔ£¬ÈçÑо¿·½·¨·½ÃæµÄ´´Ð»òÍ»ÆÆ¡£ 8^CL:8lI^\  
ҪעÒâ¿ÆÑд´ÐÂÓ¦¸Ã½¨Á¢ÔÚ¹ú¼ÊÑо¿ÒÑ´ïˮƽºÍ³Ì¶ÈµÄ»ù´¡ÉÏ£¬Êǹú¼Ê´´Ð¶ø²»ÊǹúÄÚ´´Ð¡£·ñÔò£¬ºÜÄÑ·¢±í¸ßˮƽµÄSCIÂÛÎÄ¡£µ±È»Òª¼ÇסÁ¢ÌâʱµÄ×îв»µÈÓÚ½áÌâʱµÄ×îС£ {I&>`?7.  
¡ò¿ÉÐÐÐÔ cX 9 !a,  
ËùνѡÌâµÄ¿ÉÐÐÐÔ£¬ÊÇÖ¸Äܹ»³ä·Ö·¢»Ó×÷ÕßµÄ×ÛºÏÌõ¼þ£¬¿ÉÒÔʤÈβ¢ÄÜÈçÆÚÍê³É¿ÆÑ§ÂÛÎĵİÑÎճ̶ȡ£Ó°ÏìÑ¡ÌâµÄ¿ÉÐÐÐÔÒòËØ°üÀ¨£º pGc_Klq  
¨S¿ÆÑ§Ô­ÀíÉÏÊÇ¿ÉÐе쬾ø²»ÄÜÎ¥·´¿ÆÑ§Ô­ÀíºÍ×ÔÈ»¹æÂÉ¡£ ?MHVkGD  
¨SÖ÷¹ÛÌõ¼þ£¬°üÀ¨×÷ÕßÖªÊ¶ËØÖʽṹ¡¢Ñо¿ÄÜÁ¦¡¢¼¼ÊõˮƽºÍÌØ³¤¡¢ÐËȤµÈ¡£ g0: mm,t\  
¨S¿Í¹ÛÌõ¼þ£¬°üÀ¨ÊµÑéÌõ¼þ¡¢¾­·Ñ×ÊÁÏ¡¢Ê±¼ä¡¢É豸µÈ¡£ yCwBZ/C  
¡òÖØÒªÐÔ 4nN%5c~=  
׫д¿ÆÑÐÂÛÎĵÄÄ¿µÄÊÇΪÁ˽»Á÷ºÍÓ¦Óá£Òò´Ë£¬Ò»°ãÀ´Ëµ£¬·¢±íÔÚScience¡¢NatureºÍCellµÈ¶¥¼âSCIÆÚ¿¯µÄ¿ÆÑ§ÂÛÎÄÓÚ·¢±íÔÚÆÕͨSCIÆÚ¿¯µÄѧÊõÂÛÎĵIJ»Í¬ÔÚÓÚǰÕß½â¾ö»òÕ߻شðÁËÒ»¸ö·Ç³£ÖØÒªµÄÎÊÌ⣬¸ÃÑо¿ÔÚ¿ÆÑ§ÁìÓòÖоßÓÐÉîÔ¶Ó°Ïì»òÕßÓÐÖØ´óµÄ¾­¼Ã¡¢Éç»áÐ§Òæ£¬¶øºóÕßÔò½â¾ö»Ø´ðÁËÒ»¸öÆÕͨµÄÎÊÌâ¡£Òò´Ë£¬¿ÆÑ§Ñо¿ºÍ¼¼ÊõÑо¿Ñ¡ÌâµÄÊ×ÒªÔ­ÔòÊÇ£¬ÎªÊ²Ã´ÒªÑо¿¡¢ÓÐʲôʵ¼Ê×÷Óá¢ÆäÀíÂÛºÍѧÊõ¼ÛÖµ¡¢ÀúÊ·ºÍÏÖʵµÄÒâÒåÓÖÊÇʲô¡£ mg;+Th &  
¡ò¿ÆÑ§ÐÔ }q^M  
ËùÑ¡µÄ¿ÎÌâ±ØÐëÊôÓÚ¿ÆÑ§µÄ·¶³ë£¬Êǿ͹۴æÔڵĶø²»ÊÇÐé¹¹µÄ¡£ÅжÏһƪÂÛÎÄÓÐÎÞ¼ÛÖµ»ò¼ÛÖµµÄ´óС£¬Ê×ÏÈÊÇ¿´ÎÄÕµĹ۵ãºÍÄÚÈݵĿÆÑ§ÐÔÈçºÎ¡£Æä´Î£¬ÎÄÕÂÊÇ·ñ¾ßÓпÆÑ§ÐÔ»¹È¡¾öÓë×÷ÕßµÄÀíÂÛ»ù´¡ºÍרҵ֪ʶ¡£Ð´×÷SCIÂÛÎÄÊÇÔÚǰÈ˳ɾ͵Ļù´¡ÉÏ£¬±ØÐëÓ¦ÓÃǰÈËÌá³öµÄ¿ÆÑ§ÀíÂÛȥ̽Ë÷еÄÎÊÌâ¡£Òò´Ë£¬±ØÐë׼ȷµØÀí½âºÍÕÆÎÕǰÈ˵ÄÀíÂÛ£¬¾ßÓй㲩¶ø¼áʵµÄ»ù´¡¡£Èç¹û¶ÔSCIËùÉæ¼°ÁìÓòÖеĿÆÑгɹûÒ»ÎÞËùÖª£¬¾ÍºÜÄÑд³öÓмÛÖµµÄSCIÂÛÎÄ¡£ A36dj  
4.Ñ¡ÌâµÄ»ù±¾·½·¨ NldeD2~H  
Ñ¡ÌâÒª´Óʵ¼Ê³ö·¢£¬Ñ¡ÔñÄÇЩÓмÛÖµ¡¢ÄÜ´Ù½ø¿ÆÑ§¼¼Êõ·¢Õ¹»òÐèÒªÆÈÇнâ¾öµÄÓÐÖØ´óÐ§ÒæµÄ¿ÎÌâ¡£¿ÆÑÐÂÛÎÄÊÇ·ñÄܹ»ÔÚSCIÆÚ¿¯·¢±í»òÄܹ»ÔÚʲôÑùµÄSCIÆÚ¿¯ÉÏ·¢±í£¬Ôںܴó³Ì¶ÈÉÏÈ¡¾öÓÚ¿ÎÌâµÄÖØÒªÐÔ¡£ m-xSF]q=<  
5.Ñ¡Ìâ·½Ïò \tc 4DS  
¡òÑ¡Ôñؽ´ý½â¾öµÄÖØÒªÎÊÌâ mJ2>#j;5f  
¡òÑ¡Ôñ´¦ÓÚÇ°ÑØÎ»ÖõĿÎÌ⣬Óë¹ú¼Ê½Ó¹ì s5_[[:c=^  
6.Ñо¿¿ÎÌâÑ¡ÔñµÄ;¾¶ <5%x3e"7u  
¡ò´Ó¿ÆÑ§ÎÄÏ××ÊÁÏÖÐÑ¡Ìâ K;a]+9C  
Ò»°ãÀ´Ëµ£¬SCIÆÚ¿¯Ó°ÏìÒò×ÓÔÚ3·ÖÒÔϵÄÎÄÕ¿ÉÄÜÖ»×öÁËÒ»²¿·Ö»úÀí£¨ÖÆ£©Ñо¿£¬¿Ï¶¨Óв»×ã»ò²»È«ÃæÖ®´¦¡£¹Ø¼üÊÇÄã×Ô¼ºÒªÈ¥Ë¼¿¼¡¢È¥·¢ÏÖ¡£°Ñ±ðÈ˵ÄÎÄÕÂÈÏÕæ¾«¶ÁÁË×ܻᷢÏÖ©¶´»ò²»×ãÖ®´¦¡£×¢Ò⣺ "g;^R/sfq  
¨SÏëÏë±ðÈËÕâÎÄÕÂÊÇÔõô×öµÄ¡£ Rf||(KC<  
¨SÃ÷°×ËûΪʲôҪÕâô×ö¡£ hsr,a{B%$  
¨S¸ÃÎÄÕ½â¾öÁËʲôÎÊÌ⣿Òý³öÁËʲôÎÊÌ⣿ Q x}\[  
¨S¿´±¾ÊµÑé½á¹û£¬ÔÚ˼¿¼ÓÐʲôµØ·½²»ÍêÉÆ£¿ÓÐûÓÐÉîÈë»òÍØÕ¹µ½µ×£¿ ~>2@55wElp  
¡òÔÚ¿ÆÑйý³ÌÖÐÑ¡Ìâ ~xZFm  
¡òÔÚʵ¼ùÓëм¼ÊõÓ¦ÓÃÖÐÑ¡Ìâ KSe `G;{  
7.Ñо¿¿ÎÌâÑ¡ÔñµÄÎóÇø `irz'/"p  
£¨1£©Ïë·¨£¨idea£©Ô½¶àÔ½ºÃ¡£ owM3Gz%?UA  
£¨2£©Ò»Î¶×·Çó¸ïÐÂÐԵġ¢Í»ÆÆÐԵijɹû¡£ Y3KKskhLx  
£¨3£©Êýѧ¡¢ÀíÂۺ͹«Ê¾Ô½¸´ÔÓÔ½ºÃ¡£ | # Z+s-  
£¨4£©×·ÇóÊ·ÎÞǰÀý¡£ dF$a52LS  
8.¿ÎÌâÉè¼Æ³£¼ûµÄ´íÎó \wwY?lOe  
£¨1£©Ñо¿µÄ¿ÎÌâûÓÐÑôÐÔºÍÒõÐÔ¶ÔÕÕ×é¡£ {>$i)B  
£¨2£©È±·¦Ëæ»ú×é¡£ COvcR.*0F  
£¨3£©Ñù±¾ÊýÁ¿Ì«Ð¡¡£ 0/z=G!z\  
£¨4£©È±·¦Ë«Ã¤µÄÑо¿¡£ /qM:;:N%j  
£¨5£©¹Û²âÖ¸±ê»òÑù±¾´íÎó¡£ ~IrrX,mp:  
£¨6£©´íÎóÎÊÌâ¡£ M+4>l\   
£¨7£©´íÎó·ÖÎöͳ¼Æ¡£ D_mdX9-~  
£¨8£©È±·¦Ò»¸ö¾ßÌå¼Ù˵£¬»ò¹ý·ÖÈÈÖÔÓÚÊý¾Ý²É¼¯¡£ <\40?*2  
£¨9£©È±·¦ÀíÂÛÒÀ¾Ý¡£ H&Jp,<\x  
£¨10£©Ã»ÓÐÒýÓùú¼ÊµÄ±ê×¼»òÖ¸±ê½øÐÐÆÀ¹À¡£ /=4 m4  
9. SCIÂÛÎĵĸñʽºÍÕûÌ幹˼ )%H@.;cD_r  
Ò»°ãSCIÂÛÎĵĸñʽΪ£º u By[x 0  
£¨1£©Title£¨±êÌ⣩¡£ 8NU<lV`  
£¨2£©Authors£¨×÷ÕßÐÕÃû£©ºÍAddress£¨¹¤×÷µ¥Î»Ãû³ÆµØÖ·£©¡£ 2UqLV^ZY  
£¨3£©Abstract£¨ÕªÒª£©¡£ B q/<kEgM  
£¨4£©Introduction£¨ÒýÑÔ£©¡£ !Q(xA,p  
£¨5£©Material and Metheds(²ÄÁϺͷ½·¨)¡£ a ;@G  
£¨6£©Results£¨½á¹û£©¡£ hdW}._  
£¨7£©Discussion£¨ÌÖÂÛ£©¡£ E d6k7  
£¨8£©Acknowledgements(ÖÂл)¡£ [H"\<"1 o  
£¨9£©References£¨²Î¿¼ÎÄÏ×£©¡£ 5MU-Eu|*>  
qkHdr2  
¸½£ºSCIÂÛÎĵĸñʽºÍд×÷Òªµã Js{X33^Ju  
SCIÂÛÎĵĸñʽ д×÷Òªµã [3KP@'52k  
Abstract£¨ÕªÒª£© What did I do in a nutshell?(¸ÅÂÔ) YS$42J_T  
Introduction£¨ÒýÑÔ£© What is the problem?(´æÔÚµÄÎÊÌâ) ]dvNUD   
Material and Metheds(²ÄÁϺͷ½·¨) How did I solve the problem?(ÎÒÔõô½â¾öÕâ¸öÎÊÌâ) <<#j?%  
Results£¨½á¹û£© What din I found out?(ÎÒ·¢ÏÖÁËʲô) YC,s]~[[   
Discussion£¨ÌÖÂÛ£© What does it mean?(Îҵķ¢ÏÖÒâζ×Åʲô) f&5'1tG  
Acknowledgements(ÖÂл) Who helped me out?(Ë­°ïÁËÎÒ) OH+kN /Fd  
References£¨²Î¿¼ÎÄÏ×£© Whose wok did I refer to?(ÎҲο¼ÁËÄÇЩÎÄÏ×) Wycood*  
Appendics(¸½Â¼) Extra information£¨¶îÍâÊý¾Ý»ò×ÊÁÏ£©¡£

kaobook 2011-08-17 22:28
µÚËÄÕ ÈçºÎÊéдSCIÂÛÎĵıêÌâ r0xmDJ@y  
1.SCIÂÛÎıêÌâµÄÖØÒªÐÔ m@A?'gD  
£¨1£©¾ÍÏñÎÒÃÇÆ½Ê±¿´±¨Ö½ÏÈ¿´±êÌâÒ»Ñù£¬Éó¸åÈËÒ»°ãÊ×ÏȲ鿴SCIÂÛÎĵıêÌâºÍ£¨»ò£©×÷Õß¡£Èç¹û¸ÐÐËȤ£¬ÔÙ¿´ÕªÒª¡£Èç¹û»¹ÓÐÐËȤ£¬ËûÃÇ¿´ÂÛÎÄÖеÄͼºÍ±í£¬È»ºóͨ¶ÁÈ«ÎÄ¡£Òò´Ë£¬SCIÂÛÎıêÌâµÄºÃ»µÖ±½ÓÓ°Ïìµ½¶ÔÂÛÎĵĵÚÒ»Ó¡Ïó¡£ cUB+fH<B2  
£¨2£©ÂÛÎıêÌâÊÇһƪÂÛÎĸø³öµÄÉæ¼°ÂÛÎÄ·¶Î§ÓëˮƽµÄµÚÒ»¸öÐÅÏ¢£¬Óл­Áúµã¾¦µÄ×÷Óá£ÓÐÈËÈÏΪSCIÂÛÎıêÌâÊÇÎÄÕµÄÒ»°ë¡£  -9f +O^x  
£¨3£©SCIÂÛÎĵıêÌâÊÇ·ñ·´Ó³SCIÂÛÎĵÄÄÚÈÝÊÇÉó¸åÆÀ¹À±ê×¼Ö®Ò»¡£ ZjB]pG+  
£¨4£©SCIÂÛÎĵıêÌâÊÇÎÄÕª¡¢Ë÷Òý»òÌá¼µÈÇ鱨×ÊÁϵÄÖØÒª×é³É²¿·Ö¡£Ä¿Ç°£¬ÎÄÏ×»ò×ÊÁϵļìË÷Ö÷ÒªÒÀÀµÓÚ¼ÆËã»úÍøÂçϵͳ¡££¬SCIÂÛÎıêÌâÊDzéѯµÄÒÀ¾Ý¡£Òò´Ë£¬Èç¹ûÄãµÄ±êÌâ²»³ä·Ö£¬ºÜÉÙÓÐÈË»áÕÒµ½ÄãµÄ½á¹û»òÕßÔĶÁÄãµÄÂÛÎÄ¡£Ó°ÏìÄãµÄSCIÂÛÎÄÒýÓôÎÊýºÍ½»Á÷¡£ =PQMd  
2. SCIÂÛÎıêÌâµÄÒªÇó agI"Kh]j?  
×î¼Ñ±êÌâµÄ±ê×¼ÊÇÒýÓÃ×îÉٵıØÐëÊõÓï׼ȷÃèÊöÂÛÎĵÄÄÚÈÝ¡£Ð´×÷ÒªÇó׼ȷ£¨accuracy£©¡¢¼ò½à£¨brevity£©¡¢Çå³þ£¨clarity£©¡¢ÓÐЧ£¨effectiveness£©ºÍÎüÒýÈË£¨attractive£©¡£·´Ó¦Õå×úóÈ·¶¨±êÌâ¡£ 'c6t,%  
¡ò׼ȷÍêÕû qcWY8sYf  
×÷ΪSCIÂÛÎĵġ°±êÇ©¡±£¬ÂÛÎıêÌâÒªÄÜ׼ȷ±í´ïÂÛÎÄÄÚÈÝ£¬Ç¡µ±·´Ó³ËùÑо¿µÄ·¶Î§ºÍÉî¶È£¬Ó¦¸ÃÓëSCIÂÛÎĵÄÄÚÈݷdz£ÌùÇУ¬¼´ÌâÒª¿ÛÎÄ£¬ÎÄÒ²Òª¿ÛÌ⣬ºÁ²»º¬ºý¡£ÕâÊÇ׫дSCIÂÛÎĵĻù±¾Ô­Ôò¡£³£¼ûµÄ´íÎóÖ÷ÒªÓУº 'Edm /+  
¨SÂÛÎıêÌâÌ«´ó»ò̫С¡£ RkMs!M   
ÀýÈç tjId?}\  
ÂÛÎÄÌâÄ¿Transportation of corneal stem cells cuitured on amniotic membrane for corneal burn: experimental and clinical study(Chinese Medical Journal,2002,115(5):767-769)Ì«´ó¡£¸ÃÂÛÎÄÖ÷ÒªÑо¿ÁËcorneal stem cellsµÄÌåÍâÅàÑøºÍÌåÄÚ¶ÔÍÃÉÕÉ˵ÄÓ°Ïì¡£Òò´Ë£¬Ð´³Éexperimental and clinical studyÊDz»Ç¡µ±µÄ¡£Óá°in vitro and in vivo¡±À´Ìæ´úexperimental and clinical study¸üºÏÊÊ¡£ p#QR^|7"  
¨SÂÛÎıêÌâ±í´ï²»ÕýÈ· vAV{HBQ*  
ÀýÈç awC:{5R8v  
Experimental study on mechanism and rarity of metastases in skeletal muscle(Chinese Medical Journal,2002,115(11):1645-1649)Õâ¸ö±êÌâ¾ÍûÓаÑÑо¿µÄ¶ÔÏó¡¢ÎÊÌâ˵Çå³þ¡£ G*y! Q  
¡ò  ¼òÃ÷¶óÒª e'y$X;nIv  
ÂÛÎÄÌâĿҪ¼ò½à£¬²»ÄÜÌ«³¤¡£Ò»°ãÏ£ÍûһƪÂÛÎıêÌâ²»Òª³¬¹ý100¸öÓ¢ÎÄ×Ö·û£¨characters£©£¬°üÀ¨¿Õ¸ñ¡¢±êµã¡£µ±È»²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÀýÈ磬ScienceÒªÇóÂÛÎıêÌâ²»³¬¹ý90¸ö×Ö·û¡£Journal of Biological ChemistryÒªÇóÂÛÎıêÌâ²»³¬³öÁ½ÐС£ 2d60o~ E  
ÀýÈç >@ :m#d  
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations(Proc Natl Acad Sci USA,2000,97(18):9834-9839) ¡£ÆäÖеĸ±±êÌâÆä²¹³ä¡¢²ûÃ÷×÷Óá£Science¹æ¶¨¸±±êÌâ½öÏÞÓÃÓÚÑо¿ÎÄÕ¡¢ÆÀÂÛ¡¢ÌØÑûÎÄÕ¡£ ag* 5fBF  
¡òÇå³þ uH.1'bR?a  
¾¡¿ÉÄܽ«±í´ïºËÐÄÄÚÈݵÄÖ÷Ìâ´Ê·ÅÔÚ±êÌâµÄ¿ªÍ·¡£ rm5@ dM@  
¡òÐÑÄ¿ t(.jJ>|+*  
±êÌâÒª¾ßÓÐÎüÒýÁ¦£¬Ò»Ä¿ÁËÈ»¡£ )?$zY5  
ÀýÈç `P4 3O gA  
±êÌâ¡°Identification of human brain tumor initiating cells¡±(Nature,2004-11-18,432(7015):396-401)¸ÃÂÛÎÄÌâÄ¿ÌØ±ðÐÑÄ¿£¬Ò»¿´¾ÍÖªµÀÁËËûÃÇ·¢ÏÖÁËÄÔÖ×Áö¸Éϸ°û¡£Òò´Ë¸ÃÂÛÎľßÓÐÍ»ÆÆÐÔÒâÒå¡£Èç¹û½«ÂÛÎĵıêÌâ¸ÄΪ¡°CD+133 brain tumor fraction contains cells that are capable of tumor initiation in non-obese diabetic severe combined immunodeficient mouse brains ¡±¾ÍÏÔµÃÌ«³¤£¬¶øÇÒ²»¹»ÐÑÄ¿¡£ W|I<hY\X  
µ«Òª×¢Òâ°ÑÎշִ磬²»¿É¹ý·ÖÐÑÄ¿¡£ =cwdl7N&I  
³£¼ûµÄ´íÎó°üÀ¨Ê¡ÂÔ²»µ±ºÍ½é´ÊʹÓò»µ± .[Nr2w:>  
[²»ÍƼö]Adhesion kinase controls actin assembly(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ ObzFh?W  
[ÍÆ¼ö]Focal Adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex(Ð޸ĺó) esk~\!d  
[²»ÍƼö]Mouse Behaviour(Ê¡ÂÔ²»µ±µÄ±êÌâ)¡£ pl.x_E,HP  
[ÍÆ¼ö]Androgen Administration to Aged Male Mice Increase Anti-Anxiety Behaviour and Enhance Cognitive Performance(Ð޸ĺó)¡£ S0]JeP+3!  
3. SCIÂÛÎıêÌâµÄ¸ñʽ ZP(T=Q  
±êÌâӦλÓÚÊ×Ò³¶¥²¿¡£µ±ÌâÃû½Ï³¤Ê±£¬ÌâÍ·¿Õ4-5¸ñ£¬ÈçÒ»ÐÐд²»Í꣬ÁíÆðÒ»ÐУ¬±ÈǰһÐÐËõ½øÁ½¸ñÊéд¡£ÈçÓи±±êÌâʱ£¬ÁíÆðÒ»ÐУ¬±ÈÖ÷±êÌâÃûËõ½øÁ½¸ñ¼ÓÆÆÕÛºÅÊéдÌâÃû¡£µ±±êÌâ½Ï¶Ìʱ£¬¾ÓÖÐÊéд¡£±êÌâ¿Õ¸ñÁ½ÐÐÔÙд×÷ÕßÃû×ֺ͵¥Î»¡£´ËÍ⻹ҪעÒâÒÔÏÂÊÂÏ ;/R\!E   
£¨1£©±êÌâ²»ÓÃÏ»®Ïß»òб×ÖÌå¡£ xO0}A1t Wd  
£¨2£©¾¡¿ÉÄܲ»Ó÷DZê×¼Ëõд¡£ 9H%dK^C  
£¨3£©±êÌâÒ»°ã²»Óôóд¡£ m.b}A'GT  
£¨4£©¾¡Á¿Ê¹±êÌâ³ÉΪһ¸ö¾ä×Ó£¬Ã¿¸ö´ÊµÄµÚÒ»¸ö×Öĸ´óд¡£ u+Sj#iZ  
4. SCIÂÛÎıêÌâºÍ»ù½ð¿ÎÌâÃû³ÆµÄÇø±ð /$=<RUE  
SCIÂÛÎıêÌâÑ¡ÔñÓëÈ·¶¨²»Í¬ÓÚÉêÇë¿ÎÌâÃû³Æ¡£Ç°ÕßÖ÷Òª½«ÄãµÄ½á¹û£¨Äã·¢ÏÖÁËʲô£©£¬ºóÕßÖ÷Òª²àÖØÓÚÄãµÄ¼Æ»®£¨Ä㽫Ñо¿Ê²Ã´£©¡£ XbYST%| .  
ÈçÏÂËùÁÐÊǹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖбêÏîÄ¿±êÌ⣺ ur| vh5  
£¨1£©¶ÌβºïÖÖȺÉú̬ѧÓëÐÐΪѧÑо¿¡£ ~gA^tc3G  
£¨2£©Ä§Ó󲡺¦Éú̬·ÀÖμ¼ÊõµÄ»ù´¡Ñо¿¡£ + :;6kyM6X  
£¨3£©CPKs¶ÔÑ×Ö¢ÓÕµ¼·Î΢Ѫ¹ÜÄÚÆ¤Ï¸°û¹Ç¼Ü±ä»¯µÄµ÷¿ØÑо¿¡£ 557%^)v  
£¨4£©¼¡Çòµ°°×ÇáÁ´¼¤Ã¸ÓëʵÑéÐÔ¶¯ÂöÖàÑùÓ²»¯¹ØÏµ¡£ Cb i;CF\{  
´ÓÖв»ÄÑ·¢ÏÖ£¬±êÌâ¶¼º¬ÓС°¡­¡­Ñо¿¡­¡­¡±¡£µ«ÊÇ£¬ÔÚ1972-2007ÄêNIHÖбê»ù½ð¿â£¬Ö»ÓÐÒ»¸ö»ù½ðº¬ÓÐStudy£º¡°Study of Women¡¯s Heaith Across the Nation¡£¡± D0*+7n3  
ÈçÏÂËùÁÐÊÇNIHÖбêÏîÄ¿µÄÑ¡Ì⣺ SpA-E/el  
£¨1£©Adult Stem Cells for Repsi Cardiac Damage¡£ a2.@Zyz  
£¨2£©Biology of Multiple Myeloma Stem Cells¡£ xWxgv;Ah  
£¨3£©Gene Expression Pattern of Liver Stem/Progenitor cells¡£ <gLq?~e|A  
£¨4£©mTert-GFP and Pancreatic Progenitor Cells¡£ mXJ`t5v^l  
£¨5£©The Role of ABC Transporters in Stem Cells¡£ XgPZcOzYB  
ºÜ¶à³õѧÕß°ÑSCIÂÛÎĵıêÌâд³É¡°The study of¡­¡­.¡±¡¢¡°The research on¡­¡­.¡±µÈ¡£ÕâÀà±êÌâÔÚSCIÂÛÎÄÖÐÊǺÜÉÙ¼ûµÄ¡£ G"|c_qX  
5.±êÌâµÄ¾ä·¨½á¹¹ g=Bge)  
±êÌâͨ³£ÓÉÃû´ÊÐÔ¶ÌÓï¹¹³É£¬Èç¹û³öÏÖ¶¯´Ê£¬¶àΪ·Ö´Ê»ò¶¯Ãû´ÊÐÎʽ¡£ÓÉÓÚ³ÂÊö¾äÒ×ʹ±êÌâ¾ßÓÐÅжÏʽµÄÓïÒ壬ͬʱҲ²»¼ò½à£¬Òò´Ë£¬´ó²¿·Ö±à¼­ºÍѧÕß¶¼ÈÏΪ±êÌâ²»Ó¦¸ÃÓɳÂÊö¾ä¹¹³É¡£ÓÉÓÚ±êÌâ¾ä×ӱȽϼòµ¥£¬²¢ÎÞÐèÖ÷¡¢Î½¡¢±ö£¬Òò´Ë£¬´ÊÐòÒ²¾ÍÏÔµÃÓÈÎªÖØÒª¡£ÌرðÊÇ£¬Èç¹û´ÊÓï¼äµÄÐÞÊιØÏµÊ¹Óò»µ±£¬¾Í»áÓ°Ïì¶ÁÕßÕýÈ·Àí½â±êÌâµÄÕæÕýº¬Òå¡£ 0kxe5*-|  
дSCIÂÛÎĵÄʱºò£¬²»ÒªÏÈд³ÉÖÐÎÄÔÙ·­Òë³ÉÓ¢Óï¡£ ?O.'_YS  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S

kaobook 2011-08-17 22:29
µÚ5ÕÂÈçºÎÊðÃû¡¢µ¥Î»Ãû³ÆºÍµØÖ· HzZ.q2Zz%  
1.×÷Õß×ʸñ±ê×¼ }S=m: VKH  
¹ú¼ÊÉ϶ÔÓÚ×÷ÕßµÄ×ʸñÊÇÓÐÑϸñÒªÇóµÄ¡£ÓÐ×ʸñ³ÉΪSCIÂÛÎÄ×÷ÕßÓ¦·ûºÏÏÂÁÐËùÓбê×¼£¨criteria£©¡£ V1 {'d[E*  
(1)ÖÁÉÙ²ÎÓ벿·Ö¿ÎÌâµÄ¹¹Ë¼ÓëÉè¼Æ¡¢×ÊÁÏ»òÊý¾Ý·ÖÎöºÍ½âÊÍ¡£ 5$%CRm  
(2)ÂÛÎĸåµÄÆð²Ý¡¢Ð´×÷»ò¶ÔÆäÖØÒªÑ§ÊõÄÚÈÝ×÷ÖØ´óÐ޸ġ£ $LHF=tYS  
(3)ͬÒâ×îºó¶¨¸å¡£ 4)].{Z4 q  
Òò´Ë£¬×÷ÕßµÄ×ʸñÓ¦ÒÔÊÇ·ñʵ¼Ê²ÎÓëÒÔÉÏʵ¼Ê¹¤×÷Ϊ»ù´¡¡£½ö½ö³ï¼¯»òÌṩ×ʽð»òÊÕ¼¯×ÊÁÏÕß²¢²»Ó¦µ±³ÉΪ×÷Õߣ¬¶ÔÑо¿Ð¡×é½øÐÐÒ»°ãÐԵعÜÀíÖ¸µ¼ÕßÒ²²»×ãÒÔ³ÉΪ×÷Õß¡£ -5u. Ix3  
2.ÊðÃûµÄÄ¿µÄ >d<tcaB  
£¨1£©Öø×÷ȨӵÓеÄÉêÃ÷¡£ÊðÃû±¾Éí¼´ÏòÉç»áÉêÃ÷×÷Õß¶Ô¸Ã×÷Æ·ÓµÓÐÁËÖø×÷Ȩ£¬ÈκθöÈ˺͵¥Î»²»ÄÜÇÖ·¸¡£ 1 ( vcM  
£¨2£©ÊðÃû±íʾÎÄÔð×Ô¸ºµÄ³Ðŵ¡£  G4{TJ,~  
£¨3£©ÊðÃû±ãÓÚ¶ÁÕßͬ×÷ÕßÁªÏµ¡£ m=qyPY  
3.×÷Õߣ¨Á½ÈËÒÔÉÏ£©ÅÅÐòºÍ±í´ïÐÎʽ nna boD  
£¨1£©µÚÒ»×÷ÕßÊÇÖ÷Òª¸ºÔðÊÕ¼¯ºÍ·ÖÎöÊý¾Ý¡¢ÂÛÎĸåµÄÆð²ÝºÍд×÷¡£ 5@yBUwMSj  
£¨2£©×îºóÒ»¸ö×÷ÕßÒ»°ãÊÇ¿ÎÌ⸺ÔðÈË£¬¶Ô¿ÎÌâºÍÂÛÎÄÈ«Ãæ¸ºÔð¡£ ?a{>QyL  
£¨3£©ÆäËû×ø×ÅÓ¦¸ù¾ÝÆïÔÚÑо¿ÖеĵűÏ×À´ÅÅÐò¡£ N7#,x9+E  
ÓÐʱ¿ÎÌâΪºÏ×÷ÏîÄ¿£¬Òò´Ë¿ÉÄÜÓÐÁ½Î»×÷ÕßΪͨÐÅ×÷Õß¡£±í´ïÐÎʽΪ£º Dfw%Bu  
Correspondence author: )@E'yHYO>  
Xxxx,MD,PhD l ^;=0UR_  
Department of Neurology G^A}T3  
University of San Francisco j38>5DM6L  
4410 Clement St WlRaD%Q  
San Francisco,CA 94495 mJa8;X!r6  
Tel:415-555-xxxx #p/'5lA&j  
Fax:415-555-xxxx I^!c1S   
E-mail:kxxx@ucsf.edu 4]m?8j) 6b  
Or(¿ÉÒÔ²»ÓÃ) s p&g  
Xxxx,MD,PhD FcmL 4^s.`  
Department of Neurology L,* #  
Huashan Hospital, Fudan University EQ2HQz ]  
Shanghai 200135,China Rkh ^|_<!  
Tel:021-555-xxxx e<-^  
Fax:021-555-xxxx L^{wxOf&6E  
E-mail:kxxx@yahoo.com.cn 7 ^n{BsN  
4.×÷ÕßÖ°Ôð 4<y|SI!  
(1)²»ÄÜÒ»¸åÁ½Í¶¡£(2)²»ÄÜÄóÔìºÍÆÛÆ­¡£ "-A@d&5.  
(3)ÂÛÎÄ×÷ÕßÊÇÖ÷ÒªµÄÑо¿Õߣ¬¶ÔÑо¿×÷³öÁËÖØÒª¹±Ï×£¬²¢ÊìϤԭʼÊý¾Ý¡£ R\:t 73  
(4)ËùÓÐ×÷Õß¿´¹ý×îºó¶¨¸å²¢¶ÔÆäÄÚÈݸºÔð¡£Èç¹û¸ÃÂÛÎÄ»òÆä²¿·ÖÄÚÈݱ»·¢ÏÖÓÐÎó»òÆÛÕ©£¬ËûÃÇÓ¦³Ðµ£ÔðÈΡ£ $S2kc$'F  
5.ÊðÃû¸ñʽ y3!#*NU  
×÷ÕßµÄÐÕÃûдÔÚÂÛÎıêÌâµÄÏ·½£¬¾ÓÖÐÊéд¡£µ±ÓÐÁ½Î»ÒÔÉÏ×÷Õßʱ£¬Ã¿Ò»×÷ÕßµÄÃû×ÖÓöººÅ·Ö¿ª£¬×îºó×÷ÕßµÄÃû×ÖµÄÇ°Ãæ¸ÄÓÃand·Ö¿ª¡£¹¤×÷µ¥Î»Ãû³ÆºÍµØÖ·Ó¦Î»ÓÚÊðÃûµÄÏ·½¡£µ±×÷ÕßÀ´×Ô²»Í¬µ¥Î»Ê±£¬¿ÉÒÔÓ÷ûºÅ»òÊý×Ö˵Ã÷¡£²»ÒªÔÚ¡°½ÌÊÚ¡±ºóÃæ¼Ó¡°²©Ê¿Éúµ¼Ê¦¡±¡£Ò»°ãÀ´Ëµ×÷Õߣ¨Í¨Ñ¶×÷Õß³ýÍ⣩µ¥Î»µÄÏêϸµØÖ·Èç½ÖµÀÃû»òºÅÂë²»ÐèҪдÃ÷¡£ \!!1o+#1j  
6.³£¼ûÎÊÌâºÍ×¢ÒâÊÂÏî ~)%DiGW&  
SCIÂÛÎÄÊðÃûÌåÏÖµÄÒâÒå²»½öÊÇÈÙÓþ£¬¸ü¶àµÄÊÇÔðÈΡ£µ«ÊdzÉΪSCIÂÛÎĵÄ×÷Õߣ¬ÓÈÆäÊǵÚÒ»×÷Õߣ¬¿ÉÄÜÓëÕÒ¹¤×÷»ò½úÉý»òÉêÇë»ù½ðÖ±½ÓÏà¹Ø¡£Òò´Ë£¬ÓÐʱºòϵÖ÷Èβ¢Ã»ÓÐÖ±½Ó²ÎÓë¿ÎÌâµÄÑо¿£¬µ«ÓпÉÄܱ»ÄÉÈëΪ×÷Õß¡£Äê×ʱȽϵ͵ÄÑо¿ÈËÔ±Ò²¾­³£°Ñ×ÊÉîÑо¿ÈËÔ±ÁÐΪÂÛÎÄ×÷ÕßÒÔ±íʾ¸ÐлËû£¨ÃÇ£©µÄÖ§³Ö»òÕßÌá¸ßÂÛÎÄ·¢±íµÄ»úÂÊ¡£ÓÐʱ»ù´¡Ñо¿ÕßÁÐÁÙ´²Ò½ÉúΪÂÛÎÄ×÷ÕßÒÔ×÷Ϊ×éÖ¯ÑùÆ·ºÍ²¡ÈËÊý¾ÝµÄ½»»»Ìõ¼þ¡£¸ù¾Ý¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò£¬ËùÓÐÕâЩ·½·¨»òÕßÀíÓɾù±»ÊÓΪ²»Ç¡µ±µÄÐÐΪ¡£ Jec<1|  
ÓÐʱ»áÓÐÖø×÷ȨºÍ×÷ÕßÅÅÁоÀ·×¡£±È½Ï¼òµ¥µÄ·½·¨ÊÇ£¬Ê×ÏÈ£¬ÄãºÍÄãµÄºÏ×÷ÕßͬÒâ×ñÑ­¹ú¼ÊÂÛÎÄÊðÃû×¼Ôò¡£Æä´Î£¬ÔÚÑо¿¿ªÊ¼Ö®Ç°£¬È·¶¨×÷ÕßÃûµ¥¡£×îºó£¬ÊÂÏÈ̽ÌÖ×÷ÕßÅÅÐòºÍË­½«ÊÇͨѶ×÷Õß¡£ Su/}OS\R  
7.ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖеıí´ï D[bPm:\0M  
ÖйúÈËÐÕÃûÔÚSCIÂÛÎÄÖÐÓв»Í¬µÄ±í´ï·½Ê½¡£¼ûʾÀý C5&+1VrP  
ÖйúÈËÐÕÃû£º½ðУ°²¡£ <7yn:  
±í´ï·½Ê½£º  :IX_}|  
¨SXiaoan Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X k=J T%  
¨SXiaoAn Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X NK|m7 (  
¨SXiao-An Jin£¨³£¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬XA YV"LM6`  
¨SJin,Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X VO+3@d:  
¨SJIN£¬Xiaoan£¨ÉÙ¼ûÓÚSCIÆÚ¿¯£©£¬¼ìË÷¹Ø¼ü´ÊΪ£ºJin£¬X OvtiFN^s'  
¨SXiao An Jin£¨An±í´ïΪMiddle name£¬²»ÍƼö£©  9Li.B1j  
¨SJin Xiao An£¨ÖÐʽ±í´ï£¬²»ÕýÈ·£© iWMgU:T  
¡ò¡ò¡ò¡ò¨S¨S¨S¨S¨S¨S k ks ?S',  

kaobook 2011-08-17 22:29
µÚ6Õ ÈçºÎSCIÂÛÎĵÄÕªÒª 7T@"2WYat  
1.ÕªÒªµÄ¶¨Òå IX y  $  
ÕªÒª£¨abstract»òsummary£©ÊǶÔÂÛÎÄÄÚÈݵĸÅÀ¨£¬ÊÇÒÔÌṩÎÄÏ×ÄÚÈݸü¸ÄΪĿµÄ£¬¼òÃ÷¶óÒª¡¢ÕýÈ·¼ÌÐøÎÄÏ×ÖØÒªµÄÄÚÈݵĶÌÎÄ¡£ÕªÒªÖ÷Ҫ˵Ã÷ÂÛÎĵÄÄ¿µÄ¡¢ËùÓõķ½·¨¼´È¡µÃµÄ½á¹û¼°ÒâÒå¡£ÕªÒªÊÇSCIÂÛÎĵıØÒª¸½¼Ó²¿·Ö£¬Ö»Óн϶̵ÄÎÄÕ²ÅÄÜÊ¡ÂÔ¡£ E?3$ * t  
2.ÕªÒªµÄ×÷Óà %QKRl 5RM-  
¡ò±¨µÀÂÛÎÄÐÅÏ¢ M}W};~V2ng  
ÕªÒªÓ¦¾ßÓжÀÁ¢ÐÔºÍ×ÔÖ÷ÐÔ£¬²¢ÇÒº­¸ÇÂÛÎĵÄÖ÷ÒªÐÅÏ¢£¬ÒÔ±ã¶ÁÕßѸËÙ×÷³öÅжϣ¬ÊÇ·ñÓбØÒªÔĶÁÈ«ÎÄ¡£Ðí¶à×÷ÕßµÄSCIÂÛÎÄÕªÒª½Ï¼òÂÔ£¬Ã»ÓÐ×¢Ò⽫ÎÄÕÂÖ÷ÒªÄÚÈÝÌåÏÖÔÚÕªÒªÖУ¬´Ó¶øÓ°ÏìÂÛÎĵĽ»Á÷ºÍ·¢±í¡£ &4-rDR,  
¡òµç×ÓÎÄÏ×¼ìË÷ ]z_C7Y"4BR  
ÕªÒªÊǶþ´ÎÎÄÏ×µÄÖøÂ¼ÄÚÈÝ¡£Òò´Ë£¬ÕªÒª±ØÐëÄÉÈë×ã¹»µÄ¹Ø¼üÐÅÏ¢£¬Èç½á¹û¡¢¹Û²ì¡¢Ç÷ÊÆµÈ£¬Ê¹¶ÁÕ߿ɲο¼ÄãµÄ¹¤×÷¡£ >Gyg`L\  
¡òÓÃÓÚÉó¸å¹ý³Ì }%I)bU  
Ò»°ãSCIÆÚ¿¯±à¼­°ÑÂÛÎĵÄÌâÄ¿ºÍÕªÒªË͸øºòÑ¡Éó¸åÈË£¬Éó¸åÈ˸ù¾ÝÕªÒªÄÚÈÝÀ´¾ö¶¨ÊÇ·ñÓÐÐËȤ»òÕßÖµµÃ»¨Ê±¼äÉóÔĴ˸塣 x8wal[6  
3.ÕªÒª½á¹¹ ?5#=Mh#  
Ò»°ãժҪΪһ¸ö×ÔÈ»¶Î£¨one paragraph£©¡£ÕªÒªµÄÖ÷Òª½á¹¹¿ÉÒÔ¸ÅÀ¨ÎªÒÔÏÂËĸö²¿·Ö£¬°´Ë³ÐòÅÅÁУº ?{M!syD<  
£¨1£©´æÔÚÎÊÌâºÍÖ÷ÒªÑо¿µÄÄ¿µÄ£¨Motivation/Problem Statement£©¡£ t(F] -[  
£¨2£©ÊµÑéÉè¼ÆÓë·½·¨£¨Methods/Procedure/Approach£©¡£ *,=WaODO%  
£¨3£©×îÖØÒªµÄ½á¹û£¨Results/Findings/Product£©¡£ "7tEk<x  
£¨4£©Ö÷Òª½áÂÛ£¨Conclusion/Implications£©¡£ POCFT0R}  
4.ÕªÒªµÄ¾ßÌåÄÚÈÝ ViG4tb  
ÕªÒª½á¹¹  ÄÚÈÝ  À´Ô´ 8{Id+Q>Vo,  
±³¾°×ÊÁÏÎÊÌâÑо¿Ä¿µÄ  What did you investigate and why?  Introduction *|DIG{  
ʵÑéÉè¼ÆÓë·½·¨  What did you do?  Methods ^>fjURR  
½á¹û  What did you find out?  Results <r{ )*]#l  
½âÊͺͽáÂÛ  What do you results mean? So what?   Discussion [F< Tl =  
5.ÊéдժҪµÄ»ù±¾ÒªÇóºÍ×¢ÒâÊÂÏî ]Ak@!&hyak  
£¨1£©ÕªÒªÎªSCIÂÛÎÄÈ«Îĵĸ߶ÈŨËõ¡£È·±£×¼È·¡¢¼ò½à¶ø³ä·ÖµØ±íÊöÂÛÎĵÄÖ÷ҪĿµÄ¡¢·½·¨¼°È¡µÃµÄÖ÷Òª½á¹û¼°ÒâÒå¡£ uKZe"wN;  
£¨2£©¾«¶Ì¼òÃ÷£¬ÄÚÈÝÃ÷È·ÍêÕû¡£Ò»°ãSCIÂÛÎÄÕªÒªÒÔ200-300×ÖΪÒË¡£µ«Ó¦×¢ÒⲻͬµÄSCIÆÚ¿¯ÒªÇóÒ²²»Ò»Ö£¬ÈçScienceÒªÇóÕªÒªÔÚ125×Ö»ò¸üÉÙ¡£ 32*FISH^  
£¨3£©ÕªÒªÖ»ÊÇÎÄ×ÖÃèÊö¡£Ã»ÓÐÈκÎÐÎʽµÄ˵Ã÷£¬Èçͼ¡¢±í¡¢×¢ÊÍ¡£Îª·½±ã¼ìË÷ϵͳת¼£¬Ó¦¾¡Á¿±ÜÃâʹÓû¯Ñ§½á¹¹¡¢Êýѧ±í´ïʽ¡¢½Ç¶ÈºÍÏ£À°ÎĵÈÌØÊâ·ûºÅ¡£ Ck0R%|  
£¨4£©ÕªÒªµÄµÚÒ»¾ä»°×îÖØÒª£¬ÄÚÈݰüÀ¨ÁËÑо¿¶¯»ú£¨motivation: why do we care about the problem and the results? £©ºÍ´æÔÚµÄÎÊÌ⣨problem statement: what problem are you trying to solve?£©£¬Òò´Ë·´Ó³ÄãÎÄÕÂÑо¿µÄ·½ÏòºÍÖØÒªÐÔ¡£ GL_a`.=@  
£¨5£©Ó¦²ûÊöÂÛÎĵÄÖ÷ÒªÄÚÈÝ¡£ÄÚÈݱØÐ뾫Ðıàд£¬³¢ÊÔÐí¶à°æ±¾¡£  T8i9  
£¨6£©ÒªÒýÆð¶ÁÕßµÄÐËȤ£¬ÒªÔ­´´¡£ Sh_=dzM  
£¨7£©±ÜÃâ²»±ØÒªµÄ»°£¬Èç¡°In recent years¡­¡±¡¢¡°¡­has received great attention¡­¡±¡¢¡°There has been great interest in¡­¡±¡£ 6T_Mk0Sf+  
£¨8£©±ÜÃâÓÿÉÄܵ¼Ö¶ÁÕß»ìÏýµÄËõÂÔÓï»òÊõÓï¡£ÈçÈ·ÓÐÐèÒª£¬Ó¦ÔÚËõд·ûºÅµÚÒ»´Î³öÏÖʱ¸ø³öÆäÈ«³Æ¡£ LF~=,S  
£¨9£©²»Ó¦°üº¬²Î¿¼ÎÄÏס£ ;=.QT  
£¨10£©²»Ó¦°üº¬Èß³¤µÄ±³¾°×ÊÁÏ¡£ 0Up@+R2  
£¨11£©¿ÉÒÔÓÐһЩÊý×Ö£¬µ«²»Òª¹ý¶à¡£ 43;@m}|7$  
£¨12£©ÔÙ´ÎÈ·ÈÏÕªÒªÄÚÈÝ¡£Ò»µ©ÄãÍê³ÉÕªÒª£¬ÐèÒªÔÚ¼ì²é£¬ÒÔÈ·±£ÄÚÈÝÓëÂÛÎÄÍêÈ«Ïà·û¡£ RJ_ratKN*g  
6.ժҪд×÷µÄÈ˳ƺÍÓï̬ MKdBqnM(F  
ÓÉÓÚÖ÷¶¯Óï̬µÄ±í´ï¸üΪ׼ȷ£¬ÇÒ¸üÒ×ÔĶÁ£¬Òò¶øÄ¿Ç°´ó¶àÊýSCIÆÚ¿¯¶¼ÌᳫʹÓÃÖ÷¶¯Óï̬¡£Nature¡¢CellµÈÆÚ¿¯ÆÕ±éʹÓõÚÒ»È˳ƺÍÖ÷¶¯Óï̬µÄ±í´ï·½Ê½¡£±ÜÃâʹÓõÚÈýÈ˳ƣ¬Èç¡°This paper reported that¡­¡±¡£ L/w9dk*uv  
7.ÕªÒªµÄд×÷ʱ̬ 2b]'KiX  
´óÖ¿ÉÒÔ×ñÑ­ÒÔÏÂÔ­Ôò¡£  OT9\K_  
£¨1£©½éÉܱ³¾°×ÊÁÏ»ò²ûÊÍÑо¿µÄÖ÷ҪĿ±êʱ£¬Èç¹û¾ä×ÓÄÚÈݲ»ÊÜʱ¼äÓ°Ï죬ÊÇÆÕ±éÊÂʵ£¬Ó¦Ê¹ÓÃÏÖÔÚʱ£»Èç¹û¾ä×ÓµÄÄÚÈÝÊǶÔijÖÖÑо¿Ç÷ÊÆµÄ¸ÅÊö£¬ÔòʹÓÃÏÖÔÚÍê³Éʱ¡£ *My?l75  
£¨2£©¸ÅÊöʵÑé³ÌÐò¡¢·½·¨ºÍÖ÷Òª½á¹ûʱ£¬Í¨³£Óùýȥʱ¡£ @aw aN  
£¨3£©ÐðÊö½áÂÛ»ò½¨Òéʱ£¬¿ÉʹÓÃÏÖÔÚʱ¡£ In0kP"  
È»¶ø£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÒªÇó¡£ÓÉÓÚ¸÷SCIÆÚ¿¯¶¼ÓÐÆä¾ßÌåÒªÇó£¬Òò´ËҪȷ¶¨Ôڵݽ»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßÖ¸ÄÏ£¬°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£  8IH&=3  
8.ժҪд×÷¼¼ÇÉ b\ %=mN  
¾¡¹ÜÕªÒª³öÏÖÔÚÂÛÎĵÄ×îÇ°Ãæ£¬µ«ÕªÒªÒ»°ãÓ¦¸ÃÔÚÎÄÕ¸÷Ö÷Òª²¿·ÖÍê³ÉºóÔÙд¡£ÒòΪժҪ×ܽáÁËÂÛÎÄ£¬ÕâÑùÓÐÀûÓÚÎÄÕÂÒªµãµÄÌáÁ¶¡£ÓÅÐãµÄÕªÒªÄÜÓÐЧץס¶ÁÕßµÄÐËȤ¡£¿ªÊ¼Ð´×÷ժҪʱ£¬¿ÉÒÔ´ÓIntroduction¡¢Material and Methods¡¢Results and DiscussionÕ½ÚÖÐÑ¡ÔñÕû¸ö¾ä×Ó»ò¹Ø¼ü¶ÌÓ²¢°ÑËûÃǰ´Âß¼­ÅÅÁС£È»ºó×ÅÊÖÐ޸ĻòÌí¼ÓÎÄ×Ö¡£¼òµ¥µØËµ£¬Ò»°ãÏÈ´ÓһЩ¼òµ¥µÄ±³¾°×ÊÁÏ¿ªÊ¼£¬ÓÃÒ»Á½¾ä»°½âÊÍΪʲôҪ×öÕâÏîÑо¿¼°ÓëÄãÑо¿Ïà¹ØµÄ±³¾°ÌØÉ«¡£Æä´ÎÊǼòÊö×öÁËʲô¡£×îºóÒ»¾äӦΪÑо¿½áÂÛ£¬ÎªÊ²Ã´½á¹ûÊǺÜÖØÒª£¬Ç¿µ÷Ñо¿µÄ´´ÐºÍÒâÒå¡£ $;_'5`xs  
9.Ëõ¶ÌÕªÒª·½·¨ ^ b`}g  
²»Í¬µÄSCIÆÚ¿¯ÆäÕªÒªµÄ³¤¶ÈÓÐËù²»Í¬¡£Ò»°ãËõ¶ÌÕªÒªµÄµÄ·½·¨ÈçÏ£º ~$f+]7  
£¨1£©È¡Ïû²»±ØÒªµÄ×־䣬Èç¡°It is reported¡­¡±¡°Extensive investigations show that¡­¡±¡°The author discusses¡­¡±¡°This paper concerned with¡­¡± _1c'~;  
£¨2£©¶ÔÎïÀíµ¥Î»¼°Ò»Ð©Í¨ÓôʿÉÒÔÊʵ±½øÐмò»¯¡£ )Xa`LG =|  
£¨3£©È¡Ïû»ò¼õÉÙ±³¾°½éÉÜ£¨background information£©¡£ :rb<mg[  
£¨4£©Ö»ÃèÊöÐÂÇé¿ö¡¢ÐÂÄÚÈÝ£¬¹ýÈ¥µÄÑо¿Ï¸½Ú¿ÉÒÔÈ¡Ïû¡£ Ou; ]>FJ  
£¨5£©×÷ÕßÔÚÎÄÏ×ÖÐ̸¼°µÄδÀ´¼Æ»®²»ÄÉÈëÕªÒª¡£ &G@*/2A  
£¨6£©¾¡Á¿¼ò»¯Ò»Ð©´ë´ÇºÍÖØ¸´µÄ´ÊÓï¡£ +b] g;  

kaobook 2011-08-17 22:31
µÚ7Õ ÈçºÎSCIÂÛÎĵĹؼü´Ê !>/U6h,_  
1.¹Ø¼ü´Ê ~fs{Ff'  
¹Ø¼ü´Ê£¨key word£©ÊÇÕªÒªÄÚÈݵÄŨËõ£¬ÊÇ·´Ó³SCIÂÛÎĵÄÖ÷ÌâÄÚÈݵÄ×îÖØÒªµÄ´Ê¡¢´Ê×éºÍ¶ÌÓһ°ãÑ¡ÓÃ3-6¸ö¡£¹Ø¼ü´ÊÒ²ÊÇSCIÂÛÎĵÄÎÄÏ×¼ìË÷±êʶ£¬±í´ïÎÄÏ×Ö÷Òª¸ÅÄîµÄ×ÔÈ»ÓïÑÔÓôʡ£¹Ø¼ü´ÊÊÇΪ·½±ã¼ÆËã»ú¼ìË÷£¨search engine£©Óõģ¬ÒªÇó´ÊÒåÃ÷È·£¬Ò»´ÊÒ»Òâ¡£ K,' ]G&K  
2.¹Ø¼ü´ÊµÄåàÑ¡ / MSz{ %v  
£¨1£©´ÓÌâÄ¿ÖÐÕÒ¡£ÂÛÎĵÄÖ÷ҪŨËõ£¬×îÒ×ÕÒµ½¡£ {so"xoA^c  
£¨2£©´ÓÕªÒªÖÐÕÒ¡£ÕªÒªÊÇÂÛÎĵÄÄÚÈÝŨËõ£¬°üÀ¨×îÖØÒªµÄ·½·¨¡¢½á¹û¡¢½áÂۺ͹ؼüÊý¾Ý¡£ (]>c8;o#b  
£¨3£©´ÓÂÛÎĵÄС±êÌâÖÐÕÒ¡£ËüÊÇ·´Ó³ÂÛÎÄÖ÷ÌâµÄ²ã´Î±êÌâ¡£ T"t3e=xA  
£¨4£©´Ó½áÂÛÖÐÕÒ¡£¿ÉÕÒµ½ÌâÄ¿¡¢ÕªÒª¡¢Ð¡±êÌâÖЩѡµÄ½ÏÎªÖØÒªµÄ¹Ø¼ü´Ê¡£ tCK%vd%  
3.¹Ø¼ü´ÊµÄÊéд !5 %c`4  
¹Ø¼ü´Ê£º×ó¸ñ¶¥Æð£¬ºó¿ÕÒ»¸ñд¹Ø¼ü´Ê¡£ Y-n* K'  
4.¹Ø¼ü´ÊµÄλÖà L1.<LB^4'  
Ò»°ãÇé¿öÏ£¬¹Ø¼ü´ÊλÓÚÕªÒªÖ®ºó¡£ Aa.bE, W  
5.Êéд¹Ø¼ü´ÊӦעÒâÊÂÏî %\[LM$f{z  
£¨1£©¹Ø¼ü´Ê²»ÒªÈ«²¿À´×ÔÂÛÎĵÄÌâÄ¿¡£ .0#?u1gXsX  
£¨2£©¹Ø¼ü´Ê²»ÒªÖظ´¡£ _=j0Y=/IF  

kaobook 2011-08-17 22:31
°ËÕÂÈçºÎÊéдSCIÂÛÎĵÄÒýÑÔ£¨Ç°ÑÔ£© Revc :m1o  
1.ÒýÎİüÀ¨µÄÄÚÈÝ vgHMVzxj  
£¨1£©¿ÎÌâµÄÌá³ö±³¾°¡£ GKtG#jZ&  
£¨2£©Ç°ÈËÑо¿¾­¹ý¡¢³É¹û¡¢ÏÖʵÇé¿ö¼°´æÔÚµÄÎÊÌâºÍÆÀ¼Û¡£ bKmR &  
£¨3£©ËµÃ÷Äã×öÕâÏîÑо¿µÄÔ­Òò¡£½éÉÜ¿ÎÌâµÄÐÔÖÊ¡¢·¶³ë¼°ÆäÖØÒªÐÔ£¬Í»³öÑо¿µÄÄ¿µÄ»òÕßÐèÒª½â¾öµÄÎÊÌâ¡£ [Pby  d  
£¨4£©Ñо¿¹ý³ÌËù²ÉÓõķ½·¨¡¢Ñо¿¹¤×÷µÄз¢ÏÖºÍÒâÒå¡£ qWtvo';3  
2.ÒýÎÄд×÷µÄ»ù±¾ÒªÇó hFZ7{pj  
£¨1£©ÑÔ¼òÒâê࣬ÌõÀíÇå³þ¡£ÒÔ×Á·µÄÓïÑÔ£¬±íÊöÑо¿¿ÎÌâµÄÀ´ÁúÈ¥Âö¼°Ñо¿½á¹û¡£Ò»°ãSCIÂÛÎÄÒýÑÔÔÚ450×ÖÒÔÄÚ£¬2-4¸ö×ÔÈ»¶Î¡£ Wze\ z  
£¨2£©¾¡Á¿×¼È·¡¢Çå³þÇÒ¼ò½àµØÖ¸³öËù̽Ë÷ÎÊÌâµÄ±¾Öʺͷ¶Î§£¬¶ÔÑо¿±³¾°µÄ²ûÊö×öµ½·±¼òÊʶȡ£ÎÄÏ×ÒýÓúÍÊý¾ÝÌṩһ¶¨Òª×¼È·£¬ÇмDZÜÃâÆ¬ÃæÕªÂ¼²¿·Ö½á¹û¶ø²»·´Ó¦ÎÄÏ×µÄ×ÜÌå½á¹û¡£ÒýÓõÄÊý¾ÝÒ²ÒªÕýÈ·£¬ÌرðÊǶþ´ÎÒýÓõÄÊý¾Ý¡£ JpD<2Mz_|V  
£¨3£©Òª°Ñ¸ÃÁìÓò¹ýÈ¥ºÍÏÖÔÚµÄ×´¿öÈ«Ãæ¸ÅÀ¨×ܽá³öÀ´£¬ÌرðÊÇ×îнøÕ¹µÄÒýÓá£ÔÚ±³¾°½éÉܺÍÎÊÌâµÄÌá³öÖУ¬Ó¦ÒýÓá°×îÏà¹Ø¡±µÄÎÄÏ×ÒÔÖ¸Òý×÷Õß¡£ÒªÓÅÏÈÑ¡ÔñÒýÓõÄÎÄÏ×°üÀ¨Ïà¹ØÑо¿ÖеÄԭʼ¡¢ÖØÒªºÍ×î¾ß˵·þÁ¦µÄÎÄÏס£Á¦½ä²»Ç¡µ±µØ´óÁ¿¡°×ÔÒý¡±¡£ÒýÓÃÎÄÏ×ʱ²»ÒªÔ­Îij­Â¼£¬ÒªÓÃ×Ô¼ºµÄ»°×ܽáÃèÊö¡£ 3F[z]B  
£¨4£©²ÉÈ¡Êʵ±µÄ·½Ê½Ç¿µ÷×÷ÕßÔÚ±¾´ÎÑо¿ÖÐ×îÖØÒªµÄ·¢ÏÖ»ò¹±Ï×£¬ÈöÁÕß˳×ÅÂß¼­µÄÑݽøÔĶÁÂÛÎÄ¡£ C* b!E:  
£¨5£©½âÊÍ»ò¶¨ÒåרÃÅÊõÓï»òËõд´Ê£¬ÒÔ°ïÖú±à¼­¡¢Éó¸åÈ˺ͶÁÕßÔĶÁ¸å¼þ¡£ eL#pS=  
3.ÒýÑÔµÄд×÷ %rzC+=*;  
£¨1£©´æÔÚʲôÎÊÌ⣿£¨What is the problem?£©ÂÛÎÄÒýÑÔµÄ×÷ÓÃÊÇ¿ª×ÚÃ÷ÒåÌá³ö±¾ÎÄÒª½â¾öµÄÎÊÌâ¡£ÒýÑÔÓ¦¿ªÃżûɽ¡¢¼òÃ÷¶óÒª¡£ÃèÊöÄãÖ¼ÔÚ½â¾öµÄÎÊÌâ¡£×ܽáÏà¹Ø±³¾°Ñо¿¡¢¹Ø¼ü¹ØÏµºÍ¸ÅÄʹ¶ÁÕßÄܹ»Àí½âÄãµÄʵÑé¡£ %w=*4!NWb  
£¨2£©ÎªÊ²Ã´ÄãµÄÑо¿ÊÇÖØÒªµÄ£¿£¨Why is your proposal important?£©¼òÒª²ûÊöǰÈËÔÚÕâ·½ÃæËù×ö¹ýµÄ¹¤×÷¡£Ê²Ã´ÊÇÒÑÖªµÄ£¬Ä¿Ç°´æÔÚµÄÎÊÌâ»òδ½â¾öµÄÎÊÌâ¡£»Ø´ðºÍ×ܽáÏà¹ØÑо¿£¬Ìá³öÄãÑо¿µÄÀíÓÉ¡£ÔÚ·ÖÎö¹ýÈ¥Ñо¿µÄ¾ÖÏÞÐԺͲûÃ÷×Ô¼ºÑо¿µÄ´´ÐµãʱҪÉ÷ÖØ¡£Ò»¶¨Òª×ñѭʵÊÂÇóÊǵÄÔ­ÔòÀ´¿Í¹Û¹«ÕýÆÀ¼Û±ðÈ˵Ť×÷£¬²»Òª°Ņ̃¸ß×Ô¼ºÑо¿µÄ¼ÛÖµ½¨Á¢ÔÚ±áµÍ±ðÈ˵Ť×÷Ö®ÉÏ¡£¶ÔǰÈ˹¤×÷µÄ¸ÅÀ¨Ò²²»Òª¶ÏÕÂÈ¡ÒåºÍÐîÒâÍáÇú±ðÈ˵ÄÒâ˼¶øÍ»³ö×Ô¼º·½·¨µÄÓŵ㡣ÐðÊöǰÈ˹¤×÷µÄǷȱÒÔÇ¿µ÷×Ô¼ºÑо¿µÄ´´ÐÂʱ£¬Ó¦É÷ÖØÇÒÁôÓÐÓàµØ¡£×î³£Óõıí´ï·½Ê½ÊÇ¡°To the best of our knowledge, we find/ identify for the first time¡­¡±¡£ÔÚһƪÂÛÎÄÖУ¬¶ÔǰÈ˹¤×÷µÄ¸ÅÀ¨Ó¦¾¡¿ÉÄÜ·ÅÔÚÒýÑÔÖС£ÔÚÕýÎÄÖУ¬Èç·ÇºÜ±ØÒª£¬¾Í²»ÒªÔÙÇ¿µ÷ÁË¡£ =\ iV=1iB  
£¨3£©ÄãÈçºÎ½â¾öÕâЩÎÊÌ⣿£¨What solution do you propose?£©¼òÊöÄãµÄʵÑ飻һ°ãµÄʵÑéÉè¼ÆºÍ·½·¨£»ÄãµÄз½·¨»òÖØÒª½á¹ûÓÐʲô¹ã·ºµÄÓ°Ïì»òÒâÒå¡£ TV#pUQ3K  
4.ÒýÑÔд×÷ʱ̬ºÍÓï̬µÄÓ¦Óà =" #O1$  
£¨1£©ÐðÊöÓйØÏÖÏó»òÆÕ±éÊÂʵʱ£¬³£ÓÃÏÖÔÚʱ¡£ gb|C592R5C  
£¨2£©ÃèÊöÌØ¶¨Ñо¿ÁìÓòÖÐ×î½üµÄijÖÖÇ÷ÊÆ£¬»òÕßÇ¿µ÷±íʾijЩ¡°×î½ü¡±·¢ÉúµÄʼþ¶ÔÏÖÔÚµÄÓ°Ïìʱ£¬³£²ÉÓÃÏÖÔÚÍê³Éʱ¡£ BYyR-m  
£¨3£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿µÄ·½·¨¼°½á¹ûµÄ¾ä×Óʱ£¬¶àʹÓùýȥʽ¡£ PR|F-/o  
£¨4£©ÔÚ²ûÊö×÷Õß±¾ÈËÑо¿Ä¿µÄµÄ¾ä×ÓÖÐÓ¦ÓÐÀàËÆ¡°In this study,¡­¡±¡¢¡°The experiment reported here.¡±µÈ´Ê£¬ÒÔ±íʾËùÉæ¼°µÄÄÚÈÝÊÇ×÷ÕßÏÖÔڵŤ×÷£¬¶ø²»ÊÇÖ¸ÆäËûѧÕß»òÕß×÷Õß¹ýÈ¥µÄÑо¿¡£ .v9#|d d+  
£¨5£©Êǵ±µØÊ¹ÓõÚÒ»È˳ÆÈç¡°we¡±»ò¡°our¡±£¬ÒÔÃ÷È·µØÖ¸Ã÷ÊÇ×÷Õß±¾È˵Ť×÷¡£ e]'ui<`  
¡¾ÍƼö¡¿We conducted this study to determine whether ... ly7\H3  
[²»ÍƼö]This study was conducted to determine whether ¡­ 3u^U\xB  
5.ÒýÑÔд×÷Öг£¼ûµÄ´íÎó 2)Grl;T]s  
£¨1£©ÒýÑÔ¹ý¼ò¡£  btJ:Wt}  
£¨2£©Ïà¹Ø±³¾°Ñо¿½»´úº¬ºý¡£ s% 2w&Us*  
£¨3£©ÆÌµæÌ«Ô¶£¬ÈÆÁËÒ»¸ö´óȦ×ӲŽøÈëÖ÷Ìâ¡£ 6.ASLH3#  
£¨4£©ÃèÊö¸ÃÑо¿µÄÖØÒªÐÔ£¬µ«ÊÇ¿´Ã»Óн»´úÏà¹ØµÄÀàËÆÑо¿¡£ |77.Lqqy,  

kaobook 2011-08-17 22:33
µÚ9ÕÂÈçºÎSCIÂÛÎĵÄʵÑé²ÄÁϺͷ½·¨ `G7LM55  
ʵÑé²ÄÁϺͷ½·¨£¨Materials and Methods£©Õ½ÚÃèÊöÄãÊÇÔõÑùÀ´Ñо¿ÎÊÌ⣨How did you study the problem£©£¬°üÀ¨£º¢ÙÄãÓÃÁËʲô£¿£¨What did you use?£©¢ÚʵÑé¹ý³Ì£¿£¨How did you proceed?£© 5x856RQ'  
1.ʵÑé²ÄÁϺͷ½·¨µÄÖØÒªÐÔ U4)x"s[CP  
£¨1£©¿ÆÑ§³É¹û±ØÐëÊÇ¿ÉÖØ¸´ÐԵġ£¡°ÊµÑé²ÄÁϺͷ½·¨¡±Õ½ڵĹؼüÊDZ£Ö¤ËûÈË¿ÉÒÔÖØ¸´ÄãµÄ½á¹û£¬ÒòΪ±¾Õ½ÚÃèÊöÄã×öÁËʲô¡¢Ôõô×öºÍÓÃÁËʲô¡£ OH.^m6Z  
£¨2£©ÉóºËÕß³£³£×ÐϸÑо¿±¾Õ½ڡ£Éó¸åÕ߸ù¾ÝÄãÌṩµÄʵÑé²ÄÁϺͷ½·¨À´ÅжϺ;ö¶¨ºóÊÇ·ñÂÛÎĵĽá¹û¿ÉÒÔÐÅÈΡ£Èç¹ûÉó¸åÕßÈÏΪʵÑé²ÄÁϺͷ½·¨ÓÐȱÏÝ£¬Ôò¸ÃÂÛÎĵÄÉè¼ÆÒ²ÓÐȱÏÝ¡£Æä½á¹ûÊǸÃÂÛÎı»¾Ü¾ø¡£ [rk*4b^s  
Òò´Ë£¬ËäȻʵÑé²ÄÁϺͷ½·¨µÄд×÷Ïà¶Ô½ÏΪ¼òµ¥£¬µ«ÊÇÐèҪעÒâµÄÎÊÌâ²»ÉÙ£¬Öа¡Ó´µÄÔÚÓÚÍêÕûµÄÃèÊö¡£ÍêÕûÐÔ¾ÍÊÇʵÑéµ±ÖеÄÿһ¸ö»·½Ú¶¼Òª×¢Òâµ½£¬²»Òª¹Ë´Ëʧ±Ë£¬ÒÅÂ©Ò»Ð©ÖØÒªÄÚÈÝ¡£ 9<0TF+}>  
2. ʵÑé²ÄÁϺͷ½·¨µÄÖ÷ÒªÄÚÈÝ WK$75G,  
ʵÑé²ÄÁϺͷ½·¨²¿·Ö¿ÉÒÔ°´ÒÔÏÂÈý¸ö·½ÃæÀ´ÃèÊö¡£ .)=T1^[hI  
£¨1£©ÄãÓÃÁËʲô£¬°üÀ¨£º p[oR4 HWr  
¨SʵÑé¶ÔÏó£¨experimental subjects£©£ºÒ»°ãÊÇÈË¡¢¶¯Îï¡¢Ö²Îï»òÕßһЩ×éÖ¯µÈ£¬ËûÃǵĻù±¾ÐÅÏ¢ÒªÃèÊöÃ÷È·¡£Òª×¢ÒâSCIÂÛÎÄÆÚ¿¯´ó¶à¶ÔÇ£³¶µ½ÈË»ò¶¯ÎïµÄʵÑé¶¼ÊÇÒª¶¯ÎïίԱ»á£¨Institutional Animal care and Use Committee, IACUC£©»òÂ×ÀíίԱ»á£¨Institutional review Boards, IRB£©Í¨¹ý¡£ÏêÇéÁ´½ÓÍøÖ·£ºhttp://grants.nih.gov/grants/olaw/GuideBook.pdf¡£ºÍhttp://www.hhs.gov/ohrp/irb/irb_guidebook.htm¡£·½·¨Ñ§Ò»¶¨Òª×öµ½£ºÁÙ´²Ñо¿Óв¡ÈËÖªÇéͬÒâÊ飬ͨ¹ýÂ×ÀíίԱ»áÅú×¼£»¶¯ÎïʵÑé·ûºÏ±¾ÈË´óѧ»òÕßÑо¿µ¥Î»µÄ¶¯Îï¹ÜÀíÓ붯ÎïʵÑéµÄÕ³̵ȡ£Òò´Ë£¬ÈÏÕæÔĶÁͶ¸å¿¯ÎïÖйØÓÚʵÑéµÄÏêϸ¹æ¶¨¡£Èç¹ûÎ¥·´ÕâÒ»¹æ¶¨£¬¿ÉÄܻᱻ²»½ÓÊÜÆÀÉó»ò·¢±í¡£ÒªÃèÊöʵÑ鶯ÎïµÄfull binominal latin names¡¢ÖÖϵºÍÀ´Ô´¡£ mV!Ia-k  
ʾÀýÒ» ¶¯ÎïµÄʵÑéÃèÊö SB~HHx09  
Animal model <14,xYpE  
All surgical procedures postoperative care was performed in accordance with guidelines of the Yale Animal Care and Use Committee. Focal cortical ischesia was induced in male mice(8-10 weeks old)weighing 20-25gm by photothrombosis of cortical microvessels as described previously in detail (Boquillon et al.,1992;Schroeter et al.,2002).Each mouse was anesthetized with 25 isoflurane and maintained with 1% isoflurane in an oxygen/air mixture using a gas anesthesia mask in a stereotaxic frame(Stoelting, Wood Dale,IL).The recal temperature was controlled during surgery at 37¡À0.5¡æ with a homeothermic blanket(Harvard Apparatus,Holliston,MA)¡­ <"/b 5kc  
ʾÀý¶þ ÈËÌåʵÑéÃèÊö pHKcKqB*13  
Human samples 03N|@Tu  
The experiments were carried out in accordance with the Declaration of Helsinki(2000) of the World Medical Association and the protocols approved by the Institutional Research Review Board at ¡Á¡Á¡ÁHospital of Beijing University,with informed consent¡­ ?e=3G4N  
¨SʵÑé²ÄÁÏ£¨experimental materials£©£º¶Ô²ÄÁϵÄÃèÊöÓ¦Çå³þºÍÏêϸ¡£Èç¹û²ÉÓÃͨÓòÄÁϺÍͨÓ÷½·¨£¬Ö»Ðè¼òµ¥Ìá¼°¡£ÀýÈ磬¡°Detail on calculating CBF have been described previously (reference)¡±»òÕß¡°the CBF was calculated based on X%(1C,C(  
The protocol as previously described (reference)¡±¡£Èç¹û²ÉÓÃÓиĽøµÄÌØÊâ²ÄÁϺÍʵÑé·½·¨£¬¾ÍÓ¦¸Ã½ÏÏêϸµÄ¼ÓÒÔ˵Ã÷¡£»¯Ñ§Ò©Æ·ºÍʵ¼ÊµÄÉÌÒµÀ´Ô´Ó¦¸Ã˵Ã÷£¬µ«Êǹ«Ë¾µØÖ·²»±ØËµÃ÷£¬Èç¡°¡­poly-l-Lysine(Sigma#1309)¡±·ÇÉÌÒµÀ´Ô´µÄ»¯Ñ§Ò©Æ·ºÍÊÔ¼Á±ØÐëÌṩµØÖ·£¬Èç¡°The DCX antibody was kindly provived by Peter A.Rice(Buck Institute La Jolla,CA)¡±¡£ M2Q*#U>6r  
¨SʵÑéÉ豸£¨experimental equipment£©:Òª¶ÔÒÇÆ÷Ðͺš¢Éú²ú³§¼Ò¡¢ÊµÑé¹ý³ÌÖеÄÓÃ;µÈ×÷Ïêϸ˵Ã÷£»É豸ʹÓÃʱһЩ±ØÒªµÄµÄ²½Öè²»¿ÉÊ¡ÂÔ£¬ÓÈÆäÊÇ¿ÉÄܶÔʵÑé½á¹ûÔì³ÉÌØ¶¨Ó°ÏìµÄ²Ù×÷¸üÒªÏêϸ˵Ã÷¡£ÕâÑù×öµÄºÃ´¦ÊÇΪÁËÔÚDiscussionÕ½ÚÖÐÄܹ»½øÐжÔÓ¦µÄ·ÖÎö¡£ÀýÈ磬һЩÉ豸ÔÚʹÓÃǰҪУÕý£¨calibration£©£¬ÓеÄÒªÇóÿ½×¶ÎÊÔÑéÖ®ºó¶¼ÒªÖØÐÂУÕý£¬ÒÔ±£Ö¤½á¹ûµÄÕýÈ·ÐÔ¡£Ò»¶¨ÒªÏêϸ˵Ã÷ÄãµÄ²Ù×÷²½Öè»òУÕý¹ý³Ì£¬±ãÓÚÆÀÉóÈË·ÖÎöÄãµÄ½á¹ûµÄ¿É¿¿ÐÔ¡£ t =LIkwD  
ʾÀýÈý ʵÑéÉ豸ºÍʵÑé¹ý³ÌµÄ·½·¨Ð´×÷ [A jY  ~  
Apparatus ,4W~CkLD  
NRI data were acquired at 1.5-T clinical MRI system(Signa,GE Medcial Systems)using the product head coil and foam cushions to minimize head movement. A standard 3D inversion recovery prepped T1-weighted spoiled gradient dcho(GE)sequence (echo time [TE]/repetition time [TR]=8.6/1.6ms;field of view [FOV] of 24mm, 1mm isotropic resolution)was acquire for anatomical localization and a CSF-nulled T2-weighted FLAIR sequence(TE/TR=11002/145ms,FOV 24mm,slice thinkness of 5mm,256x192matrix) was acquired to identify regions of prior cerebral infarction¡­ #*;G8yV  
Stroke,2006,37:382-387 .+3~ w  
£¨2£©ÊµÑé¹ý³Ì£¨experimental procedures£©£º¶ÔʵÑéµÄÕû¸ö²Ù×÷Á÷³ÌÃèÊöÒªÏêÂԵõ±¡¢ÖصãÍ»³ö¡£Ó¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑé¡£Èç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÐèµÄµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£ÐðÊöʱ£¬²»ÒªÂÞÁÐʵÑé¹ý³Ì£¬¶øÖ»ÐðÊöÖ÷ÒªµÄ¡¢¹Ø¼üµÄ¡£²¢ËµÃ÷ʹÓò»Í¬ÓÚÒ»°ãʵÑéµÄµÄÉ豸ºÍ²Ù×÷·½·¨£¬´Ó¶øÊÇÑо¿³É¹ûµÄ¹æ·¶ÐÔ¸ü¼ÓÏÊÃ÷¡£ÐðÊöʵÑé¾­¹ý£¬Í¨³£²ÉÓÃÑо¿¹¤×÷µÄÂß¼­Ë³Ðò£¬¶ø²»°´ÊµÑéÏȺó˳Ðò£¬Òª×¥×¡»·½Ú£¬£¬´Ó¸´ÔÓµÄÊÂÎïÖÐÀí³öÂöÂ磬°´Æä·¢Õ¹±ä»¯¹æÂÉд¡£  9}-;OJe  
£¨3£©½á¹ûµÄͳ¼Æ´¦Àí£¨How the data were analyzed?£©¡£ÊµÑéµÄ½á¹ûÐèÒª½øÐÐͳ¼Æ´¦Àíʱ£¬ÒªÌṩ×ã¹»µÄÐÅÏ¢£¬°üÀ¨£º vw~=z6Ka  
¨SʵÑéÖØ¸´Á˼¸´Î£¬Ò»°ãÀ´ËµÊµÑéÖÁÉÙÖØ¸´Èý´Î¡£ (#e,tu  
¨S¾ùÖµ¡£ K&"ZZFd_  
¨S±ê×¼Îó£¨SEM£©»ò±ê×¼²î£¨SD£©¡£ 1&Z#$iD  
¨Sͳ¼Æ·ÖÎöµÄ·½·¨¡£ H8!; XB  
¨SPÖµ£¨P value£©¡£ =w!>/#U  
3.²ÄÁϺÍд×÷·½·¨µÄÒªµã 4De2m iq  
£¨1£©ÃèÊöʵÑé¹ý³ÌÓ¦×ñÑ­µÄÔ­ÔòÊǸø³ö×ã¹»µÄϸ½ÚÐÅÏ¢ÒÔ±ãÈÃͬÐÐÄܹ»Öظ´ÊÔÑ飬±ÜÃâ»ìÈëÓйؽá¹û»ò·¢ÏÖijЩ·½ÃæµÄÄÚÈÝ¡£ Jb;@'o6  
£¨2£©Ð´×÷ʱҪÏêÂԵõ±¡£×ñÑ­µÄÔ­ÔòÊÇ£ºÈç¹û·½·¨ÐÂÓ±ÇÒ²»Ôø·¢±í¹ý£¬Ó¦ÌṩËùÓбØÒªµÄϸ½Ú£»Èç¹ûËù²ÉÓõķ½·¨ÒѾ­¹«¿ª±¨µÀ¹ý£¬ÒýÓÃÏà¹ØµÄÎÄÏ×¼´¿É¡£Èç¹û¸Ä½ø£¬¿ÉÓá°Briefly¡±¡°In brief¡±½«¸Ä½øµÄ²¿·ÖÁí¼Ó˵Ã÷¡£ P>}OwW  
£¨3£©Ò©Æ·ºÍÊÔ¼ÁµÄŨ¶È£¬Ê²Ã´Ê±ºò´¦ÀíµÄ¡¢´¦Àíʱ¼äµÄ³¤¶ÈµÈÐðÊöÒ²ºÜÖØÒª£¬ÌرðÊǵ±Ìõ¼þÓб仯ʱ¡£ bVxbQ$  
£¨4£©¿ÉÒÔÓÃÁ÷³Ìͼ½øÐÐ˵Ã÷ʵÑé¹ý³Ì¡£Á÷³ÌͼµÄ»­·¨ºÜ¶à£¬ÓÐÎÄ×ÖʽµÄ£¬ÓÐÎÄ×ÖºÍʾÒâͼ½áºÏµÄ£¬²»Í¬ÊµÑéÓв»Í¬×ö·¨¡£Ò»°ãÀ´Ëµ£¬¿ÉÄܺóÕß¶àһЩ£¨ÊµÑéÐÔѧ¿ÆÓÈÆäÈç´Ë£©£¬ÒòΪÕâÑùÄÜʹÆÀÉóÈ˶ÔʵÑé¹ý³ÌһĿÁËÈ»¡£Èç¹ûʾÒâͼ»­µÃƯÁÁ£¬»¹¿ÉÒÔÔö¼ÓһЩӡÏó·Ö¡£ÃèÊöʱҪÓÐÏÊÃ÷µÄ²ã´Î¸Ð£¬¶Ôÿ¸ö²½ÖèÖ®¼äµÄ˳ÐòºÍ¹ØÁªÒªÃèÊöÇå³þ£¬²»ÒªÔì³ÉʵÑé¹ý³Ì»ìÂÒ²»¿°µÄÓ¡Ïó¡£ ,7:? Du}  
£¨5£©²»ÒªÖظ´ÃèÊö¡£ YMG~k3Yb  
4.ÂÛÎÄÖг£´æÔÚͳ¼Æ·½·¨Ñ¡Ôñ²»µ±ºÍÓ¦Óò»ÕýÈ·µÈÎÊÌâ F+<e9[  
£¨1£©Í³¼Æ·½·¨ÃèÊö²»Ç壬½áÂÛÇ·¿ÆÑ§¡£ÎÄÖÐδ½»´ýËùÓÃͳ¼Æ·½·¨»òͳ¼Æ·½·¨½»´ú²»Çå»ò¸ù±¾²»Óè½»´ú£¬Ê¹¶ÁÕß¶ÔÂÛÎĵÄÕýÈ·Óë·ñÎÞ·¨Åжϡ£ÓеÄ×÷ÕßÖ»ÌáÒ»¾ä¡°¾­Í³¼ÆÑ§´¦Àí¡±ºó£¬¾Íд³ö½áÂÛ¡£ÓеÄÉõÖÁÖ±½ÓÓÃPֵ˵Ã÷ÎÊÌ⣬ÁýͳµØÒÔP£¾0.05»òP£¼0.05¡¢P£¼0.01±ã³Æ½á¹û²îÒìÓÐÎÞÏÔÖøÐÔ£¬PÖµµÄ´óС²»ËµÃ÷²îÖµµÄ´óС£¬Ëü»¹Óë³éÑùÎó²î´óСÓйء£Òò´Ë£¬»¹Ó¦¸ÃдÃ÷¾ßÌåµÄͳ¼Æ·½·¨£¬ÈçÓÐÌØÊâÇé¿ö£¬»¹Ó¦¸Ã˵Ã÷ÊÇ·ñ²ÉÓÃÁËУÕý£¬Ó¦Ð´³öÃèÊöÐÔͳ¼ÆÁ¿µÄ¿ÉÐÅÇø¼ä£¬×¢Ã÷¾«È·Í³¼ÆÖµ£¨ÈçtÖµ¡¢FÖµºÍuÖµµÈ£©ºÍPÖµ£¬È»ºó¸ù¾ÝPÖµ´óС×ö³öͳ¼ÆÑ§ÍƲ⣬²¢×ö³öÏàÓ¦µÄרҵ½áÂÛ¡£ `g}po%k  
£¨2£©©~ͳ¼Æ¼ìÑé·½·¨²»ÕýÈ·¡£¾ßÌå±íÏÖÔÚ£º <`)vp0  
¡òtÖµ¼ìÑéÓÃÓÚ¶à×é×ÊÁϱȽϡ£ V=d~}PJ>  
¡ò³É×ét¼ìÑéÓëÅä¶Ôt¼ìÑéÎóÓᣠMni@@W  
¡ò¶ÔÓÚÆ«Ì¬·Ö²¼µÄÊý¾Ý²ÉÓÃt¼ìÑé»ò·½²î·ÖÎö¡£ mI> =S  
¡òËĸñ±íµÄ¼ìÑéÎóÓ㬹¹³É±ÈÓëÂʵÄÎóÓ㬷ÇÕý̬·ÖÎö×ÊÁÏÓáÀSM·½Ê½À´ÃèÊö¡£ @1vpkB~ w  
ÕâЩ´íÎóµÄ·½·¨±ØÈ»µ¼Ö´íÎóµÄ½áÂÛ¡£ÕýÈ·µÄ×ö·¨ÊÇÅä¶ÔÉè¼ÆµÄ¼ÆÁ¿×ÊÁÏÒËÑ¡ÓÃt¼ìÑé¡£t¼ìÑéºÍ·½²î¼ìÑéÖ»ÄÜÓÃÓÚÕý̬·Ö²¼µÄÊý¾ÝÖС£µ±·½²î²»Æëʱ£¬Ó¦Ñ¡ÓýüËÆµÄt¼ìÑ飬ÈôΪ´óÑù±¾£¨n£¾50£©£¬¿ÉÑ¡ÓÃu¼ìÑé¡£¶à×é¼ä¾ùÊý±È½Ïʱ£¬Èç¹û×ÊÁϳÊÕý̬·Ö²¼£¬ÇÒ·½²î³ÊÆëÐÔʱ£¬Ó¦¸ÃÓ÷½²î·ÖÎö£¨Ò²½ÐANOVA·ÖÎö£¬»òF¼ìÑ飩¡£ÒªÑо¿Ä³Á½¸ö»òij¼¸¸ö×ÜÌå¾ùÊýÊÇ·ñÏàµÈ£¬»¹ÒªÔÚ·½²î·ÖÎöµÄ»ù´¡ÉÏ£¬½øÒ»²½×öÁ½Á½±È½ÏµÄq¼ìÑ飨Ҳ½ÐStudent-Newman-Keuls¼ìÑé·¨£©¡£µ±¶à¸ö¹Û²ì×éÓëÒ»¸ö¶ÔÕÕ×é½øÐоùÊý¼ä±È½Ïʱ£¬Ó¦×÷Dunnett t¼ìÑé¡£ [gaB}aLn  
5.²ÄÁϺͷ½·¨Ð´×÷ʱ̬µÄÓ¦Óà $Wn!vbL  
£¨1£©ÈôÃèÊöµÄÄÚÈÝΪ²»ÊÜʱ¼äÓ°ÏìµÄÊÂʵ£¬Ôò²ÅÓÃÒ»°ãÏÖÔÚʱ¡£ yedEI[_4  
£¨2£©ÈçÃèÊöµÄÄÚÈÝÎªÌØ¶¨¡¢¹ýÈ¥µÄÐÐΪ»òʼþ£¬Ôò²ÉÓùýȥʱ¡£ d-{1>\-_  
£¨3£©·½·¨Õ½ڵĽ¹µãÔÚÓÚÃèÊöʵÑéÖÐËù½øÐеÄÿ¸ö²½ÖèÒÔ¼°Ëù²ÉÓõIJÄÁÏ¡£ÓÉÓÚËùÉæ¼°µÄÐÐΪÓë²ÄÁÏÊÇÌÖÂ۵Ľ¹µã£¬¶øÇÒ¶ÁÕßÒÑÖ¸µ¼½øÐÐÕâЩÐÐΪºÍ²ÉÓÃÕâЩ²ÄÁϵÄÈ˾ÍÊÇ×÷Õß×Ô¼º£¬Òò¶øÒ»°ã¶¼Ï°¹ß²ÉÓñ»¶¯Óï̬¡£ y9U*E80q{  
£¨4£©Èç¹ûÉæ¼°±í´ï×÷ÕߵĹ۵ã»ò¿´·¨£¬ÔòÓ¦²ÉÓÃÖ÷¶¯Óï̬¡£ ]?*'[  
£¨5£©Á¦ÇóÓï·¨ÕýÈ·¡¢ÃèÊö׼ȷ¡£ÓÉÓÚ²ÄÁϺͷ½·¨²¿·Öͨ³£ÐèÒª²ÉÓúܼò½àµÄÓïÑÔ£¬Ê¹Óþ«È·µÄÓ¢ÓïÃèÊö²ÄÁϺͷ½·¨ÊÇÊ®·ÖÖØÒªµÄ¡£ÐèҪעÒâµÄ·½ÃæÍ¨³£ÓУº wiP )"g.t  
¨S²»ÒªÒÅ©¶¯×÷µÄÖ´ÐÐÕß¡£ =/m$ayG  
¨SÔÚ¼òµ¥±í´ïµÄͬʱҪעÒâÄÚÈÝ·½ÃæµÄÂß¼­ÐÔ¡£ M@]@1Q.p  
¨SÈç¹ûÓжàÖֿɹ©Ñ¡ÔñµÄ·½·¨ÄܲÉÓã¬ÔÚÒýÓÃÎÄÏ×ʱÌἰһϾßÌåµÄ·½·¨¡£ g/+|gHq^  
¨SÆÕͨ¡¢¼òµ¥µÄ¹ý³Ì²»±ØÏêÊö¡£ -|2k$W  
¨S±ÜÃâʹÓú¬ºý²»ÇåµÄÃèÊö¡£ nV/;yl4e{  

kaobook 2011-08-17 22:34
µÚ10ÕÂÈçºÎÊéдSCIÂÛÎĵÄÑо¿½á¹û e ~ %=H 0n  
Ñо¿½á¹û£¨Results£©ÊÇһƪÂÛÎĵĺËÐÄ£¨the core of the paper£©,Æäˮƽ±êÖ¾×ÅÂÛÎĵÄѧÊõ»áƽ»ò¼¼Êõ´´Ðµij̶ȣ¬ÊÇÂÛÎĵÄÖ÷Ì岿·Ö¡£×ܵÄÒªÇóÊDZØÐëʵÊÂÇóÊÇ¡¢¿Í¹ÛÕæÊµ¡¢×¼È·µÄÓÃ˵Ã÷ÐÔ²ÄÁÏ£¨Í¼ºÍ±í£©ÃèÊöÖ÷Òª³É¹û»òÕß·¢ÏÖ¡£ÎÄ×ÖÃèÊöÒªºÏºõÂß¼­¡¢²ã´Î·ÖÃ÷¡¢¼òÁ·¿É¶Á¡£ÓÐÈ˰ÑResultsºÍDiscussion·ÅÔÚÒ»Æðд£¬µ«ÊÇ´ó¶àÊýÂÛÎÄÒªÇó·Ö¿ªÐðÊö¡£ÕâÁ½ÖÖ×ö·¨È¡¾öÓÚÂÛÎĵÄÀàÐÍ£¬±ÈÈçÊÇresearch article»¹ÊÇrapid communication¡£ÓÐһЩSCIÆÚ¿¯µÄrapid communicationÒªÇóresultÓëdiscussionºÏ²¢¡£ *&BS[0;  
1.Ñо¿½á¹ûµÄд×÷Òªµã cT|aQM@iW  
£¨1£©ÑÔ¼òÒâêࣨbe concise£©¡£¶ÔʵÑé»ò¹Û²ì½á¹ûµÄ±í´ïÒª¸ß¶È¸ÅÀ¨ºÍÌáÁ¶¡£²»Äܼòµ¥µØ¶ÔʵÑé¼Ç¼Êý¾Ý»ò¹Û²ìÊÂʵ¶Ñ»ýµ½ÂÛÎÄÖУ¬ÓÈÆäÊÇҪͻ³öÓпÆÑ§ÒâÒåºÍ¾ßÓдú±íÐÔµÄÊý¾Ý¡£ /5Tp)h|  
£¨2£©±ÜÃâÖØ¸´£¨avoid repetition£©¡£¾ö¶¨ÄÄһЩÄÉÈë½á¹ûÕ½ڣ¬ÄÄÒ»Ð©Ç¨ÒÆµ½ÌÖÂÛÕ½ڡ£ÔÚ½á¹ûÕ½ڣ¬ÄãÖ»ÃèÊö½á¹û£¬Ò»°ã×ö²»×ö½âÊÍ¡£ÔÚÌÖÂÛÕ½ڽøÐнâÊÍ£¬²¢ÓëÒÑÖªµÄ±¨µÀ±È½Ï£¬²»ÒªÖظ´ËùÓнá¹û¡£ |>/m{L[  
£¨3£©¶ÔʵÑé»ò¹Û²ì½á¹ûÒª¿Í¹ÛµØÆÀ¼Û¡£Äã¹Û²ìµ½Ê²Ã´»òÄã·¢ÏÖÁËʲô£¿¶Ôÿ¸öʵÑé»ò³ÌÐòÒª£º Z8I0v$LjR  
¨S¼òÊöʵÑ飨£©¡£ÀýÈ磬¡°By Western bolt abnaiysis,we found that¡­¡±¡£ E_H.!pr  
¨S±¨¸æµÄÖ÷Òª½á¹û£¨mains results£©°üÀ¨Ô¤ÆÚ½á¹û£¨positive results£©ºÍÒõÐÔ½á¹û£¨negative results£©¡£ !BDJU  
¨SµäÐÍʵÀý£º×î³£¼ûµÄ£¨most common£©¡£ Gt$PBlq0  
¨S×î¼Ñ°¸Àý£º×îÀíÏëµÄÀýÖ¤£¨best example of ideal or exception£©¡£ u= Vt3%q  
£¨4£©Ñо¿½á¹ûÊDZí´ï×÷Õß˼Ïë¹Ûµã×îÖØÒªµÄ²¿·Ö¡£Îª±í´ïÇå³þ£¬¶àÑо¿¹ý±ØÐë·Ö³ÉÈô¸É¸ö²ã´ÎÀ´Ð´¡£ÓеÄÑо¿½á¹ûÖ»·Ö³ÉÈô¸É¸ö×ÔÈ»¶Î¡£×¢ÒâÒ»¸ö×ÔÈ»¶ÎÖ»Äܱíʾһ¸öÖÐÐÄ˼Ïë¡£Ò²¿ÉÒÔ·Ö³ÉÈô¸É¸öС±êÌâ½øÐзֲã±íÊö£¬¶¼Òª×¢Òâ²ã´ÎÖ®¼äµÄÂß¼­¹ØÏµ¡£¶à½á¹ûµÄÂß¼­ÅÅÁУ¬Ó¦×ñÑ­ÒÔÏÂÔ­Ôò£º M*Ri1   
¨S´Ó×îÖØÒªµ½×î²»ÖØÒª£¨from most to least impirtant£©¡£ ,uL}O]L  
¨S´Ó¼òµ¥µ½¸´ÔÓ£¨from simple to complex£©¡£ Y' O3RA5E  
¨S°´ÏàͬÀàÅÅÁУ¬Èçorgan by organ¡¢chemical class by chemical class¡£ !@T5](zV  
¨Sд×÷Ó¦°´Ñо¿ÎÊÌâµÄÂß¼­¹ØÏµÀ´Ð´£¬²»Ó¦°´ÊµÑé»òʱ¼ä˳ÐòÀ´Ð´¡£ -5y=K40  
£¨5£©Êý¾Ý±í´ï¿É²ÉÓÃÎÄ×ÖÓëͼ±íÏà½áºÏµÄÐÎʽ¡£Èç¹ûÖ»ÓÐÒ»¸ö»òÕߺÜÉٵIJⶨ½á¹û£¬ÔÚÕýÎÄÖÐÓÃÎÄ×ÖÃèÊö¼´¿É£»Èç¹ûÊý¾Ý½Ï¶à£¬¿É²ÉÓÃͼ±íÐÎʽÀ´ÍêÕû¡¢ÏêϸµØ±íÊö¡£ÎÄ×Ö²¿·ÖÔòÓÃÀ´Ö¸³öͼ±íÖÐ×ÊÁϵÄÖØÒªÐÔÌØÕ÷»òÇ÷ÊÆ¡£ %\B@!4]  
£¨6£©Ò»°ã²»½âÊÍԭʼÊý¾Ý£¨do not interpret the data£©¡£Èç¹ûÂÛÎÄÖл¹°üÀ¨¶ÀÁ¢µÄDiscussionÕ½ڣ¬Ó¦½«¶ÔÓÚÑо¿½á¹ûµÄÏêϸÌÖÂÛÁôµ½¸Ã²¿·Ö¡£ i#%!J:_=  
ʾÀýÒ» M.K%;j`  
½á¹ûûÓнâÊÍ£º¡°The duration of exposure to running water had a pronounced effect on cumulative seed grermination percentages.Seeds exposured to the 2-day treatment had the highest cumulative germination(84%), 1.25times that of the 12-h or 5-day groups and 4 times that of controls¡±¡£ jm0v=m7  
´øÓнâÊÍÐÔ£º¡°The results of the germination experiment suggest that the optimal time for running-water treatment is 2-days.This group showed the highest cumulative germination(84%),with longer(5d) or shorter(12h) exposures producing smaller gains in germination when compared to the control group¡±¡£ &~"e["gF=  
£¨7£©ÎÄ×Ö±í´ïӦ׼ȷ¡¢¼ò½à¡¢Çå³þ¡£±ÜÃâʹÓÃÈß³¤µÄ´Ê»ã»ò¾ä×ÓÀ´½éÉÜ»ò½âÊÍͼ±í¡£Îª¼ò½à¡¢Çå³þÆð¼û£¬²»Òª°Ñͼ±íµÄÐòºÅ×÷Ϊ¶ÎÂäµÄÖ÷Ìâ¾ä£¬Ó¦ÔÚ¾ä×ÓÖÐÖ¸³öͼ±êËù½ÒʾµÄÀíÂÛ£¬°Ñͼ±íÖеÄÐòºÅ·ÅÈëÀ¨ºÅÖС£ <"Yx}5n.  
ÈçʾÀý Gj&`+!\  
[²»ÍƼö]Figure 2 shows that neurons were distinguished from astrocytes by the selectivelabeling of astrocytes with SR-101. do DpTwvh  
¡¾ÍƼö¡¿Neurons were distinguished from astrocytes by the selective labeling of astrocytes with SR-101(Fig.2). _n+ 5{\z  
[²»ÍƼö]The results are given in Figure 1. qa,i:T(w  
¡¾ÍƼö¡¿Temperature was directly proportional to metabolic rate(Fig.1). |W*i'E   
£¨8£©±ÜÃâ׸Êö¡£±ÜÃâͬÑùµÄÊý¾Ý³öÏÖÔÚͼºÍ±íÖС£ LvW7>-  
£¨9£©¾¡Á¿ÓþùÖµ¡¢°Ù·ÖÊýµÈ¸ÅÀ¨Ô­Ê¼Êý¾ÝÖµ£¨raw data£©¡£ UF;iw  
£¨10£©°üÀ¨Êý¾Ý»òͳ¼Æ×ÊÁÏʱ£¬Ó¦¸Ã¸³ÓèÊʵ±µÄµ¥Î»£¨appropriate units£©¡£ V5rW_X:]8  
ʾÀýÈçÏ£º i\C~]K~O!  
µ¥¸öÊý¾Ý¡°The maximum time was 140 min¡±¡£ g_e_L39  
¶àλÊý¾ÝÐèÒª¼ÓÉÏÎó²î£¨error value£©Èç¡°¡­was 10¡À2.3h¡±. "]hQ\b\O  
һϵÁеÄÊý×Ö¶¼ÓÐÏàͬµÄµ¥Î»£¬ÔÚβÊý¼Óµ¥Î»£¨units£©£¬Èç¡°No differences were observed after 2,4,6,or 8h of incubation¡±¡£ K9c5HuGy  
2.Ñо¿½á¹ûд×÷ʱ̬µÄÓ¦Óà }TG=ZVi  
£¨1£©ÐðÊöÑо¿½á¹ûµÄÄÚÈÝ£¬Í¨³£²ÉÓùýȥʽ¡£ |g!3f  
£¨2£©Í¼¡¢±íΪÖ÷Óïʱ£¬³£ÓÃÒ»°ãÏÖÔÚʱ¡£ .Lp\Jyegs  
£¨3£©¶ÔÑо¿½á¹û½øÐÐ˵Ã÷»òÓÉÆäµÃ³öÒ»°ãÐÔÍÆÂÛʱ£¬¶àÓÃÏÖÔÚʱ¡£ oT*qMLdn  
£¨4£©²»Í¬½á¹ûÖ®¼ä»òʵÑéÊý¾ÝÓëÀíÂÛÄ£ÐÍÖ®¼ä½øÐбȽÏʱ£¬¶à²ÉÓÃÒ»°ãÏÖÔÚʱ£¨ÕâÖֱȽϹØÏµ¶àΪ²»ÊÜʱ¼äÓ°ÏìµÄÂß¼­ÉϵÄÊÂʵ£©¡£ Cn.x:I@r  
3.Ñо¿½á¹ûµÄд×÷Óï̬ ;` ! j~  
½á¹û²¿·ÖÒÔ±»¶¯Óï̬ΪÖ÷¡£¿ÉÒԲβåÖ÷¶¯Óï̬¡£ `:kI@TPI_C  

kaobook 2011-08-17 22:34
µÚ11Õ ÈçºÎÕýÈ·±í´ïSCIÂÛÎÄÖеÄͼºÍ±í }$Z0v`  
ËäÈ»ÎÄ×ÖÊÇSCIÆÚ¿¯±í´ïµÄÖ÷ÒªÊֶΣ¬µ«ÔÚ±í´ï½á¹û·½Ã棬ͼºÍ±í£¨figures and tables£©±ÈÎÄ×Ö¸ü¾ßÓÐÖ±¹ÛÐÔ£¬ÇÒ¼òµ¥Ã÷ÁË£¬±ÜÃâÁËÈß³¤µÄÎÄ×ÖÐðÊö¡£ËüÄܹ»ÒÔ½ÏСµÄ¿Õ¼ä³ÐÔØ×Ž϶àµÄÐÅÏ¢£¬Ö±¹Û¡¢¸ßЧµØ±í´ï¸´ÔÓµÄÊý¾ÝºÍ¹Ûµã£¬Ê¹¶ÁÕßÀí½âÎÄÕÂËùÐðÊöÊÂÎïµÄÐÎ̬¼°±ä»¯¹æÂÉ£¬²¹³äÎÄ×ÖÐðÊöµÄ²»×ã¡£ÓÈÆäÊÇÔÚÃèÊö±äÁ¿¼äµÄÏ໥×÷Óûò·ÇÏßÐÔ¹ØÏµÊ±£¬ËüÒ²Äܹ»°ÑÓÃÎÄ×ÖÓïÑÔÄÑÒÔ±íÊöÇå³þµÄÄÚÈÝ£¬¼òÃ÷µØ³ÊÏÖ³öÀ´£¬Ê¹ÂÛÎĵÄÄÚÈݱí´ïµÄ¸üºÏÀí¡¢¸üÍêÉÆ¡£Òª¼Çס£º¡°A picture is worth a thousand words¡±¡£ ##BfI`FJ  
1.²åͼµÄÀàÐÍ SCIÂÛÎÄÖеIJåͼÖÖÀàºÜ¶à£¬³£ÓõÄÓУº ;P9cjfSn  
£¨1£©ÏßÐÎͼ£¨line graphs£©¡£ÓÃÓÚ˵Ã÷Á½¸ö±äÁ¿£¨two variables£©Ö®¼äµÄ¹ØÏµºÍÇ÷ÊÆ(trends and relationships between data)¡£×Ô±äÁ¿£¨independent variable£©±êÔÚX-ÖáÉÏ£¨X-axis£©£¬Òò±äÁ¿(dependents variable)±êÔÚY-ÖáÉÏ(Y-axis)¡£³£ÓÃÓÚÏÔʾÁ¬ÐøÐԱ仯¡£ÏßÐÎͼÖеÄÏßÌõÊýĿһ°ã²»³¬¹ý5Ìõ£¬µ«ÎÞÂÛ¼¸Ìõ£¬¶¼Ó¦ÒÔÄܹ»ÇåÎú·Ö±æÎªÔ­Ôò¡£ÏßÐÎͼҪÇó£º kR65{h"gZT  
¨SÏßÌõÇåÎú¼ò½à¡£ 1s 6L]&B  
¨SͼÐÎÖеÄÎÄ×Ö¡¢±êÖµÓ¦Ò×ÓÚ±æÈÏ¡£ ^n9)rsb  
¨S×ø±êÖáÅԵıêĿӦ°üº¬²âÁ¿µ¥Î»¡£ 4#lOAzDtv  
¨S±íʾ²»Í¬±äÁ¿µÄ·ûºÅÈÝÒ×Çø·Ö¡£ ?XB[awTD~  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏò´¹Ö±¡£ @ ('/NjTZ  
£¨2£©ÌõÐÎͼ»òÖ±·½Í¼£¨bar graphs or histograms£©¡£ GEtzLaq<  
µ±×Ô±äÁ¿ÊÇ·ÖÀàÊý¾Ýʱ£¬¿ÉÒÔ²ÉÓÃÌõÐÎͼ»òÖ±·½Í¼À´ËµÃ÷×Ô±äÁ¿µÄ¹ØÁª¡£ÌõÐÎͼ»òÖ±·½Í¼Ö÷ÒªÓÃÓÚ½ÒʾÁ˱仯·ù¶È£¨change in magnitude£©£¬¶øÏßÐÎͼÖ÷ÒªÊÇÓÃÀ´ÏÔʾ¸Ä±ä·½Ïò»òÕßÇ÷ÊÆ£¨change in direction£©¡£ÌõÐÎͼ»òÖ±·½Í¼¿ÉÒÔÊÇ×ÝÏò»òºáÏò¡£Ã¿Ìõ´ú±íÒ»ÀàÊý¾Ý£¬ÌõµÄ³¤¶Ì±íʾÊý¾ÝµÄ´óС¡£ÓÐʱһÀà±äÁ¿ÓÖ·ÖΪ¼¸¸öˮƽ£¬¾ÍÐèÒªÓÃÏàÓ¦ÊýÁ¿µÄÌõÀ´±íʾ¡£³£¼ûÌõÐÎͼ¾ßÓÐÏÂÁÐÀàÐÍ£º PdSYFJM  
¨SÊúʽÌõÐÎͼ£¨vertical bar graphs£©¡£ >8.o  
¨SµþʽÌõÐÎͼ£¨stacked bar graphs£©¡£ ph>0?Z =bn  
¨SµãʽÌõÐÎͼ£¨dot graphs£©¡£ {8T/;K@  
ÌõÐÎͼ»òÖ±·½Í¼ÒªÇó£º GGez!?E%  
¨S²»Í¬µÄÌõÓÐÃ÷ÏÔÇø·Ö¡£ si#1sdR  
¨SÖáÉϵĿ̶ÈÒ×ÓÚ±æÈÏ£¬×Ý×ø±êµÄ±êÄ¿°üº¬²âÁ¿µ¥Î»¡£  P@FE3g  
¨S×Ý×ø±êµÄ³¤¶ÈÖÁÉÙºÍ×µÄÌõµÄ³¤¶ÈÏàµÈ¡£ <g1=jG:7k  
¨SͼÖеÄÎÄ×Ö¡¢Êý×ÖÓ¦Ò×ÓÚ±æÈÏ¡£ )Y:C'*.r  
¨S×Ý×ø±ê±êÄ¿µÄÎÄ×Ö·½ÏòÓë×ø±êÖáÏà´¹Ö±¡£ KZGy&u >`  
£¨3£©±ýÐÎͼ»ò°Ù·Ö±Èͼ£¨pie or percentage graphs£©¡£ W]I+Rlv)U  
ÓÃÀ´ÏÔʾ¸÷ÖÖÊý×Ö±ÈÀý¹ØÏµµÄͳ¼ÆÍ¼¡£°Ñµ¥Î»Ô²ÊÓΪ100%£¬¸÷ÖֳɷֵÄÊýÁ¿°´ÔÚÕûÌåÖÐËùÕ¼µÄ·Ý¶îÔÚÔ²ÐÎÖÐÏÔʾ¡£ÔÚÓÃÓڶԱȼ¸¸öÊý¾ÝÔÚÆäÐγɵÄ×ÛºÏÖÐËùÕ¼°Ù·Ö±Èֵʱ×îÓÐÓ᣾¡¹Ü±ýÐÎͼÒ×ѧºÃÓ㬵«ÔÚʵ¼Ê¹¤×÷ÖÐʹÓñȽÏÉÙ¡£ÆäÔ­Òò£ºÊ×ÏÈ£¬±È½ÏµÄÏîĿһ°ã²»Äܳ¬¹ý6¸ö¡£·ñÔòͼÐλáÌ«¸´ÔÓÄÑÒÔÀí½â¡£Æä´Î£¬µµ±È½ÏµÄÊý¾ÝºÜ½Ó½üʱ£¬¾ÍºÜÄÑ¿´µ½¸÷²¿·ÖµÄ²îÒ졣ͻ³ö¸÷²¿·Ö½ÏºÃµÄ·½·¨Ö®Ò»ÊÇ´ÓÃ÷µ½°µÓò»Í¬µÄÑÕÉ«»òµã¸ø¸÷¸ö²¿·ÖͼÉÏÒõÓ°£¬×îСµÄ²¿·Ö×îºÚ¡£»òÕßÓò»Í¬µÄÑÕÉ«À´±íʾ¡£ÖÆÍ¼µÄ¼ÆËã·½·¨£º°Ù·Ö±È¡Â100¡Á360¡ã=¡Á¡Á¡Á¡ã H cCT=x7:  
£¨4£©É¢µãͼ£¨scatter graphs, scatterplot£©¡£ÓÉÈô¸É¸öµã×é³É£¬ÕâЩµã¶ÔÓ¦ÓÚÆ½ÃæÖ±½Ç×ø±êϵÖеÄ×ݺáÖáÁ½¸ö±äÁ¿£¬±íʾij¸öʼþµÄÊýÖµ¡£Í¨³£ÓÃÓڱȽϿçÀà±ðµÄ·ÇÖØ¸´Öµ¡£¿É´ÓµãµÄλÖÃÅжϲâÁ¿ÖµµÄ¸ßµÍ¡¢´óС¡¢±ä¶¯Ç÷ÊÆ»ò±ä»¯·¶Î§¡£É¢µãͼ¼ÓÈëÇúÏߣ¬¿ÉÒÔ¿´µ½Ç÷ÊÆ¡£Èç¹ûËùÓеĵ㹹³ÉÒ»¸öÌõÐΣ¬Ôò˵Ã÷´æÔÚÏà¹Ø¹ØÏµ¡£ÀýÈç£¬ÑØ×ÅбÏßÉϵÄÒ»µãÒâζ×ÅÏßÐÔÏà¹Ø£¬Èç¹ûËùÓе㶼ÂäÔÚÒ»ÌõбÏßÉÏ£¬ÄÇôÆäÏà¹ØÏµÊýΪ1.00¡£ )jGB[s";)y  
£¨5£©½á¹¹Í¼»òÁ÷³Ìͼ£¨structure graph or flow chart£©Äܹ»ÃèÊö²Ù×÷¹ý³ÌµÄ²½ÖèÖ®¼ä¡¢Ð¡×éÄÚ¸÷²¿·ÖÖ®¼äµÄ¹ØÏµ¡£½á¹¹Í¼¾­³£ÊÇ·½¿é»òԲȦÓëÏßÁ¬Óá£ÀýÈ磬×éÖ¯½á¹¹Í¼¿ÉÒÔÏÔʾ³ö³ÉÔ±¼äµÄµÈ¼¶£»Á÷³Ì½á¹¹Í¼ÏÔʾһ¸ö¹ý³ÌÖеĸ÷¸ö²½Ö裻ģÐͽṹͼ¿ÉÒÔÏÔʾ²»Í¬±äÁ¿Ö®¼äµÄ¹ØÏµ¡£ 2Z+:^5  
½á¹¹Í¼ÒªÇó£º )8%m|v#W  
¨SͬһÐÔÖʱäÁ¿ËùÓõķ½¿ò»òԲȦӦ´óСÏàͬ£¬ÏßÐÎÒ»Ö¡£ A5go)~x\  
¨SËùÓеÄÏßÌõµÄ´Öϸ¡¢¼ýÍ·µÄÐÎ×´Ó¦Ò»Ö¡£ \S0QZQbz/  
£¨6£©ÕÕÆ¬Í¼£¨£©ÓÃÓÚÏÔʾÏÔ΢¾µÏÂ×éÖ¯ÇÐÆ¬Ïà¡¢·ÅÉäÓ°Ïñ¡¢´óÌå±ê±¾¼°ÐÎÌ¬Ñ§ÌØÕ÷£¬ÕæÊÇ¡¢Ö±¹Û¡¢ÐÅÏ¢Á¿´ó¡£ÕÕÆ¬Í¼ÖÊÁ¿µÄºÃ»µÊǾö¶¨ÂÛÎÄÄÜ·ñ·¢±íµÄÒ»¸öÖØÒªÒòËØ¡£ WB5M ![  
ÕÕÆ¬Í¼ÒªÇó£º Mb=j'H<N@  
¨SÇåÎú¶È¸ß£¬¶Ô±È¶ÈºÃ¡£ _~bG[lX!  
¨S×éÖ¯ÇÐÆ¬ÕÕÆ¬Ó¦±êÃ÷±ÈÀý³ßºÍȾɫ·½·¨¡£ SAhk`_  
¨SʵÎïÕÕÆ¬Îª±íÃ÷ʵÎï´óС£¬²¢½«±ÈÀý³ßͬʱÅÄÔÚÕÕÆ¬ÉÏ¡£ e[Jh7r>'  
¨SÒª¶Ô±ÈÇ¿ÁÒ¡¢ÖصãÍ»³ö¡£ _K3;$2d|R  
2.²åͼµÄÌØÕ÷ [oOV@GE  
SCIÂÛÎĵIJåͼÆäÌØÕ÷ÓУº s9,Z}]Th  
¨SͼÐεÄʾÒâÐÔ¡£´ÓͼÖеóö¸÷Á¿ÖµÖ®¼äµÄ¾«È·¹ØÏµ¡£ eI1C0Uz1  
¨SÄÚÈݵÄдʵÐÔ¡£·´Ó¦±ä»¯¹æÂÉ£¬¸÷Á¿ÖµÖ®¼äµÄÏ໥±ä»¯¹ØÏµ¡£ Ie(M9QMp  
¨S±í´ïµÄ¹æ·¶ÐÔ¡£Í¼ÖеÄÏßÐΡ¢ÎÄ×Ö¡¢·ûºÅµÈÓ¦·ûºÏÓйرê×¼µÄ¹æ¶¨ºÍ¹«ÈϵÄϰ¹ß¡£ÔÚͬһƪÎÄÕÂÖУ¬Í¬Ò»ÐÔÖʲåͼµÄ×ÖÌå¡¢×ֺš¢Ö÷¸¨ÏßÌõ´Öϸ¡¢µ¥Î»·ûºÅµÈÒªÏàͬ¡£ S,f:nLT  
3.²åͼҪÇó v]y=+* A  
ͼÒ×ÓڱȽϡ¢ËµÃ÷ÎÊÌâ¡£²àÖØ±íÏÖ¹ØÁª¡¢Ç÷ÊÆ¡¢Òò¹û¹ØÏµµÈ¡£Ê¹ÓÃʱӦÉÙ¶ø¾«£¬Òª»æÖƵÄÇåÎú¡¢¼òÃ÷¡¢´ó·½¡¢ÃÀ¹Û£¬Ê¹ÈËͨ¹ý¿´Í¼Äܹ»¼ÓÉî¶ÔÄÚÈݵÄÀí½â¡£ I ;F\'P)e  
£¨1£©Í¼±íÓ¦¾ßÓÐ×ÔÃ÷ÐÔ£¨£©£¬¼´Ö»¿´Í¼¡¢Í¼½âºÍͼÀý¡¢²»ÔĶÁÕýÎÄ£¬¾Í¿ÉÒÔÀí½âͼÒâ¡£ La$?/\Dv)  
£¨2£©²¹³ä¶ø²»ÊÇÖØ¸´ÎÄ×ÖµÄÃèÊö¡£ 6 -BC/  
£¨3£©ÃèÊö×î»ù±¾¡¢×îÖØÒªµÄÊÂʵ¡£ Bdm05}c@u  
£¨4£©¼òÃ÷£¬Ê¡ÂÔ²»±ØÒªµÄϸ½Ú¡£ ZMGC@4^F  
£¨5£©²åͼӦ¸ÃÓÐͼÐòºÍͼÌ⡣һƪÎÄÕÂÖ»ÓÐÒ»¸ö²åͼÕßÒ²Ó¦ÓÐÐòºÅ£¬ÈçFigure 1(Fig 1)¡£Í¼ÌâÓ¦¼ò¶Ì¡¢×¼È·¡£ HL%|DCo  
£¨6£©ÏßÌõͼӦÏßÌõÇåÎú£¬´Öϸ¾ùÔÈ£¬±ÈÀýÊʵ±¡£ > 1=].  
£¨7£©ÕÕÆ¬Í¼Ó¦Í¼ÏñÇåÎú£¬²ã´Î·ÖÃ÷£¬·´²îÊʶȡ£ =-] NAj\  
£¨8£©²åͼ¾ùÁíÖ½¸½ÓÚÎĺó£¨submission by mail£©»òÕßÁí´æÎªJPEG»òÕßTIFFÎļþ£¨online submission£©£¬²¢ÔÚÎÄÕÂÖÐÏàÓ¦¶ÎÂäºó±êʾÆäλÖᣠ28>/#I9/]  
4.²åͼµÄÉè¼Æ 6|QIzs<Z-X  
ÀûÓòåͼÀ´±í´ï½á¹û£¬Ó¦¶Ô²åͼ½øÐо«ÐÄÉè¼Æ£¬Ê¹Í¼ÃæµÄ±ÈÀýÊʵ±£¬ÇåÎúÃÀ¹Û¡£ 6*:U1{Gl)  
£¨1£©±êÄ¿ÊÇÓÃÀ´ËµÃ÷×ø±êÖáµÄº¬ÒåµÄ£¬Ó¦¸ÃÓë±»±ê×¢µÄ×ø±êÖáÆ½ÐУ¬¾ÓÖÐÅÅÓ¦ÔÚ×ø±êÖáºÍ±êÖµµÄÍâ²à£¬ÎÄ×Ö·½ÏòÓ¦¸ÃÓë×ø±êÖá·½Ïò´¹Ö±¡£Í¼ÖеÄ×Ö£¨±ê¼ÇÖáµÈ£©Ó¦¸ÃÊÇСдÀàÐÍ£¬µÚÒ»×Öĸ´óд£¬Ã»ÓоäºÅ¡£ byPqPSY  
£¨2£©±êÖµÊÇ×ø±ê¶¨Á¿±íÊöµÄ³ß¶È¡£±êÖµÓ¦·ÀÖ¹±ê×¢¹ý·ÖÃܼ¯ÒÔÖÁÓÚÊýÂëǰºóÁ¬½Ó£¬±æÊ¶²»Çå¡£±êÖµÅÅÓ¦ÔÚ×ø±êÖáÍâ²à£¬½ô¿¿±êÖµ¶ÌÏߵĵط½¡£ÎªÁËÇåÎú£¬±êÖµµÄÊý×ÖÓ¦¾¡Á¿²»³¬¹ý3λÊý¡£Òò´Ë£¬ÒªÈÏÕæÑ¡È¡±êÄ¿Öеĵ¥Î»£¬ÈçÓÃ3kg´úÌæ3000g¡¢ÓÃ5ug´úÌæ0.005mgµÈ¡£×ø±êÖáÉϵıêÖµ·¶Î§ÊǸù¾ÝͼÐεÄÊý¾ÝÈ·¶¨£¬µ«×ø±êÖáÉϱêÖµµÄ¼ä¾àÔòÊÇÈÎÑ¡µÄ£¬²»Í¬µÄÑ¡Ôñ½«Ê¹Í¬Ò»ÌõÇúÏßÓв»Í¬µÄÐÎ×´¡£Òò´Ë£¬±êÖµµÄÈ·¶¨Ó¦¿¼ÂÇÒÔϼ¸µã£º DDe`Lb%%  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄܺ­¸ÇÕû¸öÊý¾Ý¡£ VjJ}q*/3e  
¨SÑ¡ÔñÊʵ±µÄ±êÖµ¼ä¾à£¬ÒÔ±ãËùÃè»æµÄÇúÏßÄÜÕýÈ·µØ·´Ó³Êý¾Ý¡£ÒòΪÁ½×ø±êÖáµÄ±êÖµ¼ä¾à²»Êʵ±½«»áŤÇúÊý¾ÝµÄÏÔʾ¡£ [JKLlR  
¨SÈç¹ûÔÚ×ø±êÖáÉϵIJâÁ¿µ¥Î»²»ÊÇ´Ó0¿ªÊ¼£¬ÄÇôÓá°//¡±·ûºÅÔÚ×ø±êÖáÉÏ·Ö¼¸¶Î¡£ {J-Ojw|Y b  
£¨3£©±äÁ¿ÏàͬµÄ¼¸ÌõÇúÏßÓ¦»æÖÆÔÚͬһ·ùͼÄÚ¡£ a1z*Z/!5  
£¨4£©¶ÔÓÚͬһƪÂÛÎÄÖеĶà·ù²åͼÀ´Ëµ£¬Ó¦¾¡Á¿Ê¹ÓòåͼµÄ¸÷ÒªËØÏ໥ͳһ£¬ÓÈÆäÊÇʹÓÃÏàͬ±äÁ¿µÄ±êÄ¿¡¢±êÖµ¡¢Í¼ÀýµÈÓ¦Ï໥һÖ¡£ /L=Y8tDt  
£¨5£©ÕÕÆ¬Í¼»òÉè¼ÆÍ¼£¬Ó¦×¢Ã÷³ß´ç´óС¼°³¤¶Èµ¥Î»¡£ mXI'=Vo!S  
£¨6£©Í¼Æ¬ÖеÄËõÂÔÓï¡¢·ûºÅ±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ <sG}[:v  
£¨7£©ÂÛÎĵIJåͼÓ븽±í²»ÒËÌ«¶à£¬Ö»¸½×î±ØÒªµÄ¡£ *d:$vaL  
£¨8£©Í¼·ùµÄ´óСÓëͼÄÚËùÌṩµÄÐÅÏ¢Á¿ÏàÆ¥Å䣬²»ÖÁÓÚÊ¹Í¼Ãæ¸Ðµ½¿Õ¿õ»òÓµ¼·¡£ ' ^(qlCI  
£¨9£©²åͼµÄ´óСºÍ±ÈÀý¡£ 6t3Zi:=I  
¨S²åͼҪ°´ÔÓÖ¾µÄ°æÃæ´óС±ÈÀý½øÐÐѹËõ¡£³ýÌØÊâÒªÇóÍ⣬ͼµÄ´óС±ØÐëÒªÏÞ¶¨ÔÚÆÚ¿¯µÄ°æÐÄÖ®ÄÚ¡£ T=':$(t  
¨SͬÀàÐÍ»òͬµÈÖØÒªµÄͼµÄ´óСӦ¸Ã¾¡¿ÉÄܵر£³ÖÒ»Ö£¬µ¥Î»¿Ì¶ÈÏàͬ¡£ a~Yq0d?`D  
¨S¿ÉÒÔ°ÑÀàËÆµÄͼ£¨ÈçÁ½¸öͼµÄ×ø±êÖáÏàͬ£©ºÏ²¢ÆðÀ´¡£ gnlU  
£¨10£©Í¼ÄÚµÄÏßÐÎÓë·ûºÅ¡¢Êý×ֵȱÈÀýÊʵ±¡£ DJ`xCs!R  
£¨11£©Í¼»­Ïß²»Ò˹ýϸ»ò¹ý´Ö£¬¹ýϸÈÝÒ×ÔÚÖÆ°æ¹ý³ÌÖжÏÏߣ¬¹ý´ÖÏԵñ¿´ÖÄÑ¿´¡£ tNljv >vI  
£¨12£©Í¼Ó¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬Ã¿Ò»Í¼Ó¦Óмò¶ÌÈ·ÇеÄÌâÃû¡£ r-,u)zf"  
£¨13£©»æÖƲåͼʱ£¬³ý·ÇÌØÊâÐèÒª£¬²»ÒªÎªÁË×·ÇóЧ¹û¶øÔö¼ÓһЩÎÞÒâÒåµÄϸ½Ú£¬Èç°Ñ¶þάµÄÌõÐÎͼ»­³ÉÈýάµÄÖùÐÎͼ¡£ uG(XbDZZ1W  
£¨14£©ÓзûºÏͼʱ£¬Ã¿Ò»Í¼Ó¦¸ÃÇå³þµØ±»±ê¼ÇΪA(a)¡¢B(b)¡¢C(c)µÈ¡£ _% i!LyG  
£¨15£©°±»ùËáºÍºËÜÕËáÐòÁÐÓ¦¸Ã¿¼ÂÇÓÃFigure,¶ø²»ÊÇTable¡£ /]2I%Q  
5.±í¸ñ XQZiJ %'  
±í¸ñÊǼǼÊý¾Ý»òÊÂÎï·ÖÀàµÄµÈµÄÒ»ÖÖÓÐЧ±í´ï·½Ê½£¬¾ßÓмò½à¡¢ÇåÎú¡¢×¼È·µÄÌØµã¡£Âß¼­ÐԺͶԱÈÐÔÓÖºÜÇ¿£¬Òò¶ø±í¸ñÔÚSCIÂÛÎÄÖб»¹ã·º²ÉÓᣱíµÄÖÖÀà½Ï¶à£¬Ö÷ÒªÓÐʾÒâ±í¡¢Í³¼Æ±í¡¢ËµÃ÷¶ÔÕÕ±íµÈ¡£ÊÊÓÃÓÚ³ÊÏֽ϶àµÄ¾«È·ÊýÖµ»òÎÞÃ÷ÏÔ¹æÂɵĸ´ÔÓ·ÖÀàÊý¾ÝºÍƽÐС¢¶Ô±È¡¢Ïà¹Ø¹ØÏµµÄÃèÊö£¬µ«È±·¦Ç÷ÊÆ¡£ !e}4>!L,(^  
¡ò±í¸ñµÄ»ù±¾½á¹¹ G4uA&"OE  
SCIÆÚ¿¯³£Ê¹ÓÃÈýÏß±í£¨£©£¬¼´Ö»Óбí¸ñ¶¥Ïß¡¢À¸Ä¿ºÍµ×Ïß¡£±íÖÆ°æÈÝÒ×£¬ÏÔʾ¼òÁ·¡£ f |NXibmP  
¨S±íÐòºÍ±íÌ⣺±íÐò¼°±í¸ñµÄÐòºÅ¡£±íÌâ¼´±í¸ñµÄÃû³Æ£¬Ó¦×¼È·µÃÌ壬¼ò¶Ì¾«Á¶µÄÎÄ×ÖÓÃÀ´±í´ï±íÌ⣬Á¬Í¬±íºÅÖÃÓÚ±í¸ñ¶¥ÏßÉÏ·½¡£±íÐòºÍ±íÌâ³£ÓúÚÌå×Ö¡£ Dlz1"|SF  
¨S±íÍ·£ºÖ¸±í¸ñ¶¥ÏßÓëÀ¸Ä¿ÏßÖ®¼äµÄ²¿·Ö£¬±íÃ÷±í¸ñÄÚµÄÏîÄ¿»ò·´Ó³Á˱íÉíÖиÃÀ¸Ä¿ÐÅÏ¢µÄÌØÕ÷¼°ÊôÐÔ¡£ } wx(P3BHD  
¨S±íÉí£ºÀ¸Ä¿ÏßÓëµ×ÏßÖ®¼äΪ±íÉí£¬ÊDZí¸ñµÄÖ÷Ìâ¡£ J:G {  
¨S±í×¢£º±ØÒªÊ±£¬Ó¦½«±íÖеķûºÅ¡¢±ê¼Ç¡¢´úÂ룬ÒÔ¼°ÐèҪ˵Ã÷µÄÊÂÏÒÔ×î¼òÁ·µÄÎÄ×Ö£¬×÷Ϊ±í×¢ºáÅŵ×ÏßÏ·½¡£ 1i;Cw/mr  
¡ò±í¸ñÒªÇó nGxG!  
¨SһƪÎÄÕÂÖв»ÊDZí¸ñÔ½¶àÔ½ºÃ£¬¶øÊÇÒª¸ù¾ÝÆä±ØÒªÐÔ½øÐо«Ñ¡¡£Èç¹ûÓÃÒ»Á½¾ä»°¼´¿É˵Ã÷µÄÄÚÈݾͲ»±ØÁбí¸ñ£»Èç¹û²ÉÓöà×éÊý¾Ý±í˵Ã÷ͬһÏÖÏó£¬Ôì³ÉÁ˱í¸ñ±¾ÉíµÄÖØ¸´£¬Ó¦¸ÃÑ¡ÔñÒ»×é×î׼ȷ¡¢×îÓÐ˵·þÁ¦µÄ±í¸ñ£¬¶ø½«Öظ´µÄ±í¸ñɾ³ý¡£Èç¹ûÎÄ×ÖÐðÊöÓëͼºÍ±íÏàÖØ¸´£¬Ò²Ó¦¸ÃÖ»±£ÁôÈýÕâÖÖ×îºÏÊʵÄÒ»ÖÖ±íÊö·½Ê½£¬ÕâÑù²ÅÄÜʹÎÄÕ¼ò½à¡¢¾«Á·¡£ bd[iD?epD]  
¨S±í¸ñµÄÉè¼ÆÓ¦¸Ã¿ÆÑ§¡¢Ã÷È·¡¢¼ò½à¡¢ÖصãÍ»³ö¡¢±í´ï¹æ·¶¡£±í¸ñÓ¦°´ÆäÔÚÕýÎÄÖгöÏÖµÄ˳Ðò±êºÅ£¬ÐòºÅÓð¢À­²®Êý×Ö±íʾ£¬ÈçTable1,Table2¡£¼´Ê¹Ö»ÓÐÒ»·Ý±í¸ñÒ²Òª±êTable1¡£ .dj}y jd]f  
¨S±í¸ñÖеÄËõÂÔ´ÊÓë·ûºÅ£¬±ØÐëÓëÕýÎÄÖÐÒ»Ö¡£ iyr<qtwK  
¨S±íÄÚͬһÀ¸µÄÊý×Ö±ØÐëÉÏÏß¶ÔÆë¡£±íÄÚ²»ÒËʹÓá°¡±ºÍÀàËÆ´Ê£¬Ò»ÂÉÌîÈë¾ßÌåÊý×Ö»òÎÄ×Ö¡£Èç¡°N/A¡±´ú±íδ²â»òÎÞ´ËÏ¡°¡ª¡±´ú±íδ·¢ÏÖ£¬¡°0¡±´ú±íʵ²â½á¹ûȷΪÁã¡£ SDjJ?K  
¨S±í¸ñÖеIJÎÊýÓ¦±êÃ÷Á¿ºÍµ¥Î»·ûºÅ¡£ÈôËùÓÐÀ¸Ä¿»ò´ó²¿·ÖÀ¸Ä¿µÄµ¥Î»Ïàͬ£¬¿É½«¸Ãµ¥Î»±ê×¢ÔÚÏàÓ¦µÄÀ¸ÄÚ¡£ @>+`1C  
¨S±í¸ñÄÚ£¬Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£ÀýÈç3.4ºÍ2.56ºÍ1µÄÕýÈ·±í´ïÓ¦¸ÃÊÇ3.40¡¢2.56ºÍ1.00¡£¡ò±í¸ñ±à¼­ Qjmo{'d  
±í¸ñÒª×÷Ϊһ¸ö¶ÀÁ¢µÄÐÅÏ¢µ¥Î»ÁîÒ³´òÓ¡¡£ÔÚÕýÎÄÄÚ£¬Ã¿·ùͼ»ò±í¸ñÓ¦°´ÆÚ³öÏÖµÄ˳Ðò±êºÅ¡£ YMj iJTl  
6.Figure LegendsÒªÇó *!yA'z<  
£¨1£©Figure LegendsÒªÁíҳ˫ÐдòÓ¡¡£ÅÅÔÚ±í¸ñ»ò²Î¿¼ÎÄÏ׺óÃæ¡£Ò²¾ÍÊÇ˵Figure LegendsÅÅÂÛÎĵÄ×îºó¡£.Figure Legends²»ÒªÅÅÔÚ²åͼÏÂÃæ¡£ wpt5'|I  
£¨2£©Í¼Ðò¼´²åͼµÄÐòºÅ¡£¸ù¾Ý²åͼÔÚÕýÎÄÖб»Ìá¼°µÄ˳Ðò£¬Óð¢À­²®Êý×Ö½øÐÐÅÅÐò£¬ÈçFigure 1¡¢Figure 2µÈ¡£²¢¾¡Á¿°Ñͼ°²ÅÅÔÚ¿¿½üµÚÒ»´ÎÌá¼°ËüµÄλÖᣠ@_?Uowc8  
£¨3£©Figure Legends²»Ó¦¸Ã°üº¬·½·¨Ï¸½Ú£¬»òÕß²»³¬³ö100¸ö×Ö¡£Èç¹ûSCIÂÛÎÄûÓз½·¨²¿·Ö£¬Figure LegendsÓ¦¸ÃÉÙÓÚ300¸ö×Ö¡£ r|y\FL  
£¨4£©Í¼Ìâ¼´²åͼµÄ±êÌ⣬ҪÇó¼òÃ÷׼ȷ£¬ÒªÓнϺõÄ˵Ã÷ÐÔºÍרָÐÔ£¬²»ÒªÎª×·ÇóÐÎʽÉϵļò½à¶øÑ¡ÓùýÓÚ·ºÖ¸µÄͼÌâ¡£ kArF Gb2c  
£¨5£©Í¼ÖÐδÄܱí´ïÓÖ±ØÐëÒªÇó±í´ïµÄÐÅÏ¢Ó¦¸ÃÔÚͼעÖÐ˵Ã÷£¬ÈçÐèÒª½âÊ͵ĶÈÁ¿µ¥Î»¡¢·ûºÅÒÔ¼°ËõÂԴʵȡ£²»Ó¦¸ÃÈöÁÕßÈ¥²Î¿¼Õ÷ÎIJÅÄÜÀí½â²åͼµÄÐÅÏ¢¡£Èç¹ûÄãµÄ²åͼ°üÀ¨Îó²îÏߣ¬ÄÇô»¹ÐèҪ˵Ã÷ËûÃÇÊDZê×¼Îó¡¢±ê×¼²î¡¢ÐŶȱ߽绹ÊÇÊýÖµ·¶Î§£¬ÕâÓÐÖúÓÚ¶¨ÒåËù²ÉÓõÄÑù±¾´óС¡£Èç¹ûÔÚͼÖбê³öÁËÏÔÖøÐÔµÄÖµ£¬ÄÇôÔÚͼעÖоÍҪ˵Ã÷¡£ Z8Tb43?  
£¨6£©µ±²åͼÖÐÓмýÍ·£¨arrow£©¡¢·ûºÅ£¨symbol£©¡¢Êý×Ö£¨number£©»ò×Öĸ£¨letter£©Ê±£¬ÒªÔÚÕⲿ·Ö£¨²»ÊÇÔÚ²åͼҳÉÏ£©¶ÔÆä·½Ïò¡¢Î»ÖõÈ×ö³ö·Ç³£Ã÷È·µÄ˵Ã÷¡£ |}@teN^J*U  
7.ÔõÑùÕýÈ·µØÊ¹ÓÃͼºÍ±í f;!L\$yKy  
ÄãÐèҪעÒ⼸¸ö·½ÃæµÄÎÊÌ⣺ 9H2mA$2jnE  
£¨1£©Í¼¡¢±í»¹ÊÇÎÄ×ÖÄĸöʹÓøüÓÐЧ?Èç¹ûÓëÎÄ×Ö²ÄÁÏÖØ¸´£¬ÄÇô¾ÍûÓбØÒªÊ¹ÓÃͼºÍ±í¡£Èç¹ûÄܹ»²¹³ä˵Ã÷ÎÄ×Ö²ÄÁÏ»òÕßÄܹ»Ëõ¶ÌÌÖÂ۵ij¤¶È£¬ÄÇô²åͼ¾ÍÊdzÊÏÖÐÅÏ¢µÄÓÐЧ·½Ê½¡£ G<Urj+3/Xo  
£¨2£©ÄÄÖÖͼ¡¢±í×îÊʺÏÄãµÄÄ¿µÄ£¿ÊÇ·ñÐèÒªÖÆ×÷ÏêϸµÄ¡¢¸ß·Ö±æÂʵIJåͼ£¿ÄÜ·ñÓÃÒ»·ù¼òµ¥µÄ½öÓÃÏßÌõ»òµã¾ÍÄܱíʾµÄ²åͼ£¿Á½Õß±í´ïµÄÐÅÏ¢ÊÇ·ñÒ»Ñù£¿ V!s#xXD}  
£¨3£©Í¼¡¢±íÊÇ·ñÕæÊµ¡¢ÓÐЧ¡¢¿Í¹ÛµØÕ¹Ê¾ÁËÊý¾Ý£¿ %&eBkN!T  
£¨4£©Í¼¡¢±íÊÇ·ñչʾÁËÊý¾ÝµÄ±¾Öʺ͹æÂÉ£¿ &UAYYH  
£¨5£©Í¼¡¢±íÊÇ·ñ±í´ïÁËÂÛÎĵÄÖ÷Ìâ»ò¹Ûµã£¿ j{@li1W @  
8.²åͼµÄºË²éÇåµ¥ >RrG&Wv59  
£¨1£©Õâ¸ö²åͼÓбØÒªÂð£¿Óë±í¸ñ»òÕýÎÄÊÇ·ñÖØ¸´£¿ L%Ms?`i,  
£¨2£©ÓÐͼÐòºÍͼÌâÂ𣿠>AWWwq -  
£¨3£©Õâ¸ö²åͼ¼ò½àÂ𣿻¹ÓÐûÓÐɾȥµÄÎÞ¹ØÏ¸½Ú£¿ =FQH5iSd  
£¨4£©×ø±êÖáµÄ±êÖµÊÇ·ñºÏÊÊ£¿ ~|ha9 1  
£¨5£©ÀàËÆµÄ²åͼ»òÕßÖØÒªÐÔÏà·ÂµÄ²åͼÊÇÒÔͬÑùµÄ×ø±êϵ»­µÄÂ𣿠=[0| qGzg  
£¨6£©ËùÓеÄÊõÓïÆ´Ð´ÊÇ·ñÕýÈ·£¿ fsWPU]\)  
£¨7£©²åͼÖеķûºÅ¼°Ëõд¶¼ÔÚͼעÖÐÓÐËù˵Ã÷Âð£¿ÕâЩ·ûºÅ¡¢ËõдÓë±êÌâÊÇ·ñÒ»Ö£¿ÔÚÆäËû²åͼ»òÕýÎÄÖÐÊÇ·ñ±£³ÖÒ»Ö£¿ oAv LSFn  
£¨8£©ËùÓеIJåͼÔÚÕýÎĵÄÏàӦλÖô¦ÊÇ·ñ±»Ìá¼°£¿ E9]*!^=/  
ÔÚÒ»°ãÇé¿öÏ£¬Ðí¶àSCIÆÚ¿¯¶Ô²åͼºÍ±í¸ñÒªÇóÓÐÃ÷È·µÄ˵Ã÷¡£²»Í¬µÄÆÚ¿¯¶Ô²åͼºÍ±í¸ñÓв»Í¬µÄÒªÇó¡£Òò´ËҪȷ¶¨ÔÙ½»ÄúµÄÂÛÎÄ֮ǰͨ¶Á×÷ÕßµÄÖ¸ÄÏ¡£°´ÕÕ¸ÃÆÚ¿¯µÄÒªÇó½øÐÐÕýÈ·µÄ¸ñʽ»¯¡£ 9 $^b^It  
9.ͼ±íÔÚÂÛÎÄÊÖ¸åÖеÄλÖà [}5mi?v  
¨Sͼ£ºÔÚͼעºóÃæ£¬Ã¿¸öͼһҳ£¨submission by mail£©¡£Èç¹ûon line submission,ÔòͼΪÁí´æ¡£ g|j15&x  
¨Sͼע£ºÍ¼×¢ÅÅÔÚ±í¸ñºóÃæ£¬ÁíÆðÒ»Ò³¡£ f67t.6Vw2+  
¨S±í¸ñ£ºÅÅÔÚÕýÎÄÖвο¼ÎÄÏ׵ĺóÃæ£¬Ã¿¸ö±í¸ñÒ»Ò³¡£ :W$- b  
10.SCIÂÛÎÄͼ±íÉè¼ÆÖг£¼ûµÄ´íÎó n^<J@uC  
£¨1£©Í¼¡¢±í¸ñÄÚÈÝÓëÎÄ×ÖÖØ¸´¡£ÔÚSCIÂÛÎÄÖУ¬ÏàͬÄÚÈݲ»ÒËÓÃÎÄ×Ö¡¢±í¸ñºÍͳ¼ÆÍ¼Öظ´±í´ï£¬Ó¦¸ù¾ÝÄÚÈݵÄÐèҪѡÔñÒ»ÖÖ±í´ï·½Ê½¼´¿É¡£Õâ·½ÃæµÄÔ­ÔòÓ¦ÊÇ£º·²ÊÇÓüò½àµÄÎÄ×ÖÄܹ»±í´ïÇå³þµÄ¾Í²»ÓÃͼºÍ±í¸ñ±í´ï£¬£»·²ÊÇÓñíÄܹ»Ò»Ä¿ÁËÈ»±íʾµÄ¾Í²»ÓÃͼ¡£ÎªÊ¹¶ÁÕß±ãÓÚ¶ÔÕձȽϺÍÁ˽⾫ȷ½á¹ûʱ£¬ÒÔ±í¸ñÐÎʽΪÒË¡£ QE721y   
£¨2£©±í¸ñÖÐÊý¾Ý¼ÆËã²»¾«È·£¬±£ÁôλÊý²»Ò»Ö¡£±íÖÐÊýÖµ¾«È·Óë·ñÊǾö¶¨Í³¼Æ±íÖÊÁ¿µÄ¹Ø¼üÒòËØ£¬Ò²ÊÇ¿ÆÑ§ÊµÑé½á¹ûÊÇ·ñÑÏÃܵľßÌåÌåÏÖ¡£ÓÉÓÚ±í¸ñÖеÄÊý¾ÝÊǾ­¹ýԭʼÊý¾Ý¼ÆËãµÃ³ö£¬Òò´ËÍùÍù²»ÊÇÕûÊý¡£Ó¦¸ÃʹÓÃÏàͬµÄСÊýλ¡£±í¸ñÖÐͬһָ±êÊý×ÖµÄÓÐЧλÊýÓ¦Ò»Ö£¬²»×ãÕßÒÔ¡°0¡±²¹×ã¡£¼ÆËã°Ù·Ö±Èʱ£¬Ó¦×¢Òâ¸÷°Ù·Ö±ÈÏà¼ÓӦΪ100%¡£ 'Jd*r(2d  
£¨3£©ËõÂÔÓï¼°Á¿ºÍµ¥Î»²»¹æ·¶¡£±í¸ñÖÐËùÁеÄÖ¸±êÃû³Æ²»ÒËËæÒâ¶ø¶¨£¬Ó¦Ê¹Óù̶¨µÄËõÂÔÓï¡£ÌØÊâÇé¿öÏÂʹÓò»³£Óõĵ¥Î»ºÍËõд´Êʱ£¬ÐèÔÚ±í×¢ÖÐ˵Ã÷¡£µ¥Î»Ó¦¸Ã×ñÑ­¹ú¼Ê±ê×¼ÃüÃûÔ­Ôò¡£ÔÚÊý×ֺ͵¥Î»Ö®¼äÓ¦¸ÃÓÐÒ»¸öµ¥Ò»¿Õ¸ñ¡£Ç§¼Æµ¥Î»Ó¦¸ÃÓöººÅ·ÖÀ루1,000£©¡£ H% FP!03  
£¨4£©±íÖзÖ×é±äÁ¿Óë¹Û²âÖ¸±êµÄλÖõߵ¹¼°Êý¾ÝÅÅÁв»µ±¡£±íÖÐÊý¾ÝµÄÅÅÁÐÓ¦°´Í¬ÀàÊý¾Ý×ÝÅŵÄÔ­Ôò°²ÅÅ£¬ÅÅÁв»µ±Ôòµ¼Ö¶Á±í·ÑÁ¦£¬²»Ò×¶ÔÕձȽϺʹÓÖÐÁ˽â±ä»¯¹æÂÉ¡£ N9~'\O$'7  
£¨5£©±íע˵Ã÷¹ý·±¡£±í×¢ÊǶԱíÖÐÓйØÄÚÈݵıØÒª²¹³äºÍ˵Ã÷£¬Ó¦¼òÃ÷¶óÒª¡£ÈçÐèҪ˵Ã÷µÄÄÚÈݽ϶àʱ£¬Ó¦ÒÆÈë±íǰµÄÕýÎÄÖÐÓÃÎÄ×Ö½éÉܱíÖÐÊý¾ÝµÄ¼ÆË㹫ʽ£¬Ó¦ÔÚÂÛÎĵġ°Materials and Methods¡±²¿·Ö½éÉÜ£¬²»ÒËÁÐÈë±í×¢¡£ "i&9RA ! 1  
£¨6£©ÂÞÁÐԭʼ¼Ç¼Êý¾Ý¡£µäÐ͵ıíºÍͼʾ¶Ô½á¹ûµÄ×ܽᣬÑо¿¹ý³ÌÖеÄԭʼÊý¾Ý£¬²»±ØÈ«²¿ÂÞÁÐÓÚ±íÖС£±í¸ñÖеÄÊý¾ÝÒ»°ãÓ¦ÊǾ­¹ýͳ¼ÆÑ§´¦ÀíµÄ¡£ NMzq10M=6  
£¨7£©ÎÞ±íÌâ»ò±íÌⲻȷÇлòÖØµã²»Í»³ö¡£±íÌâÊDZí¸ñµÄÖØÒª×é³É²¿·Ö£¬ÊǶԱíÖÐÄÚÈݵĸÅÀ¨£¬±íÌâÓ¦¸ÃÖ÷νÓÐÐò£¬¼ò½à¡¢×¼È·¡£ 3;AJp_;  
£¨8£©Í¼¡¢±íÖеÄÊõÓï¡¢·ûºÅ¡¢µ¥Î»ÓëÎÄÖÐÎÄ×ÖÐðÊö²»Ò»Ö»òÕßÕýÎÄûÓÐÌἰͼºÍ±í¡£Í¼±íÖгöÏÖµÄÊõÓï¡¢·ûºÅ¡¢µ¥¡¢Ó¦ÓëÎÄ×ÖÐðÊöÏàÒ»Ö£¬ÒÔÏÔʾÕû¸öÂÛÎĵÄÍêÕûÓëͳһ¡£ }taG/kE62  
£¨9£©Í³¼ÆÍ¼±íÉè¼Æ²»¹æ·¶¡£Èç±íÖÐÏßÌõ¹ý¶à¡£ &d]@$4u$;  
11.³£¼ûµÄ´íÎóÇé¿ö A.(e=;0bu  
¨S×ø±êÖáÉϱêÖµ²»µ± >[Tt'.S!?  
¨Sȱµ¥Î»£¬×ø±êÖáµßµ¹£¬¾â³ÝÐÎÏßµÄÁ¬½ÓûÓиù¾Ý£¬Í¼Ìå²»Ã÷È·£¨¸ü¶àÄÚÈÝ¿ÉÒÔ¼ûhttp//:www.ruf.rice.edu/~bioslabs/tools/tools.html£© :es=T`("A8  
¨S´æÔÚÎÊÌ⣺Ñù±¾Ì«ÉÙ r(rT.D&  
¨S´æÔÚÎÊÌ⣺×ÊÁÏûÓÐåàÑ¡ uvi&! )x  
¨S´æÔÚÎÊÌ⣺±í¸ñ²»¹æ·¶£¬Ã»Óбí¸ñ±êÌâ NHe[,nIV  

kaobook 2011-08-17 22:35
µÚ12 ÕÂÈçºÎÊéдSCIÂÛÎĵÄÌÖÂÛ nd w&F'.r  
ÌÖÂÛ£¨Discussion£©ÊÇһƪÎÄÕµľ«»ª¡¢È«ÎĵÄÁé»ê£¬Ò²ÊÇ×îÄÑдµÄ²¿·Ö¡£DiscussionÖ®ËùÒÔÄÑд£¬ÊÇÒòΪÌÖÂÛ²¿·Ö×îÄÜ·´Ó³×÷Õߵĸ´Ï°µÄÎÄÏ×Á¿ºÍ¶Ôij¸öѧÊõÎÊÌâÁ˽âÒÔ¼°Àí½âµÄÉî¶ÈºÍ¹ã¶È¡£Éî¶È¾ÍÊÇÂÛÎĶÔÓÚÌá³öÎÊÌâµÄÑо¿µ½ÁËÒ»¸öʲôÑùµÄ³Ì¶È£¬¹ã¶ÈÖ¸ÊÇ·ñÄܹ»´Ó¶à¸ö½Ç¶ÈÀ´·ÖÎö½âÊÍʵÑé½á¹û¡£ WT}x Cni  
1.ÌÖÂÛ²¿·ÖµÄÖØÒªÐÔ Uy?X-"UR  
ÒªÈÃÉó¸åÈ˺ͶÁÕßÁ˽âÄãµÄÂÛÎÄΪʲôֵµÃÒýÆðÖØÊÓ£º 6=S z5MC  
£¨1£©ÄãµÄ½á¹ûÓÖÓÐʲôÀíÂÛÒâÒ壿 )5u#'5I>  
£¨2£©ÄãµÄ½á¹ûÓÐʲôʵ¼ÊÓ¦ÓüÛÖµ£¿ "*:?m{w5  
£¨3£©ÄãµÄ·¢ÏÖÊÇ·ñ¿ÉÒÔÀ©Õ¹µ½ÆäËûÁìÓò£¿ Q x&7Ceu"  
£¨4£©ÄãµÄ½á¹ûÊÇ·ñÓÐÖúÓÚÎÒÃÇÀí½â¸ü¹ã·ºÁìÓò£¨a broader topic£©£¿ E&)o.l<h|  
2.ÌÖÂÛµÄÄÚÈÝ O\h%ZLjfO  
ÔÚDiscussionÕâÒ»Õ½ڣ¬ÄãÓ¦¸Ã½âÊÍÄãµÄ½á¹û¡£Òò´Ë£¬ÌÖÂÛµÄÄÚÈÝÖ÷ÒªÓУº 8!MVDp[|"  
£¨1£©¸ÅÊö×îÖØÒªµÄ½á¹û¡£ÄãµÄ½á¹ûÓÐʲôÒâ˼£¿Êý¾ÝÊÇ·ñ·ûºÏÄãµÄ×î³õ¼ÙÉ裿Èç¹ûûÓеϰ£¬ÎªÊ²Ã´£¿ÄãÊÇ·ñÐèÒªÐ޸ļÙ˵£¿ 2'Raj'2S4  
£¨2£©Ö¸³öÆäÊÇ·ñÄܹ»Ö§³ÖÏÈǰµÄ¼ÙÉèÒÔ¼°ÊÇ·ñÓëÆäËûѧÕߵĽá¹ûÏ໥һÖ£»Èç¹û²»Êǵϰ£¬ÎªÊ²Ã´£¿ÊÇ·ñËûÃǵÄÉè¼ÆÓÐȱÏÝ£¿ @9l$j Z~x  
£¨3£©¶Ô½á¹ûÌá³ö˵Ã÷¡¢½âÊÍ»ò²Â²â£¬¸ù¾ÝÕâЩ½á¹û£¬ÄܵóöºÎÖÖ½áÂÛºÍÍÆ¶Ï£¿ R_"6E8N  
£¨4£©ËµÃ÷Ñо¿µÄ¾ÖÏÞÐÔÒÔ¼°ÕâЩÏÞÖÆ¶ÔÑо¿½á¹ûµÄÓ°Ïì¡£ÓÐʲô½øÒ»²½µÄʵÑéÐèÒª½øÐУ¿Èç¹ûÄãµÄ½á¹ûÄ£ÀâÁ½¿É£¬»¹ÐèҪʲôʵÑéÄÜʹ½á¹û¸ü¼ÓÃ÷È·£¿ u/xP$  
£¨5£©Ö¸³ö½á¹ûµÄÀíÂÛÒâÒåºÍʵ¼ÊÓ¦ÓüÛÖµ¡£ <RcB: h  
3.ÌÖÂÛ²¿·Öд×÷µÄ»ù±¾ÒªÇó 4\j1+&W   
DiscussionµÄÖØµãÔÚÓÚ¶ÔÑо¿µÄ½á¹ûµÄ½âÊͺÍÍÆ¶Ï£¬²¢ËµÃ÷×÷ÕߵĽá¹ûÊÇ·ñÖ§³Ö»òÕß·´¶ÔijÖֹ۵㣬ÊÇ·ñÌá³öÁËеÄÎÊÌâ»ò¹ÛµãµÈ¡£Òò´Ë׫дÌÖÂÛʱҪ±ÜÃ⺬Ð¾¡Á¿Ö±½Ó¡¢Ã÷È·µØ×ö³öÍêÕûµÄ½âÊÍ¡£ËµÀíÒªÓиù¾Ý£¬ÎÊÌâÒª½²Çå³þ¡¢½²Í¸³¹¡£Òò´Ë£¬Ã¿¸ö½áÂÛ¶¼ÒªÓÐÖ¤¾Ý¡£×ÜÊǾ۽¹ÔÚÄãµÄ½á¹ûÉÏ£¬²»ÒªÌÖÂÛÓëÄãÏÖÔڵŤ×÷Î޹صϰÌâ¡£ 'C@yJf  
4.ÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ l9 n$cv^  
Ò»°ãʵÑéÐÔSCIÂÛÎĵÄÌÖÂÛ²¿·ÖµÄд×÷½á¹¹ÈçÏ£º r4fd@<=g  
µÚÒ»¶Î£¨first paragraph£© Oq(FV[N7t  
²ûÊö·¢ÏÖ¡£¿ÉÒÔ´ÓÕªÒª¸Äд£¬ÀýÈ磺 @c }Gw;e  
In this study, we have shown that tumor cells organize a mitochondrial chaperone network,, which involves Hsp90, its related molecule, TRAP-1, and the immunophilin CypD. This complex maintains mitochondrial homeostasis and antagonizes the function of CypD in permeability transition. Conversely, inhibition of mitochondrial Hsp90 chaperones with a novel class of mitochondria-directed ATPase antagonists cause sudden loss of mitochondrial membrane potential, release of cytochrome c, and massive death of tumor but not normal cells. 99n; %W>  
Öмä¶ÎÂ䣨middle paragraph£© =E:sEw2j  
¶ÎÂäµÄ¶àÉÙ¸ù¾Ý½á¹û¶àÉÙ¶ø¶¨£¬¿ÉÒÔÊDz¢ÁйØÏµ»òÕßÊǵݽø¹ØÏµ¡£µ«Òª±£Ö¤Ã¿Ò»¶Î¶¼Ò»¸öÖ÷Ìâ¡£¶øÇÒÿһ¶ÎÖÐҪ˵Ã÷ÒÔϼ¸µã£º c?6(mU\ x  
£¨1£©ÄãµÄÑо¿½á¹ûÊÇʲô£¿ÓÐʲôÒâÒ壿ÀýÈ磺 *2/6fhI[p  
The results presented here demonstrate an involvement of Shh signaling in the regulation of SVZ stem cells, leading to sustained neurogenesis, in the postnatal and adult mouse brain. Taken together , the gene expression and analyses and the in vitro and in vivo experiment indicate that Shh signaling is critical for the proliferation of the number of cells with stem cell properties, for the proliferation of early precursors and consequently TQOJN  
for the production of new neurons. ,V)hV@Dk  
£¨2£©ÄãµÄÑо¿½á¹ûºÍ±ðÈ˵ĵÄÀàËÆÑо¿ÓÐʲôÒìͬ£¿Èç¹û²»Í¬£¬¿ÉÒÔÌÖÂÛһЩ²úÉú²îÒìµÄ¿ÉÄÜÔ­Òò¡£ÀýÈ磺 X5= Ki $+  
In contrast to other data(ref), we show that Shh is sufficient to increase the number of neurospheres derived from SVZ cultures grown over quiescent astrocytes. This difference might relate to the method used:it is possible that the astrocytes in the in the feeder layer produce enough cofactors but at low enough levels for Shh to act, whereas saturating levels of EGF mask the effects of Shh(ref). 4 C3i  
£¨3£©Èç¹ûÄãÔÚÑо¿½á¹ûÖгöÏַdz£ÐµĶ«Î÷£¬ÓÃÒÔǰ±ðÈ˵ÄÀíÂÛºÜÄѽâÊÍ£¬ÄÇôÄã¿ÉÒÔÌá³öÄãµÄ¼ÙÉèÀíÂÛÀ´½âÊÍÊÇÑÏÖØÀ´½âÊÍʵÑéÖзdz£ÐµĶ«Î÷£¬Ò»¶¨Òª×öµ½ÄÜ×ÔÔ²Æä˵¡£ g_eR&kuh  
Ä©¶Î£¨last paragraph£© 9l,8:%X_  
ÔÚDiscussion µÄ×îºóÒª×ܽáһϣ¬¸æËß±ðÈËÄãÕâ¸öÑо¿µÄ¼¸¸öÖ÷Òª½á¹û£¨Á½Èý¾ä»°£©¡£ÀýÈ磺 4-9cp=\PE  
In summary, Hsp90-directed protein folding/refolding functions as a novel regulatory mechanism of mitochondrial permeability transition (reference).Although this pathway is selectively exploited in tumor cells to elevate an antiapoptotic threshold, the development of Hsp90 antagonists competent to accumulate in mitochondria may provide a new class of potent and selective anticancer agents,potentially devoid of side effects for normal tissues. \*pS 4vy5x  
5.ÌÖÂÛ²¿·Öд×÷µÄ³£¼ûÎÊÌâ Xd.y or  
£¨1£©Ã»ÓÐÑ¡ÔñÉîÈëÌÖÂÛµÄÎÊÌ⡣ѡÔñºÏÊʵĽá¹ûÔÚDiscussion²¿·Ö½øÐÐÉîÈëÌÖÂÛ£¬ÊÇдºÃ¸Ã²¿·ÖÊ×ÏÈÒªÃæÁÙµÄÎÊÌâ¡£ÒªÒÔÿһ¸öÖØ´ó½á¹ûΪ»ùµã¡£Ò»°ãÀ´Ëµ£¬¿É¸ù¾ÝÒÔÏÂÔ­ÔòÀ´ÅжϣºÈç¹ûÄãµÄ½á¹ûÌåÑéÁËʵÑéµÄ¶ÀÌØÐÔ£¬ÊÇÆäËûÑо¿¾ÍÖÐûÓеõ½µÄ£¬ÄÇôÕâ¸öÑо¿½á¹û¾ÍÊÇÒªÖØµãÌÖÂÛµÄÎÊÌ⣻ÓÐЩ½á¹ûºÍǰÈ˵ÄÑо¿½á¹ûÒ»Ö£¬²¢Ã»ÓÐÏÔÖøÐÔ²îÒ죬¾ÍÓ¦¸ÃÒ»±Ê´ø¹ýÎÞÐèÉîÈëÌÖÂÛ¡£DiscussionµÄÒ»¸öÖØÒª×÷ÓþÍÊÇҪͻ³ö×Ô¼ºÑо¿µÄ´´ÐÂÐÔ£¬²¢ÌåÏÖ³öÏÔÖøÇø±ðÓÚËûÈ˵ÄÌØµã£¬Çø±ð´óºÍСÊÇÁíÍâÒ»¸öÎÊÌâ£¬ÖØÒªµÄÊÇÓÐÇø±ð£¬Çø±ð¾ÍÊÇ´´Ð¡£ W k"_lJ  
£¨2£©Ã»ÓжÔÑ¡ÖеÄÎÊÌâ°´Ò»¶¨²ã´Î´Ó¶à¸ö½Ç¶È½øÐÐÌÖÂÛ¡£Ñ¡ÔñµÄÎÊÌâÓÐʱ²»Ö¹Ò»¸ö£¨¶àÊýÇé¿öÊÇÁ½¸öÒÔÉÏ£©£¬Òò´Ë£¬Òª°´Ò»¶¨²ã´ÎÃèÊöÇå³þ¡£ÎÊÌâÎÞÂÛ´óС¡¢ÊÇ·ñÖØÒª£¬¶¼Òª´Ó¶à¸ö½Ç¶ÈÕ¹¿ªÉîÈëÌÖÂÛ¡£ MfA %Xep  
¨SÊ×ÏÈÒªÓÐÀàËÆ½á¹ûµÄ¶Ô±È£¬ËµÃ÷×Ô¼º½áÂ۵ĶÀÌØÐÔ¡£ 1y eD-M"w  
¨SÆä´ÎҪϵͳ²ûÊöΪʲô»áÓÐÒìͬ¡£·½·¨ÓжàÖÖ£¨´ÓʵÑéÉè¼Æ½Ç¶È¡¢´ÓÀíÂÛÔ­Àí½Ç¶È¡¢´Ó·ÖÎö·½·¨½Ç¶È»ò½è¼ø±ðÈË·ÖÎö·½·¨µÈ£©¡£ÖØÒªµÄÊǽ«ÕâÎÊÌâÉîÈë²ûÊöÇå³þ£¬²»ÄÜÈÃÈËÓÐÒâÓÌδ¾¡Ö®¸Ð£¨So What£¿£©¡££¨3£©ÓëResultsµÄ²»Ò»ÖÂÐÔ¡£¾ÍÊǽá¹ûºÍÌÖÂÛûÓÐÒ»Ò»¶ÔÓ¦¡£ÉÙÊý³öÏÖÌÖÂÛµÄÄÚÈÝ¿ÉÒÔÍÆ³öÓëʵÑéÏà·´µÄ½áÂÛ¡£ PGb}Y {  
£¨4£©×÷ÕßÔÚÌÖÂÛʱ²»ÒýÓûòûÓÐϵͳÒýÓÃÏà¹ØÎÄÏס£·¢ÉúÕâÖÖÇé¿öµÄÖ÷ÒªÔ­ÒòΪ£º×÷ÕßûÓÐÒâʶµ½²éÕÒºÍÒýÓÃÏà¹ØÎÄÏ׵ıØÒªÐÔ£»×÷ÕßÒòÌõ¼þËùÏÞ£¬ÎÞ·¨²éµ½»ò²éÈ«Ïà¹ØÎÄÏ×£»ÉÙÊý×÷Õß¹ÊÒâ²»ÒýÓÃÏà¹ØÎÄÏ×£¬ÒÔÍ»ÏÔ×Ô¼ºÑо¿µÄ"ÐÂÓ±"Óë"¼ÛÖµ"¡£ -:wV3D  
£¨5£©×÷ÕßËäÒýÓÃÏà¹ØÎÄÏ×£¬µ«Ã»ÓнáºÏ×ÔÉíµÄÑо¿ÌÖÂÛ£¬Ò²¾ÍÊÇ˵£¬×÷ÕßËäÈ»²éµ½²¢ÒýÓÃÁËÏà¹ØÎÄÏ×£¬µ«Ã»ÓаÑÒÔǰµÄ½á¹ûºÍ×Ô¼ºµÄ½á¹ûÈÚºÏÔÚÒ»ÆðÌÖÂÛ¡£ÕâÁ½ÖÖÂÛÎÄ·Ö¸îµÄ½á¹û¶¼Ò»Ñù£¬¾ÍÊÇʹ¶ÁÕß¿´ÍêÂÛÎĺó£¬ÈÔ¶Ô¸ÃÑо¿È±·¦ÏµÍ³¡¢ÍêÕû¡¢ÉîÈëµÄÁ˽âºÍÀí½â¡£ Q[lkhx|.B  
£¨6£©¼òµ¥Öظ´IntroductionµÄÄÚÈÝ¡£ËäÈ»ÌÖÂÛ×ÜÓëIntroductionÖÐÄúÔ®ÒýµÄÎÊÌâ»ò¼Ù˵ÏàÁ¬¡£µ«²»ÊǼòµ¥µÄÖØ¸´£¬¶øÊÇIntroductionµÄÕ¹¿ª¡£ 3Q,p,  
£¨7£©Öظ´ResultsµÄÄÚÈÝ¡£²»ÒªÔÚÌÖÂÛÖÐÖØ¸´ÉêÃ÷ÄãµÄ½á¹û¡£ËäÈ»Äã¿ÉÒÔż¶ûÔÚDiscussion²¿·ÖÀïÌἰͼºÍ±í¸ñ°ïÖú½âÊÍijÊ£¬µ«²»Äܰüº¬ÐµÄÊý¾Ý¡£¿ÉÒÔÓÃÁ÷³Ìͼ˵Ã÷¡£Èç¹ûÄãÐèÒªÌáÐѶÁÕßÌÖÂ۵Ľá¹û£¬¿ÉÒÔÓÃbridge sentenceÀ´½øÐÐÁ¬½Ó¡£ÀýÈ磬The increased expression of neuroglobin in the damaged region after focal isechemia suggests that¡­(½âÊÍ)¡£ la_  
6.ÌÖÂÛ²¿·Öд×÷µÄÈ˳ƺÍÓï̬ [p )2!]y  
ÔÚÕâÒ»½Ú¾¡¿ÉÄÜʹÓÃÖ÷¶¯Óï̬¡£É÷·ÀÂÞà´ʾ䣬Ҫ¼ò½à¡£¿ÉÒÔʹÓõÚÒ»È˳ÆÃèÊö×Ô¼ºµÄ½á¹û¡£ÏÖÔÚʱºÍ¼òµ¥µÄ¹ýȥʱ¿ÉÒÔÓÃÓÚÌÖÂۺͽáÂÛÕ½ڣ¨Present and simple past tenses may both be correct for results discussion and conclusions£©¡£

kaobook 2011-08-17 22:35
µÚ13ÕÂÈçºÎÊéдSCIÂÛÎĵĽáÂÛ l%`~aVGJ  
½áÂÛ£¨Conclusion»òSummary£©ÓֳƽáÊøÓï¡¢½áÓï¡£ËüÊÇÕû¸ö¿ÎÌâÑо¿µÄ×ܽᣬȫƪÎÄÕµĹé½á¡£Ò»°ãÀ´Ëµ£¬½áÂÛÖгöÏÖµÄÎÊÌⲻ̫¶à¡£ÓÐЩSCIÆÚ¿¯ÒªÇóÓнáÂÛÎÄÕ£¨¶ÎÂ䣩£¬Î»ÓÚÂÛÎĽáÂÛ½áÊøÊ±¡£ 0JhUncx  
1.½áÂÛд×÷µÄÄÚÈÝ , - _ReL  
£¨1£©½á¹ûÒªµã¡£±¾Ñо¿½á¹ûÓÐʲôз¢ÏÖ£¬µÃ³öÁËʲô¹æÂÉÐÔ½áÂÛ£¬½â¾ö»òÍêÉÆÁËʲôÀíÂÛ£¬ÊÊÓÃÓÚʲôÑùµÄ·¶Î§¡£¶ÔǰÈËÓйر¾ÎÊÌâµÄÀíÂÛ¡¢·½·¨»ò¼¼Êõ×öÁËÄÄЩ¼ìÑ飬ÄÄЩÓë±¾Ñо¿½á¹ûÒ»Ö£¬ÄÇЩÓë±¾Ñо¿²»Ò»Ö£¬×÷³öÁËÄÄЩÐÞÕý¡¢²¹³ä¡¢·¢Õ¹»ò·ñ¶¨¡£ |D8c=c%  
£¨2£©ÒâÒå»òʵÓÃÐÔ¼ÛÖµ¡¢Íƹãǰ¾°¡£ Q}#H|@  
2.½áÂÛд×÷ÒªÇó ,qhv(  
£¨1£©¸ÅÀ¨×¼È·£¬´ë´ÇÑϽ÷¡£×¼È·¡¢ÍêÕûµØ¸ÅÀ¨ÂÛÎÄÖд´ÐµÄÄÚÈÝ¡£ ?_/T$b ]  
£¨2£©Ã÷È·¾ßÌå¡¢¼ò¶Ì¾«Á¶¡£½áÂÛÓ¦ÌṩÃ÷È·¡¢¾ßÌåµÄ¶¨ÐÔÓ붨Á¿µÄÐÅÏ¢¡£¶ÔÒªµãÒª¾ßÌåÂÛÊö£¬²»ÄÜÓóéÏóºÍÁýͳµÄÓïÑÔ¡£ >*} m .'u  
£¨3£©×ۺϷÖÎö£¬¿Í¹ÛÆÀ¹À£¬Å¨Ëõ±í´ï¡£±ÜÃâÒÔ¼ÙÉèÀ´¡°Ö¤Ã÷¡±¼ÙÉ裬ÒÔδ֪À´ËµÃ÷δ֪£¬²¢ÒÀ´ÎÑ­»·ÍÆÂÛ¡£²»Òª°ÑǰÑÔ²¿·ÖµÄÄÚÈÝ£¬ÈçÁ¢ÌâÒÀ¾Ý¡¢Ñо¿Ä¿µÄµÈдÔÚ½áβ²¿·ÖÀ´ÌÖÂÛ¡£ 1$"wN z  
3.½áÂÛд×÷·½·¨ r\|" j8  
£¨1£©ÓÉÓÚMS Word µÈÎÄ×Ö´¦ÀíÈí¼þÌṩµÄ¿½±´£¨copy£©¡¢Õ³Ìù£¨paste£©¹¦ÄÜ£¬ÂÛÎÄÕªÒªÖеÄһЩ»°¿É±»¿½±´µ½½áÂÛÖС£µ«Òª×¢Òâ¸Ä±äʱ̬¡£ nm<S #i*  
£¨2£©½áÂÛÒ»°ã¿ÉÒÔÓü¸¾ä»°À´±íÊö¡£ÓÐʱҲ¿ÉÒ԰ѽáÂÛ·Ö³ÉÈô¸ÉÌõÀ´Ð´£¬µ«²»³£¼û¡£ o5NrDDH  
£¨3£©½áÂÛҪǡÈçÆä·Ö¡£ PmDar<m  
£¨4£©±¾Ñо¿ÉÐδ½â¾öµÄÎÊÌâ¼°½ñºóÑо¿·½ÏòµÄÉèÏë»ò½¨ÒéºÍÓ¦Óü¼ÊõÓÐÄÄЩ¸Ä½øµÄ½¨ÒéÒ»°ã²»·ÅÔÚ½áÂÛÖС£µ«ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚ½áÂÛÖмÓÈëÕâЩÉèÏë»ò½¨Òé¡£ËùÒÔͨ¶ÁSCIÆÚ¿¯µÄ×÷ÕßÖ¸ÄÏÊ®·ÖÖØÒª¡£ _?>f9K$1  
4.½áÂÛÈ˳ƺÍд×÷ʱ̬µÄд×÷ }iR!uhi#  
дËûÈËÑо¿½á¹ûÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£»ÃèÊö±¾ÎĵÄÑо¿½á¹ûÓùýȥʱ£»ÆÕͨʵÓõĽáÂÛÊÇÏÖÔÚʱ¡£½áÂÛÖв»Ê¹ÓõÚÒ»È˳Ƶ¥ÊýÖ÷¸ñ¡°I¡±£¬¶ø½Ï¶àʵÓõÚÒ»È˳Ƹ´ÊýÖ÷¸ñ¡°We¡±£¬ÒÔ˵Ã÷¸Ã¹¤×÷ÊÇÓɶàÈËÍê³ÉµÄ¡£

kaobook 2011-08-17 22:36
µÚ14ÕÂÈçºÎÊéдSCIÂÛÎĵÄÖÂл L=Q- r[  
1.ÖÂлÄÚÈÝ 4w^B&e%  
ÖÂлÄÚÈÝÖ÷Òª·ÖΪÁ½·½Ã棺 2>#Pt^R:C  
£¨1£©±íÃ÷¸ÃÑо¿ÊÇʲô×ʽð»ò»ù½ð×ÊÖúµÄÇé¿öÏÂÍê³ÉµÄ¡£ÖйúÒ»°ã¶¼Êǹú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¨Nature Science Foundation of China, NSFC£©¡£ÃÀ¹ú´ó¶àÊÇÃÀ¹ú¹ú¼ÒÎÀÉúÑо¿Ôº£¨National Institute of Health, NIH£©ºÍÃÀ¹ú¹ú¼Ò¿ÆÑ§»ù½ð£¨National Science Foundation, NSF£©¡£Ð´»ù½ðʱһ°ãÒª±ê×¢Çå³þ»ù½ðºÅÂë£*****rant number£©£¬Ö»ÓÐÕâÑù²ÅËãÊǸÃÏî»ù½ðµÄÑо¿³É¹û£¬Ò²¿ÉÒÔËã×÷ʵÑéÊÒµÄÑо¿³É¹û¡£ ;8;nY6Ie  
£¨2£©¶Ô²ÎÓëÈËÔ±ºÍµ¥Î»±íʾ¸Ðл¡£Ó¦¶ÔÕû¸öÑо¿¹ý³ÌÖУ¬ÓÈÆäÊDzÎÓ벿·ÖÑо¿¹¤×÷£¬°üÀ¨ÌṩʵÑéÉè¼Æ»òʵÑé²ÄÁÏ£¬µ«Ã»ÓÐÁÐÔÚ×÷ÕßÖеÄÑо¿ÈËÔ±£¬Òª¿Ï¶¨ËûµÄ¹±Ï×£¬ÓèÒÔÖÂл¡£ÓÐЩÉó¸åÈËÒ²ºÜ¿´ÖØÕâЩ·½Ãæ¡£Òò´Ë£¬ÒªÒýÆðÖØÊÓ¡£ J4h7] qt  
µ«ÊÇ£¬Èç¹ûÌṩ°ïÖúµÄ¹ý¶à£¬¾Í²»±ØÒ»Ò»ÌáÃû£¬³ýÖ±½Ó²ÎÓ빤×÷¡¢°ïÖúºÜ´óµÄÈËÔ±ÁÐÃûÖÂл£¬Ò»°ãÈ˾ùÁýͳ±íʾлÒâ¡£Èç¹ûÓеĵ¥Î»»ò¸öÈËȷʵ¸øÓè°ïÖúºÍÖ¸µ¼£¬ÉõÖÁÑо¿·½·¨¶¼ÊÇ´ÓÈ˼ÒÄÇÀïѧµ½µÄ£¬Ò²Ö»×ÖδÌᣬÊDz»Ó¦¸ÃµÄ¡£Èç¹ûдÉÏһЩ´Óδ¸øÓè°ïÖúºÍÖ¸µ¼µÄÈË£¬ÎªÕչ˹ØÏµ£¬Ìá³öÖÂлҲÊDz»Ö÷ÕÅ¡£ n *%<!\gJ  
2.ÖÂлÔÚÂÛÎÄÊÖ¸åÖеÄλÖà iLn)Z0<\o  
ÖÂлͨ³£Î»ÓÚÂÛÎĽáÊøÖ®ºó»ò½áÊøÊ±¡£µ«ÉÙÊýSCIÆÚ¿¯ÒªÇó°ÑÂÞÁÐÖÂл·ÅÔڲο¼×ÊÁÏ֮ǰ£¬»òÕßÔÚµÚÒ»½Ú¡£ vbmSbZ"y  
3.ÀûÒæ³åÍ» &"fMiK3  
ÓÐЩSCIÆÚ¿¯ÒªÇóÔÚÖÂлÕ½ÚÄÚ˵Ã÷¡°Any clarification regarding conflicts of interest of the authors¡±¡£Èç¹ûûÓУ¬Äã¿ÉÒÔдÉÏ¡°The authors indicate no potential conflicts of interest¡±»òÕß¡°The authors declare that they have no competing financial interests¡±¡£ |HJdpY>Uu  
4.ÊéдÖÂл³£¼ûµÄ´íÎó )+Wx!c,mb  
£¨1£©Êéд»ù½ðÀ´Ô´Ê±£¬Ã»Óбê×¢»ù½ðºÅÂë¡£µ±È»£¬ÓÐЩ»ù½ðûÓлù½ðºÅÂë¡£ g.X?wyg5  
£¨2£©ÓÐÈË»ùÓÚÀñò£¬ÌíÉ϶ÔeditorºÍanonymous reviewersµÄ¸Ðл£¬ÕâÊÇûÓбØÒªµÄ¡£ "-kb=fY  
£¨3£©ÓÐЩÃû¼Ò¡¢Ñ§Õß»ò½ÌÊÚ£¬´Óδָµ¼£¬Ò²Ã»ÓÐÔĶÁ¹ýÂÛÎÄ£¬½è¡°ÖÂл¡±À´Ôö¼ÓÂÛÎÄ·¢±íµÄ¿ÉÄÜÐÔ£¬ÊDz»¶ÔµÄ¡£ÖÂл´ÊºÍÖÂл·½Ê½±ØÐëÕ÷µÃÊÜлÈ˺͵¥Î»µÄͬÒâ¡£

kaobook 2011-08-17 22:36
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× Rk5 6H  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ v I@Wuu:  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õß¶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëÎ´ÔøÔĶÁµÄÎÄÕ¡£ 7am. _K  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò ZebXcT ,41  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ _L(6F T J  
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© 3'O+  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© n[CESo%[  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© +q"d=   
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ zF.rsNY  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ eHi|_3A&*  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî q/Ba#?sen  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠWu<  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åǰ£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ \f1r/e(G|  
£¨3£©¾¡Á¿²»ÒªÒÅÂ©ÖØÒª²Î¿¼ÎÄÏס£ iDlIx8PI  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ xIf,1g@Cq9  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£ K!"[,=u_  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æÊ±£¬¿ÉÒÔд³Éin press¡£ 9`i=kp  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ QQ!%lbMK]  
4.²Î¿¼ÎÄÏ׵ĸñʽ p@/!+$^{  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚǰ£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 %Y M4x!6  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ 5Y#yz>B@ ]  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ =|bM|8,  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚǰ£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ *TVr| to  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊǰ´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊǰ´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ <33[ qt~  

kaobook 2011-08-17 22:37
µÚ15Õ ÈçºÎÒýÓòο¼ÎÄÏ× = \AI92  
1.²Î¿¼ÎÄÏ×µÄÄ¿µÄ w o$9$~(  
±ãÓÚ¶ÁÕß²éÔÄԭʼÎÄÏ××ÊÁÏ£¬±ãÓÚ×Ô¼º½øÒ»²½Ñо¿Ê±²Î¿¼¡£Ó¦¸Ã×¢ÒâµÄÊÇ£¬·²ÁÐÈë²Î¿¼ÎÄÏ×£¬×÷Õß¶¼Ó¦ÏêϸÔĶÁ¹ý£¬²»ÄÜÁÐÈëÎ´ÔøÔĶÁµÄÎÄÕ¡£ $SRpFz5y$  
2.ÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò Y[i>  
£¨1£©Ö÷ÒªµÄÎÄÏ×£¨Primary literature£©¡£ Zk"'x,]#  
¨S¸ÃÑо¿ÓÉË­´´Ê¼µÄ£¿£¨Who first laid the basic idea?£© (Ybc~M)z  
¨SÊÇË­×öÁË×îÖØÒªµÄ¹¤×÷£¿£¨Who did the most important work before?£© 3bu VU& ap  
¨S»¹ÓÐË­¹±Ï׺ܴ󣿣¨Who else contributed significantly?£© 8 ]]uk=P  
£¨2£©ÊÕ¼Õýʽ·¢±íµÄÎÄÏס£ D'ZR>@w@  
£¨3£©¹æ·¶µÄÊÕ¼¸ñʽ¡£ Bab`wfUve  
3.ÊÕ¼²Î¿¼ÎÄÏ×ӦעÒâÊÂÏî _,"T;i  
£¨1£©×îºÃÒýÓÃԭʼÎÄÏ×£¬²»Òª¶þ´ÎÒýÓᣠ3ox%1x NA  
£¨2£©×¢ÒâÎÄÏ×±àÅŸñʽ£¬ÓëÄãҪͶµÄ¿¯ÎïÒªÒ»Ö¡£ÒòΪ£¬²»Í¬µÄSCIÆÚ¿¯Óв»Í¬µÄÎÄÏ×±àÅŸñʽ¡£Í¶¸åǰ£¬Ê×ÏÈÒªÁ˽â¸ÃÆÚ¿¯µÄͶ¸åÖ¸ÄÏ¡£ G)]'>m<y  
£¨3£©¾¡Á¿²»ÒªÒÅÂ©ÖØÒª²Î¿¼ÎÄÏס£ wUW^ O  
£¨4£©ÒýÓÃÎÄÏ×ʱ£¬²»ÒªÍêÈ«ÒÀÀµÓÚ×ÛÊö¡£ "6 |j 0?Q  
£¨5£©¾¡Á¿ÒýÓÃÔ­´´ÕßµÄÎÄÏס£ 8{#W F#  
£¨6£©µ±ÒýÓÃ×Ô¼ºÒѾ­Í¶¸å£¬µ«»¹Ã»ÓнÓÊܵÄÂÛÎÄʱ£¬¿ÉÒÔд³Ésubmitted¡£Èç¹ûÄãµÄÂÛÎÄÒѾ­±»½ÓÊÜ£¬µ«»¹Ã»Óгö°æÊ±£¬¿ÉÒÔд³Éin press¡£ qc2j }D0  
£¨7£©²Î¿¼ÎÄÏ×µÄÒýÓÃÒª¸ù¾ÝÊÕ¼²Î¿¼ÎÄÏ×µÄÔ­Ôò¡£ÒòΪ£¬±à¼­²¿Ò»°ãÑ¡ÓøÃÁìÓòÖеÄר¼ÒÀ´ÆÀÉó¡£Èç¹ûÆÀÉóר¼Ò·¢ÏÖËûµÄÂÛÎÄûÓб»ÒýÓ㬿ÉÄÜ»áÔì³ÉÒ»¶¨µÄ¸ºÃæÓ°Ïì¡£ÖÁÉÙÆÀÉóר¼Ò»áÈÏΪÄã¶Ô¸ÃѧÊõÎÊÌâµÄÁ˽âºÍÀí½âµÄÉî¶ÈÒÔ¼°¹ã¶È²»¹»¡£ Xt^ldW  
4.²Î¿¼ÎÄÏ׵ĸñʽ H dw;=]-  
£¨1£©×÷ÕßµÄд·¨£ºÓеÄÊǼòдÔÚǰ£»ÓеÄÊǼòдÔÚºó£»ÓеļòдÓе㣻ÓеļòдûÓе㡣 t>N~PXr  
£¨2£©ÎÄÕµÄÃû×Ö£ºÓеÄÒª¼ÓÉÏÒýºÅ£¬ÓеÄÔò²»±Ø¼Ó¡£ R2vT\ 6xv  
£¨3£©ÆÚ¿¯µÄд·¨£ºÓеÄÒª¼òд£¬ÓеÄҪȫ³Æ£¬ÓеÄҪбÌ壬ÓеÄÔò²»ÐèÒª¡£ :f G5?])  
£¨4£©ÄêºÍÆÚ¾íºÅµÄ˳Ðò£ºÓеÄÊÇÄê·ÝÔÚǰ£¬ÓеÄÊÇÄê·ÝÔÚºó¡£ 8om6wALXB  
£¨5£©ÎÄÏ×µÄÅÅÁÐ˳Ðò£ºÓеÄÊǰ´ÕÕ×ÖĸµÄ˳Ðò£¬ÓеÄÔòÊǰ´ÕÕÔÚÂÛÎÄÖгöÏÖµÄ˳ÐòÓð¢À­²®Êý×ÖÅÅÁС£ %O B:lAeJ  

kaobook 2011-08-17 22:37
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ &a5UQ>  
1.¸½Â¼µÄÄÚÈÝ [Ul"I-K  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ Q@?8-  
2.¸½Â¼µÄÓ¦Óà *`Swv`  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖÆµÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠH )hO/1 m  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ !iA 3\Ai"  
3.×¢ÒâÊÂÏî ^\ A[^' 9  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ e+6mbJ7y  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ Swz{5 J2C  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ _;!7:'J  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ 6D|[3rXr  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓÆµ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøÊ¹ÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓÆµ¡£ J|,Uu^7`  
4.¸½Â¼µÄ¸ñʽ k#F |  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ17Õ ÈçºÎÑ¡Óø½Â¼ 3}aKok"k  
1.¸½Â¼µÄÄÚÈÝ ' L?e)u.  
¸½Â¼£¨appendix¡¢supporting information¡¢supplemental data£©°üº¬SCIÂÛÎĵIJ¹³äÐÅÏ¢¡£¶ÔÑо¿ÂÛÎı¾ÉíÓÐÓ㬵«²»Êǹؼü½á¹û¡£¿ÉÒÔ°üÀ¨½á¹ûµÄÏêϸÊý¾Ý¡¢Í¼±ê¡¢Í¼±íµÈ¡£ -!;2?6R9{  
2.¸½Â¼µÄÓ¦Óà @~k4,dJ  
£¨1£©¸½Â¼²¢·Ç°üº¬¶ÔÕýÎÄÀí½âµÄ±ØÐëÐÅÏ¢£¬µ«Ò²Ðí¶ÔSCIÂÛÎÄÖÐijһЩ¹Ûµã¿ÉÒÔ½øÐнøÒ»²½³ÎÇå²¢ÓÐÀûÓÚ¶ÁÕßÀí½âÂÛÎĵÄÄÚÈÝ¡£¸½Â¼Ê®¶ÔÕ÷ÎÄijЩ²¿·ÖµÄ²¹³ä˵Ã÷[¿ÉÑ¡£¨optional£©],ºÜÉÙÓÃÓÚSCIÆÚ¿¯¡£Ö»ÊÇÔÚÂÛÎÄ×ÖÊýÊܵ½ÏÞÖÆµÄSCIÆÚ¿¯ÈçNatureºÍScienceÖвŻáʹÓᣠ'&hz *yk  
£¨2£©ÓÐЩÄÚÈݲ»ÄÜÌåÏÖÓÚÓ¡Ë¢ÆÚ¿¯£¬Èçµç×ÓÊÓÌýÎļþ£¨E-component£©¡¢¶Ì¼ÏñƬ£¨video clip£©¡¢¶¯»­£¨short cartoon£©µÈ¡£µ«¿ÉÒÔÔÚÍøÉÏ·¢±í¡£ pHQrjEF *  
3.×¢ÒâÊÂÏî 94^)Ar~O  
£¨1£©¸½Â¼×ÊÁÏÈÔ°´ÕÕÕý³£Éó¸å³ÌÐòÉó¸å¡£ dUN{@a\R0  
£¨2£©Ö»ÓÐÕýÎÄÖÐÌáµ½µÄ²Å¿ÉÒÔÁÐÈ븽¼¡£ hr$Wt ?B  
£¨3£©Èç¹ûÄãʹÓöà¸ö¸½Â¼Ê±£¬Ó¦¸Ã°´Êý×Ö˳ÐòÅÅÁУ¬¼´¸½Â¼I¡¢¸½Â¼II»ò¸½Â¼1¡¢¸½Â¼2µÈ¡£ÎļþµÄÃüÃûÓ¦¸ÃÊÇOne word,ûÓпոñ£¬Èçmovielink¡¢mov¡¢movie2.qt¡¢table1.xls¡£ j9gn7LS  
£¨4£©Ã¿¸ö¸½Â¼Ó¦¸Ã°üº¬²»Í¬µÄ²ÄÁÏ¡£ SU ,G0.  
£¨5£©ÎªÁ˱ÜÃâÏÂÔØÎļþÀ§ÄÑ£¬ÊÓÆµ²»Ó¦¸Ã³¬¹ý5MbµÄ´óСºÍ30-60sµÄ³¤¶È¡£¹ÄÀøÊ¹ÓÃQuickTimeÀ´¡°Ñ¹Ëõ¡±ÊÓÆµ¡£ r$[`A_  
4.¸½Â¼µÄ¸ñʽ /tm2b<G  
¸½Â¼µÄ¸ñʽ°´ÏàÓ¦µÄSCIÆÚ¿¯³ö°æÎïµÄÖ¸ÄÏ×¼±¸¡£

kaobook 2011-08-17 22:38
µÚ19ÕÂÈçºÎÏòSCIÆÚ¿¯Í¶¸å rFUR9O.{E  
1.×¼±¸Í¶¸åÐÅ )I#{\^  
SCIÆÚ¿¯µÄ±à¼­ÍùÍùÐèҪһЩÓйØ×÷Õß¼°ÆäÂÛÎĵÄÐÅÏ¢£¬¶ø×÷ÕßҲϣÍû¸ø±à¼­ÌṩһЩÓÐÖúÓÚÆäÈ«ÎÄËÍÉó¼°¾ö²ßµÄÐÅÏ¢¡£ÕâЩÐÅÏ¢¶¼Ó¦¸Ã°üÀ¨ÔÚͶ¸åÐÅ£¨covering letter£©ÖС£Í¶¸åÐÅÓ¦°üÀ¨ÒÔϼ¸·½ÃæµÄÄÚÈÝ£º WBD?|Ss  
£¨1£©ÂÛÎĵÄÌâÄ¿ºÍËùÓÐ×÷ÕßµÄÐÕÃûÒÔ¼°µØÖ·¡£ @9eN\b%I^H  
£¨2£©ÉêÃ÷ÎĸåȨתÈᣠG6QD`ED  
£¨3£©ÎÞÒ»¸å¶àͶ¡£ ZIKSHC9  
£¨4£©ËùÓÐÁгö×÷Õß¾ù¶ÔÎĸåÓÐÈ·Çй±Ïס£ Jz}`-fU`  
£¨5£©ÎĸåÄÚÈÝÕæÊµ£¬ÎÞαÔì¡£ iC3C~?,7  
£¨6£©ËùÓÐ×÷Õß¾ùÒÑÔĶÁÎĸ壬ÇÒͬÒâË͸塣 s+~GQcj<T  
£¨7£©½¨ÒéÉó¸åÈ˼°Òò´æÔÚ¾ºÕù¹ØÏµ¶ø²»ÒË×öÉó¸åÈ˵ÄÃûµ¥¡£ []v$QR&u#v  
£¨8£©Í¨ÐÅ×÷Õߣ¨corresponding author£©µÄÐÕÃû£¬ÏêϸµØÖ·£¬µç»°ºÍ´«ÕæºÅÂ룬E-mailµØÖ·¡£ "~=-Q#xO  
£¨9£©Í¨ÐÅ×÷ÕßÇ©Ãû¡£ Vm8@ LA  
Science¶ÔͶ¸åÐÅÒªÇó¹ý¶à£º wVqp')e  
¡òThe title of paper and a statement of its main point. RC}m]!Uz  
¡òAny information needed to ensure a fair review process. ,PmUl=  
¡òNames of colleagues who have reviewed the paper. (i L*1f   
¡òAlso required for submission are the following: Names, telephone, and E-mail addresses for all authors. ?JG^GD7D  
¡òA statement that none of the material has been published or is under consideration elsewhere, including the Internet. Jz=|-F(Sy  
¡òNames, affiliations, and E-mail addresses of five potential referees. S)g:+P  
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. Cdy,8*   
¡òFor investigations on humans, a statement indicating that informed consent was obtained after the nature and possible consequences of the studies were explained. 5x%Blkx  
¡òFor authors using experimental animals, a statement that the animals¡¯ care was in accordance with institutional guidelines. n\)1Bz  
¡òCopies of any paper by you or your coauthors that is in press or under consideration elsewhere that relates to the work submitted to sciences, or of any paper that is cited in your paper as in press. These materials should be sent as attached PDF files in an E-mail to science_editors@aass.org. iGSA$U P|  
¡òWritten permissions from any authors who is not an author of your manuscript but whose work is cited as a personal communication or in press. Permission must allow distribution of in press manuscripts or relevant data to reviewers or any interested reader upon publication. ^*i0~_  
Ͷ¸åÐÅʾÀý1 I 1n,c d[  
Dear Editor: s;YbZ*oaMe  
Enclosed for your consideration is an original research article, entitled ¡°X X X X X¡±. S.4+tf 7+  
1.All authors of this research paper have directly participated in the planning, execution, or analysis of this study. /!2`pv  
2.All authors of this research paper have read and approved the final version submitted. 4w~%MZA^  
3.The contents of this manuscript are not been copyrighted or published previously. r88De=*  
4.The contents of this manuscript are not now under consideration for publication elsewhere. z~X /.>  
5.The contents of this manuscript will not be copyrighted, submitted ,or published elsewhere ,while acceptance by the Journal is under consideration. (ix .  
6.There are no directly related manuscripts or abstracts ,published or unpublished, by any authors of this paper. 4xEw2F  
We believe the paper may be of particular interest to the readers of your Journal because the study reports that ¡­. E( j# R"  
Correspondence and phone calls about the paper should be directed to X X X X X at the following address, phone and fax number ,and E-mail address: #gqh0 2 7  
(your name and address here) Y*$>d/E  
Thanks very much for your attention to our paper. y/y~<-|<@  
Sincerely yours, bq9w@O  
(your name here) 3ZI7;Gw  
Ðí¶àÂÛÎÄÒòSCIÆÚ¿¯±à¼­²¿ÍùÍùÕÒ²»µ½ºÏÊʵÄÉó¸åÈË£¬ÖÂʹ¸å¼þÒ»ÔÙÍÏÑÓ¡£ÌṩÉó¸åÈËÃûµ¥ºÍÏêϸͨѶµØÖ·£¬»á¼Ó¿ìÉó¸åÈËËÙ¶È¡£Òò´Ë£¬ÔÚͶ¸åµÄͬʱ£¬ÌṩһЩÊìϤÂÛÎÄÄÚÈݵÄÉó¸åÈËÊDZØÐèµÄ¡£ 9M;t4Um  
Ͷ¸åÐÅʾÀý2 | bz%SB  
Dear Dr. XXX, ')!X1A{  
I would like to submit the attached manuscript,¡°XXX¡±,for consideration for possible publication in the Research Articles section of JCI. MNWI%*0LO  
My two nominees for associate editor are Dr. Smith and Dr. XXX.. Dr. Smith is well versed in the topic of the paper, while Dr. XXX has used a methodology in his own research that is related to the methodology in the paper being submitted. -z~!%4 a  
Reguarding the option of nominating up to four reviewers, my nominees are: *9"x0bth  
Name-1,E-mail adderess-1 _ Lb"yug  
Name-2,E-mail adderess-2 '"fJA/O  
Name-3,E-mail adderess-3 =K18|Q0m  
Name-4,E-mail adderess-4 N"G aQ  
The nominees for associate editor and reviewers have no conflict of interest with any of the authors of the paper being submitted. 1f}(=Hv{  
This paper (or closely related research) has not been published or accepted for publication. It is not under consideration at another journal. No other papers using the same data set have been published.(NONE: If other papers using the data set have been published, please indicate the differences between the submitted paper and the other published papers.) zk FX[-'O  
Sincerely, UMR?q0J  
(your name and address here) !Fp %2gt|  
2.ÔĶÁͶ¸åÐëÖª ##=$ $1 Ki  
´ÓÏàÓ¦µÄSCIÆÚ¿¯ÍøÕ¾µÄhomepageÏÂÔØInstruction for Author,²¢ÇÒ°´ÕÕÒªÇó×¼±¸ºÃÔ­¸åËùÓÐÎļþ£¬ÈçͶ¸å·ÝÊý¡¢ÂÛÎĸñʽ¡¢³¤¶È¡¢Í¼±í¡¢²Î¿¼ÎÄÏ׸ñʽ¡¢Åäͼ˵Ã÷£¨Figure legends£©µÈ£¬ÖðÌõ×ñÑ­¡£Ò»°ãSCIÂÛÎĿɷÖΪ»Ø¹ËÐÔÎÄÕ£¨review article£©¡¢ÆÕͨÂÛÎÄ£¨regular/research article£©¡¢¿ìѶ£¨short communication£©µÈ¡£²»Í¬µÄѧ¿Æ£¬ÕýÎĵÄÄÚÈݺÍÐÎʽ»áÓÐËùÔö¼õ£»Í¼±í¡¢¹«Ê½µÄÊýÁ¿Ò²»áÓÐËù²»Í¬¡£´ËÍ⣬²»µ«Ô­¸æµÄÄÚÈÝÒª·ûºÏSCIÆÚ¿¯µÄµÄÒªÇ󣬶øÇÒÔÚÊý×Ö¡¢Ò³Êý¡¢¸ñʽ¡¢Îļþ´¢´æÐÎʽµÈ·½Ã棬¾ùÐèÓëͶ¸åµÄµÄSCIÆÚ¿¯ÒªÇóÒ»Ö¡£·ñÔò£¬ÂÛÎÄÔÚ³õÑ¡½×¶Î»áºÜ¿ìÂäÑ¡¡£ )Q'E^[Ua  
3.ÏòSCIÆÚ¿¯Í¶¸åµÄ·½Ê½ NC%hsg^0/  
£¨1£©ÓʼÄÐÎʽ¡£¼´Í¨¹ý¹ú¼Ê¿ì¼þ»òº½¿Õ½«ÂÛÎĵÄÔ­¸åÓʼĸøÆÚ¿¯µÄÖ÷±à»ò±à¼­²¿¡£ T:$^1"\  
a£©¸å¼þ°ü×°£ºÒ»°ãÓ¦°´ÒÔÏÂ˳Ðò±¸Æë×ÊÁÏ£º N! 7}B  
¨SͶ¸åÐÅ¡£ IibrZ /n6  
¨SÂÛÎĸ忽±´·ÝÊý¡£ÒÔ´òÓ¡¸å£¨hard copy£©Í¶¸å¡£ o=3hWbe  
¨S°æÈ¨×ªÈÃÉêÃ÷£¨¿ÉÒÔÔÚÂÛÎĽÓÊܺó×·¼Ó£©¡£ );h(D!D,  
b£©¸å¼þÓʼġ£Óʼĸå¼þӦעÒ⣺ (c(F1=K  
¨SÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¼û¡°Í¶¸åÐëÖª¡±£©¡£ÓеÄSCIÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÌØ±ðÖ¸³öͶ¸åµØÖ·Ó붨¿¯»ò¶©µ¥Ðб¾µØÖ·²»Ò»Ñù£¬ÒÔÃâÔì³Éʱ¼äµ¢¸é¡£ Nv7-6C6<  
Óʼĸå¼þµÄÐÎÊ½Ôø¾­ÊÇSCIÂÛÎÄͶ¸å½üºõΨһµÄ·½Ê½£¬ÏÖÔÚ²ÉÓÃÕâÖÖ·½Ê½½ÓÊÜÀ´¸åµÄSCIÆÚ¿¯Ô½À´Ô½ÉÙÁË¡£ FAEF  
£¨2£©µç×ÓÓʼþÐÎʽ¡£¼´×÷Õß½«SCIÂÛÎÄE-mail±à¼­²¿¡£ÏÖÔÚÓÐÐí¶àSCIÆÚ¿¯ÒѾ­¸æ±ðÁËÓʼĺ͵ç×ÓÓʼþµÄʱ´ú£¬¿ªÊ¼Ö»ÊÜÀíÍøÉÏͶ¸å¡£Ä³Ð©ÆÚ¿¯½öÔÊÐíһЩûÓÐͼ±íµÄ¶ÌÎÄ¡¢ÌØÑûÂÛÎÄ£¨reviewer£¬book chapter£©»ò¡°¸ø±à¼­µÄÐÅ¡±Í¨¹ýE-mailͶ¸å¡£¼¸ºõËùÓеÄSCIÆÚ¿¯¾ù²»½ÓÊÜfaxͶ¸å¡£ I_<XL<  
£¨3£©ÍøÉÏͶ¸å£¨online submission£©¡£ÍøÉÏͶ¸å·½Ê½Ëٶȸü¿ì£¬¶øÇÒ¸å¼þ²»»á¶ªÊ§¡£ÍøÉÏͶ¸å³£ÐèÒª×÷Õßonline×¢²á¡£Ò»µ©×÷ÕßÔÚÍøÉϵǼÇ×¢²áͶ¸å£¬Ã¿¸öÖ÷Òª²½Öè¶¼ÓмǼ£¬ºÜÊÜSCIÆÚ¿¯×÷Õߵ϶ӭ¡£ ;Z d_2 CZ  
4.ÍøÉÏͶ¸å +:.Jl:fx4  
£¨1£©ÍøÉÏ×¢²á£¨online registration£©£¬Ò²½Ð×÷Õß×¢²á¡£ÍøÉÏͶ¸å£¨online submission£©Ê±£¬Òª°Ñ×Ô¼ºµÄÐÕÃû¡¢µ¥Î»¡¢ÁªÏµµØÖ·£¬°üÀ¨µç»°¡¢´«ÕæºÍµç×ÓÓÊÏäµÈµÇ¼Ç׼ȷÎÞÎó¡£×¢²á³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ r%?-MGc  
×¢²á³É¹¦ÊÂÀý $V(]z`b&  
Dear Dr .XXX, WFOJg&  
Thank you for registering for the Elsevier Editorial System online submission and peer review tracking system for Neurobiology of Disease. {*7MT}{(  
Here is your username and confidential password, which you need to acess the Elsevier Editorial System :http://ees.elsevier.com/ynbdi/ .J)TIc__|A  
Your username is: XXX and Your password is: XXX PC_!  
You can change your password and other personal information at: http://ees.elsevier.com/ynbdi/ Cg): Q8  
info_update.asp N&NBn(  
Editorial Office eWcqf/4?"  
£¨2£©°´²¿¾Í°àµÄÊäÈëÂÛÎĵĸ÷¸öÖ÷Òª²¿·Ö¡£ÈçÌâÄ¿¡¢×÷Õß¡¢ÕªÒª¡¢¹Ø¼ü´Ê¡¢ÕýÎÄ¡¢Í¼±íµÈ¡£ÔÚÊäÈëÿ¸ö²¿·ÖµÄʱºò£¬Ò»ÊÇҪͨ¹ý¸Ã²¿·ÖµÄÓйØÒªÇó£¬ÔÙ´ÎҪȷÈÏ×Ô¼ºÊäÈëµÄÎļþÊÇ·ñ·ûºÏÒªÇó¡£ÕâÌýÆðÀ´²¢²»ÄÑ£¬µ«Êµ¼ÊÉÏ×÷ÕßÔÚÕâ·½ÃæµÄÊèºöÈ´ºÜ¶à¡£ R+M=)Z  
£¨3£©È·ÈÏÿ¸ö²¿·ÖÊäÈëµÄÍêÕûÐÔ¡£ÓÐЩ×÷ÕßÔÚÊäÈëÎļþʱ¹ýÓÚ´Òæ£¬Ê®¸öͼֻÊäÈëÒ»°ë£¬ÕâÑùµÄ¸å¼þ¼´Ê¹Äܵ½Á˱༭²¿Ò²²»ÄÜËÍÉó£¬Ö»ÄÜ·µ»Ø×÷Õß²¹Â©¡£Èç¹ûÉóУԱһʱÊèºö»òÖ÷±àûÓвì¾õ£¬½«ËùÓÐǷȱµÄÎÄÕ·¢³öËÍÉó£¬ÔòÉó¸åÈËÒòΪȱͼ£¬²»ÄÜÕý³£ÉóÔÄÎÄÕ¡£ÕâÑùÔì³ÉµÄÂé·³Ëùµ¢ÎóµÄʱ¼ä»á¸ü¶à¡£ X&pYLm72;  
£¨4£©ÊäÈëÎļþÍê±Ïºó£¬Ò²¾ÍÊÇËùÓеIJ¿·Ö³É¹¦µØÊäÈëºó£¬²»ÒªÍü¼Çµã»÷Ͷ¸å·¢Ëͼü£¨¡¾Sending¡¿»ò¡¾submitting¡¿£©¡£·ñÔò£¬¸å¼þÖ»»á´æ´¢ÔÚ×÷Õß×Ô¼ºµÄÎļþ¼ÐÖУ¬¶ø²»ÊÇ·¢Ë͵½±à¼­²¿µÄÎļþ¼ÐÀï¡£ÂÛÎÄÌá½»³É¹¦ºó£¬×÷Õß»áÊÕµ½E-mail»ØÖ´¡£ mVZh_R=a  
Ͷ¸å·¢Ëͳɹ¦Ê¾Àý *p}mn#ru-  
Dear DrXXX£¬ S/'0czDMW  
This is confirm that the above-mentioned manuscript has been received for consideration y|5s  
in Neurobiology of Disease. %bDxvaftT  
You will be able to check on the progress of your manuscript by logging on to the Elsevier Editorial System for Neurobiology of Disease as an author. 5naFnm7%  
You will be given a manuscript number shortly and you will soon receive an E-mail '47 b"uV  
with this number for your reference. 1INX#qTZ  
Thank you for submitting your manuscript to Neurobiology of Disese. Should you have Zhq_ pus"a  
any questions, please feel free to contact our office. N(&{~*YE  
Kind regards,  )d2Z g  
Editorial Office m-AF&( ;K  
Ŀǰ£¬Ðí¶àSCIÆÚ¿¯ÍøÉÏͶ¸å£¬Ðè°ÑÎļþÓÐÒ»ÖÖ´æ´¢ÐÎʽת»»µ½ÁíÍâÒ»ÖÖ´æ´¢ÐÎʽ£¬±ÈÈçWordÎļþ±ä³ÉPDFÎļþ¡£ÔÚÕâ¸öת»»¹ý³ÌÖУ¬¼ÆËã»úÆÁÄ»ÉÏ»áÏÔʾͣÖÍ״̬£¬¿´ÉÏÈ¥ºÃÏñËÀ»úÁË¡£Æäʵ²»È»£¬Ö»ÐèÄÍÐĵȴý¡£Èç¹ûÓÐÎÊÌ⣬ÆÁÄ»ÉÏÔò»á³öÏÖÎÊÌâÔ¤¾¯»ò½â¾öÎÊÌâµÄÌáʾ¡£Èç¹û×÷Õß²»ÄÜ×ÔÐнâ¾ö¹ÊÕÏ»òÎÊÌâ·´¸´³öÏÖ£¬×÷Õß¿ÉÓë³ö°æÉçµÄÔÚÏßͶ¸åÖ§³ÖϵͳµÄÏà¹Ø²¿ÃÅ£¨online submission support team £©ÁªÏµ£¬ÇóµÃ°ïÖú¡£´ËÍâÖµµÃÒ»ÌáµÄÊÇ£¬²¿·ÖÖøÃû³ö°æÉçµÄÍøÒ³Éϳý¸½ÓÐͶ¸åÐëÖªÍ⣬»¹ÓÐרÃÅÉè¼ÆÁËÕë¶ÔÍøÉÏͶ¸åµÄÖ¸µ¼Ê¾·¶Îļþ£¨£©¡£×ÜÖ®£¬ÍøÉÏͶ¸å²¢²»ÄÑ£¬¹Ø¼üÊÇ×¼±¸³ä·Ö£¬¶øÇÒÔÚʵ¼ÊÉÏ»ú²Ù×÷ʱ°´²¿¾Í°à£¬²»Äܵ¥´¿Çó¿ì£¬·ñÔòÓûËÙ¶ø²»´ï¡£ < ~ smBd  
ÍøÉÏͶ¸åºó£¬±à¼­²¿»¹»á¸øÄãÒ»¸öÕýʽµÄ»ØÖ´ºÍ¸å¼þ±àºÅ¡£ 4[gmA  
£¨5£©¸å¼þ±àºÅ¿ÉÓÃÓÚ¸å¼þ×·×Ù£¨following-up£©¡£Òò´Ë£¬Òª±£´æºÃ¡£ b#6S8C+@  
Ͷ¸åÊÕÌõʾÀý v"G1vSx)BT  
Dear Authors£¬ ;kgP:n  
This is to inform you that the following manuscript has been submitted to the JCB. ]cpb;UfM  
Manuscript Number: F-00555-2008 T2e-RR  
Manuscript Title: X X£Ø.Author list:XXX 1q}L O2  
You can track the status of the manuscript in your author center at http://mc.manuscriptcentral.com/JCN. aCG rS{  
If you have received this message in error, or if one of your co-authors did not receive this message, please contact the corresponding author:Dr.XXX. vzIo2 ,/7  
Regards, Vq'7gJj'  
Peer Review Manager 7V"?o  
5.ÍøÉÏͶ¸å³£¼ûÎÊÌâ $J7V]c*-b  
ÍøÉÏͶ¸åͨ³£ÊÇ¿ìËÙ²¢Ïà¶ÔµØÈÝÒס£È»¶ø£¬Èç¹û×÷ÕßÊèºö×ñÊØÆÚ¿¯µÄÒªÇ󣬿ÉÄÜÑÓ³Ù»òÍ£Ö¹·¢ËͺÍÉó¸å¹ý³Ì£¨The submission and peer-review process£©¡£ÍøÉÏͶ¸å³£¼ûµÄÎÊÌâÓУº UleT9 [M  
£¨1£©ÂÛÎÄ×ÖÊdz¬¹ý¹æ¶¨µÄÒªÇó¡£ ea 3w  
±ÈÈç°´ÒªÇó£¬Ô­¸å²»Äܳ¬¹ý3000×Ö£¬¿ÉÓеÄÔ­¸å³¤´ï3200×Ö£¬ÉõÖÁ¸ü¶à¡£ ~apt , hl  
£¨2£©Í¼²»¹æ·¶¡£ t#NPbLZ  
¨SµÝ½»Í¼Îļþ£¨Figure file£©·½Ê½²»ÕýÈ·¡£¶àÊýSCIÆÚ¿¯ÒªÇóÿµ¥¶Àͼ×÷Ϊһ¸öµ¥¶ÀÎļþµÝ½»£¬¶ø²»ÊǰÑËùÓеÄfigure fileºÏ³ÉÒ»¸öÎļþÔٵݽ»¡£ v vErzUxN  
¨SͼµÄ·Ö±æÂÊÌ«µÍ¡£Ó¦¸ÃÓø߷ֱæÂʵÄͼ£¨300dots per inch£©¡£ (?qCtLZ  
¨SͼµÄ¸ñʽ£¨format£©²»¶Ô¡£³£ÓÃͼµÄÖ¸¶¨¸ñʽΪGIF¡¢JPEG¡¢TIFF¡£²»ÒªÓ÷ÇÖ¸¶¨¸ñʽ£¬ÀýÈ磬PDF¡¢WBMP¡¢Word.doc¡¢RLEºÍPowerPoint¡£ zj`c%9N+  
¨SûÓÐͼ½â£¨Figure legend£©¡£ PL:(Se%  
£¨3£©Ã»Óеݽ»¡°A conflict of interest disclosure¡±¡£ lJK]S=cd  
ÓÐЩSCIÆÚ¿¯ÒªÇó×÷ÕßÔÚͶ¸åµÄͬʱ£¬ÒªµÝ½»¡°A conflict of interest disclosure¡±¡£ Ik:G5m<ta  
£¨4£©È±Title page¡£ , 'pYR]3  
£¨5£©È±ÕªÒª¡£ c9|4[_&B~  
£¨6£©È±Í¶¸åÐÅ¡£ V;SfW2`)  
£¨7£©¶¯ÎïºÍÈËÌåÊÔÑéûÓб»Â×ÀíίԱ»áÅú×¼¡£ .eJKIck  
£¨8£©ÂÛÎĵĸñʽ²»·ûºÏËùͶSCIÆÚ¿¯µÄÒªÇó¡£

kaobook 2011-08-17 22:39
µÚ20ÕÂSCIÂÛÎÄÉó¸å¹ý³Ì q~qz^E\T  
1.±à¼­²¿³õÉó C?. ;3 h  
³õÉó°üÀ¨£º !+$qSD,%x  
£¨1£©×î»ù±¾µÄ¼¼Êõ¼ì²é¡£Ö÷ÒªÊǼì²ìÔ­¸åÊÇ·ñ°üº¬ÁËÓ¦¸ÃÓеĻù±¾ÄÚÈÝ¡£°üÀ¨ÎļþÐÎʽ¡¢ÄÚÈÝ¡¢×÷ÕßÁªÏµ·½Ê½ÒÔ¼°ÂÛÎÄÊÇ·ñÊôÓÚÖØ¸´ÐÔͶ¸åµÈ¡£ uNf'Zeo  
£¨2£©ÂÛÎĵÄÓ¢ÎÄÊÇ·ñ»ù±¾¹ý¹Ø£¨·ÇÓ¢Óï¹ú¼Ò£©¡£ W@}@5,}f>  
£¨3£©ÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ Qe~C}j%  
£¨4£©ÂÛÎĵÄˮƽÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯ÒªÇó¡£ 2K~v`c*4  
2.±à¼­²¿³õÉóºóµÄ½á¹û yc0 1\o  
£¨1£©½øÒ»²½ËÍÉó¡£ !jP[=  
£¨2£©Ðè²¹³äºÍÐ޸ġ£Ò»µ©¼¼Êõ·¢ÏÖÎÊÌ⣬±ÈÈçÔ­¸å¹ý³¤µÈ£¬Ô­¸å»áÂíÉÏ·µ»Ø×÷Õߣ¬½øÐбØÒªµÄ²¹³äºÍÐ޸ġ£Ô­¸æÒ»µ©ÍË»Ø×÷Õߣ¬Îļþ±ã»áÖØÐ»ص½×÷Õß×Ô¼ºÔÚÍøÉϵÄͶ¸åÎļþ¼ÐÀµÈºòÐ޸ġ£Óë´Ëͬʱ£¬×÷Õߵĵç×ÓÐÅÏäÄÚͬÑù»áÊÕµ½Ò»·â±à¼­²¿µÄÀ´ÐÅ£¬Ã÷È·¸æÖª¸å¼þÓ¦¸Ã½øÐÐÐ޸Ļò²¹³äµÄµØ·½¡£×÷ÕßÖ»ÐèÉÏÍø´Ó×Ô¼ºµÄÎļþÖе÷³öÎļþÐ޸ļ´¿É¡£Ò»µ©ÎļþÐÞ¸ÄÍê±Ï£¬×÷ÕßÓÖÒª¸ù¾Ý³ö°æÉçÐź¯µÄÌáʾ£¬ÉÏÍø°´²½Öè»á×ßÔÙ½«Ô­¸å·¢»ØSCIÆÚ¿¯µÄ±à¼­²¿¡£Õâ¸ö²Ù×÷¹ý³ÌÓë×î³õµÄͶ¸å³ÌÐò´óͬСÒì¡£ iu{y.}?  
£¨3£©Ö±½Ó±»¾Ü¾ø¡£ T3b0"o27  
Ö±½Ó±»¾Ü¾øµÄÔ­ÒòÖ÷ÒªÓУº |TJ gH<I  
µÚÒ»£¬ÂÛÎĵÄˮƽûÓзûºÏ¿¯ÎïÒªÇó¡£ÀýÈ磬Nature´óÖÂµÄÆÀÑ¡»úÖÆ£º±à¼­Ê×ÏȾö¶¨ÕâÆªÂÛÎĵ½µ×ÓжàÉÙ·ÖÁ¿£¬Õâ¸ö¾ö¶¨ÒªÔÚ¼¸ÌìÄÚ¾ÍÍê³É£¬Èç¹û·ÖÁ¿²»¹»£¬¾ÍÖ±½Ó¾Ü¾ø£¬Ã¿ÄêÈ«Çò´óÔ¼ÓÐ1ÍòƪÂÛÎÄÌá½»£¬60%-70%µÄÂÛÎĵ±¼´·ñ¾öµô£¬´ËºóÇëרҵÆÀÉóÍÅÆÀ¹À£¬´óÔ¼3¸ö×óÓÒ£¬¶¼ÊÇÏàͬÁìÓòµÄר¼Ò£¬Í¨¹ýÆÀÉóÂÊ´óÔ¼ÊÇ20%£»ÔÚÌýÈ¡ÆÀÉóÍÅÒâ¼ûºóÔÙ·ñ¾ö´óÔ¼2000-3000ƪ£¬×îºóֻʣÏÂ1000ƪ·¢±í£¬×îºóµÄ×Ü·¢±íÂÊÊÇ10%¡£ S> Fb'rJ3  
µÚ¶þ£¬ÂÛÎĵÄÄÚÈݲ»·ûºÏ¸ÃÆÚ¿¯µÄµÄ°ì¿¯×ÚÖ¼ºÍ·¶Î§ÒªÇó¡£ #W:.Fsq  
ÂÛÎÄÖ±½Ó±»¾ÜʾÀý s\'t=}0q  
Dear Dr.XXX qLBQ!>lR  
I am writing to you on behalf of the Journal of Clinical Investigation,s Editorial Board to thank you for submitting your manuscript,¡°Xxxx¡± (our reference 5555-RG-1).The Broad has now had a chance to carefully consider your manuscript, but I regret to inform you that we feel the manuscript would not be appropriate for publication in the Journal of Clinical Investigation. 8?~>FLWTXZ  
More than 4,000 manuscripts are submitted annually to the JCI,of which only a small percentage can be published. To facilitate the review process, we submit all manuscripts to a review by the Editorial Board to determine their appeal to the Journal¡¯s general readership. 1sUgjyGQ  
Although the Board regrets that it cannot offer to publish your manuscript, I would stress that this decision was based on issues relating to the priority assigned to your work relative to the other submissions under consideration. m<Gd 6V5  
Thank you for allowing us to review this work.We hope that you will continue to consider sending your work to the Journal in the future. YloE4PAY7  
Sincerely, ]_ LAy  
Editor-in-Chief i{g~u<DH)Q  
3.±à¼­²¿ËÍÉó %5ov!nm7  
¡òÆÀÉóÈ˵ÄÑ¡Ôñ o<|u4r={s  
SCIÆÚ¿¯µÄÉó¸åÈË´ó¶àÊǸ÷ÁìÓòר¼Ò£¬ÔÓÖ¾³ö°æÕß¾­³£Õ÷ѯ±àίÒâ¼û£¬Ñ¡Ôñ×î¼ÑÉó¸å¶ÓÎé¡£Éó¸åÈ˵ÄÔðÈÎÊǶÔÂÛÎĵĴ´ÐÂÐÔºÍÕþÈ·¶¨½øÐÐÉó²é£»Éó¸åÒâ¼ûÒ»°ãÓ¦°üÀ¨ÎªÌá¸ß¸å¼þÖÊÁ¿¶øÓ¦×öµÄÐ޸ĵĽ¨Òé¡£Éó¸åÈËÊÇÎÞ±¨³êµÄ£¬Éó¸åÈ˵Ä̬¶È´ó¶à¼«ÆäÈÏÕæ¡£Ã¿Ò»ÂÛÎÄÓÉ2-4λÆÀÉóÈËÀ´ÅÐ¶ÏÆä¼ÛÖµ£¬²¢½¨Òé±à¼­ÊÇ·ñ½ÓÊÜ»ò¾Ü¾ø¸ÃÂÛÎÄ¡£µ«±à¼­×ö³ö×îºóµÄ¾ö¶¨£¬Ò»°ã²»»áÒòΪ±à¼­¸öÈ˵ĺöñ»òÆäËû·Ç¿ÆÑ§ÒòËØ¶øÓ°ÏìÂÛÎĵĽÓÊÜ¡£ÒòΪ£¬±à¼­À´×Ô²»Í¬µÄ¹ú¼ÒºÍµØÇø£¬ÓÐ×Ų»Í¬¿ÆÑ§µÄרҵ±³¾°£¬×Ô¼ºÊ×ÏȾÍÊǸÃÁìÓòµÄר¼Ò£¬ËûÃǵÄÖ°Ôð¾ÍÊǾ¡×Ô¼º×î´ó¿ÉÄÜ£¬Ñ°ÕÒ×îÓÅÐãµÄÂÛÎÄ¡£ 6\h*SBI?(  
EditorÑûÇëReviewerÉó¸åµÄÑù¸åÐÅʾÀý 0>Kgz!I  
MS TITLE£ºXXX  w&U28"i>  
Dear Dr.XXX '<"%>-^Gn  
I would appreciate your expert opinion as a reviewer of the above manuscript recently submitted for publication to Science. Given your knoeledge and expertise in the subject areas upon which this manuscript is focused, I hope you will agree to participate in the reviewer process. iR4"I7J  
Please advise the editorial office in your reply of any relevant relationship that might be reasonably perceived as a real or potienial conflict of interest that could potentially influence or bias your review of this manuscript. +MS*YpPW  
While most relationships are not disqualifyin, if you believe that you have a disqualifying conflict of interest, financial or otherwise, please contact the editorial office immediately. A relationship is ¡°relevant¡± if the relationship or interest relates to the topic of the manuscript in terms of any of the following: the same or similar subject matter or topic; the same, similar or competing drug or device, product or service, intellectual property or asset; a drug or device company or its competitor; or has the reasonable potential to result in financial, professional or other personal gain or loss for you, members of your household or employer. $7-4pW$y  
To view the abstract and accept/decline this invitation, please go to: http://submit-science.org :>y5'q@R  
Enter your ¡®Reviewer Area¡¯ and click on ¡®Requests for Review¡¯. Please accept or decline via the appropriate alternative reviewers, giving their name(s),institution(s), and E-mail address(es). Nj;(QhYZ  
Sincerely, wC1) \ld  
Editor 7CT446  
Èç¹ûͬÒ⣬Editor»á¸øReviewerÒ»·âÐŲ¢¸æËßReviewerÈçºÎÏÂÔØÂÛÎÄºÍÆÀÉó¡£ V2Z^W^  
Editor¸øReviewerµÄÑù¸åÐÅʾÀý 787i4h:71  
Dear Dr.XXX ZU:c[`  
Thank you for agreeing to review Manuscript ID-07-555 entitled ¡°XXX¡± for Cell. 'pAq;2A A  
In your review, please answer all questions. On the review page, there is a space for ¡°Comments to Editor¡± and a space for ¡°Comments to the Author¡±.Please be sure to put your comments to the author in the appropriate space. Ob'[W;p)[w  
To access the manuscript, login to Cell-Manuscript Central site at http://mc.manuscriptcentral.com/cell. Once you are logged in, the Main Menu will be displayed.Please click on the Reviewer Centre, where you will find the manuscript listed under ¡°Review and Score¡±.You can click on the ¡°View Details¡± button to begin reviewing the manuscript. It is essential that you click the ¡°Save¡± button if you wish to exit the review before you submit it to the Editor. Otherwise, none of the information that your have completed your review and are ready to submit it to the Editor, click on ¡°Submit¡±. Kt#X'!9/<  
Thank you for evaluating this manuscript. Si;eBPFH  
Best regards, `yXHb  
Executive Editor "jq F  
¡òÂÛÎĽøÈëSCIÆÚ¿¯µÄ×î»ù±¾ÒªÇó ovtZHq/  
Ô­´´ÐÔÊǺܶàSCIÆÚ¿¯ÊÇ·ñ¼ÓÃÂÛÎĵÄ×îÖ÷Òª³ö·¢µã¡£ÈÎºÎÆÚ¿¯¶¼²»Ï£Íû·¢±íÒѾ­¼ûÓÚÆäËûÔÓÖ¾£¬»òÓÉÆäËûÓïÑÔ·¢±í¡¢»òÒÔÉÔÓв»Í¬µÄÐÎʽ·¢±íµÄÂÛÎÄ£¬SCIÆÚ¿¯Ò²ÊÇÈç´Ë¡£ÒªÏëÔÚSCIÆÚ¿¯·¢±íÂÛÎÄ£¬Ô­´´ÐÔ×î»ù±¾µÄÒªÇó¡£ =rNI&K_<  
¡òÂÛÎÄÆÀÉó±ê×¼ 5X`m.lhUc  
ÏÖ½éÉÜÂÛÎÄÆÀÉó±ê×¼ÈçÏ£º h>NuQo*  
¨SÂÛÎĵÄÄÚÈÝÊÇ·ñ·ûºÏ¸ÃÆÚ¿¯µÄ·¶Î§£¨aims and scope£©¡£ U_0"1+jbq  
¨SÂÛÎÄÊÇ·ñÌá³öÁËÒ»¸öеÄÎÊÌâ»òÕß¶ÔÒÑÓÐÎÊÌâÌá³öÁËÒ»¸öеĽâ¾ö·½°¸¡£ j W|M)[KJN  
¨SÂÛÎĵÄÔ­´´ÐÔÖÊ£¨°üÀ¨¸ÅÄî¡¢ÖÎÁÆ¡¢·½·¨¡¢Êý¾Ý¡¢½âÊͺÍ/»òÓ¦Óã©»ò½ñºóµÄ¼ÛÖµ»òÒâÒå¡£ uY )|   
¨SÂÛÎĵÄÖ÷Òª½á¹û»ò½áÂÛÊÇʲô£¿ÊµÑé½á¹û»ò½áÂÛÊÇ·ñ³ä·Ö£¿ w##$SaTI  
¨SÂÛÎÄËùʹÓõķ½·¨µÄÆÀ¼Û£¿ÂÛÎļ¼Êõº¬Á¿ÈçºÎ£¿ H+5N+AKb@  
¨S½á¹û»ò½áÂÛÊÇ·ñ¾ßÓÐÐÂÓ±ÐÔ£¿½áÂÛÊÇ·ñÓëÌá³öµÄ¼Ù˵»òÎÊÌâ¹ØÁª£¿½áÂÛÊÇ·ñ±»Ö¤Ã÷Çå³þ£¿ $T'lWD*  
¨SÖ÷Òª½á¹û»ò½áÂÛÊÇ·ñÕýÈ·£¿ DTV"~>@  
¨SÂÛÎÄÊÇ·ñ¶ÔËùÌá³öµÄ¼¼Êõ/½á¹ûµÄÓÐЧÐԺ;ÖÏÞÐÔ½øÐÐÁËÆÀ¼Û£¿ Gy[m4n~Z5  
¨SÂÛÎÄд×÷ÊÇ·ñÇåÎú£¬ÊÇ·ñÄÜÈñ¾ÐÐÒµÄÚ¶àÊýÑо¿ÈËÔ±¶Á¶®£¿ " IdN*K  
¨SÎÊÌâ¡¢¸ÅÄî¡¢¶¨ÒåºÍ/»ò¼Ù˵µÄ³ÂÊöÊÇ·ñÇå³þ£¿ ~p/1 9/  
¨SÂÛÎÄÊÇ·ñÊʵ±µØÒýÓúͽéÉÜÁËÓëÖ®Ïà¹ØµÄÀúÊ·ÎÄÏ×£¿ÒýÓÃÎÄÏ×ÊÇ·ñ³ä·Ö£¿ 9 &KiG* .  
¨SÊÇ·ñ¾ßÓÐÒ»ÖÂÐÔ£¨Ç°/ºó£¬ÂÛÊö/½á¹û£©£¿ `oH6'+fT`;  
¨SÂÛÎĵÄÓ¢ÎÄÊÇ·ñ¹ý¹Ø£¿ 2G`tS=Un  
¡ò¸å¼þ×·×Ù %wux#"8  
Ͷ¸åºó¸å¼þ×·×Ù£¨follow-up£©¡£Èç¹ûͶ¸å2ÖܺóÈÔÎÞÈκÎÓйظå¼þÊÕµ½µÄÐÅÏ¢£¬¿ÉÒÔ´òµç»°¡¢·¢E-mail»òдПø±à¼­²¿ºËʵ¸å¼þÊÇ·ñÊÕµ½¡£ÏÖÔÚµÄÓʼþ¶ªÊ§Êdz£ÓеÄÊ£¬¼´Ê¹Í¨¹ýE-mail×÷Ϊ¸½¼þ·¢µÄ£¬Ò²ÓзþÎñÆ÷´íÈÏΪ²¡¶¾¶øÉ¾µôÄãµÄͶ¸å¡£E-mail×îºÃÒԻظ´µÄÐÎʽ£¬±£ÁôÔ­Ðżþ£¬ÌáÐѱ༭²¿ÉÏ´ÎͨÐŵÄʱ¼ä¡¢ÄÚÈݺ͸å¼þ±àºÅ¡£Ñ¯ÎÊÎÄ×ÖÒª¼ò½à£¬¿ªÃżûɽ£¬²»ÓÿÍÌ×»°¡£ ]$WwPDZ  
¸å¼þ×·×ÙÑù¸åÐÅʾÀý =I9RM9O<  
Dear Dr.XXX "PY&NL?  
I am just writing to enquire if you have received our manuscript (MS#:55555)? |lf,3/*jDB  
Best f>_' ]eM%  
(your name here) GZqy.AE,  
ËùÓÐͨÐÅÓ¦±£³Ö¼Í¼£¬±ÜÃâÎʵĹýÇÚ¡£¿ÉÒÔÔÚÍøÉϲéѯ¸å¼þ״̬¡£

kaobook 2011-08-17 22:40
µÚ21Õ ÈçºÎÕýÈ·¶Ô´ýÉó¸åÒâ¼ûºÍÍ˸å >a2i%j/T  
1.Ͷ¸åºóµÄ½á¹û jG&gd<^  
ͨ³£ÔÚÁ½Öܵ½Á½¸öÔ£¬Äã»áÊÕµ½±à¼­µÄ»Ø¸´£¬°üÀ¨Éó¸åÈ˵ÄÒâ¼û£¨Reviewers, comments£©ºÍÒ»·â±à¼­²¿µÄ¸ÅÀ¨ÐÅ£¨Covering letter£©¡£Ò»°ãÓÐÏÂÁпÉÄÜÐÔ£º 3It9|Y"6[  
£¨1£©Ô­¸æ½ÓÊÜ£¬ÎÞÐèÐ޸ģ¨Publish without changes£©¡£º±¼û¡£ TW}nO|qw  
Dear XXX $4&e{fLt|v  
On the basis of reviewer¡¯s comments on your manuscript, I am pleased to inform you that your manuscript has been accepted for publication in the ¡°XXX iournal¡±. ?T <2Cl'C  
For the pre-publication preparation, please read carefully the document of ¡°name of document¡± at ¡°XXX website¡± to access the resources you need for preparing the reference styles and the final complete package. When you same your manuscript into an MS-Word file, please use your Paper ID as the file name. For our production schedule, please submit your complete package to me within 14 calendar days. \$[S=&E  
Normally, the pre-publication process takes up to three months. During this period, galley proofs will be sent to you for checking and corrections purposes.The galley proofs must be returned to the production office within 7 callendar days. Furthermore, you are responsible for any error in the published paper due to your oversight. EG[Rda  
I look forward to receiving the electronic file of your final manuscript. w0L+Sj db  
Best Regards, avo[~ `.  
Editor HTU?hbG(  
£¨2£©¸å¼þÍËÐÞ£¬ÐèÇá΢Ð޸ģ¨Publish with minor changes£©¡£²»¶à¼û¡£ "nEfk{g  
Dear Dr. XXX ]3iQpL  
Your manuscript, entitled ¡°title of the paper¡±, has been subjected to a double-blind review process by the reviewers who are experts in the related fields. Enclosed please find the reports from these reviewers. `suEN @ ^  
Based on the reviewers, recommendations, I am delighted to inform you that your manuscript has been ACCEPTTED WITH MINOR REVISIONS for the ¡°name of the journal¡±. { vOr'j@  
Please note that it is imperative for you to revise the manuscript according to reviewers, comments and guidelines. Once you have revised the manuscript, please E-mail it in an MS-Word format to me at ¡°Your E-mail Address¡± on or before MM DD,YYYY, with a cover letter outlining point-by-point the revisions you have made in regards to the reviewers comments and guidelines. 9( "<NB0y  
Thank you very much for submitting your article to ¡°the name of the journal¡±. I look forward to receiving the revised version of your manuscript. Xe7/  
Sincerely, w[X/|O  
Editor I=G-(L/&  
Enclosures: Referees reports. nkn4VA?"  
£¨3£©¸å¼þÍËÐÞ£¬ÐèÖØ´óÐ޸ģ¨Publish with major changes£©¡£ºÜ³£¼û¡£ ^\ocH|D  
Dear Dr. XXX K{WLo5HP  
We have now received the reviews of your manuscript referenced above. While the reviewers believe that this paper would ultimately make a significant contribution to the literature and could be acceptable for publication in The Journal of Neuroscience, they have also raised a number of serious concerns. These concerns are outlined in their reviews which have been included below. We invite you to revise and resubmit the manuscript. 4V9S~^v|  
Please carefully address the issues raised in the attached comments, points by points, and make appropriate changes in the manuscript, or provide a suitable rebuttal to any specific request for change that you believe is unwarranted. When the revised manuscript is received, it will be sent for re-review. -- chU5  
When submitting your revised paper, please include a separate document called ¡°Response to Reviews¡± detailing your responses to the comments of the reviewers, we request that your manuscript text, tables and figure legend be submitted in an editable format(Word or La Tex only), and all figures uploaded individually. TIF or EPS files are the preferred formats for figures; however, Power point, Word, and Excel files will also be accepted. DPI minimums are as follows: 84eqT[I'  
-Line art must be at least 1000dpi. EAPjQA-B?  
-Line/tone(combination of photographs and lines or labels )must be at least 500dpi. }5qpiS"V9  
Thank you and we look forward to receiving yopur revised manuscript. z[~ph/^  
Kind regards, "|KhqV=?v  
Associate Editor A4>j4\A[M  
£¨4£©ÂÛÎÄÐèÒªÖØ´óÐ޸ģ¬ÖØÍ¶²¢µ±×÷иå¼þ´¦Àí£¨not publish in its present form, but resubmit after major modifications to then be treated like a new submission£©¡£³£¼û¡£ rCp'O\@S  
Dear Dr. XXX X&14;lu%p  
Your manuscript has been reviewed by referees who specialize in the subject matter addressed by the submitted material. The general and specific comments of the referees are below. I regret to inform you that the reviewers raised serious concerns about the manuscript and submitted low priority ratings. In particular the concern was raised that the work was only a minor advance of the field and that several of the findings are already well established. Accordingly, I must reject your manuscript for publication in The Journal of Clinical Investigator. I hope that the reviewers comments will be of assistance to you if you decide to submit your work elsewhere. U1^3 &N8  
If you choose to rewrite your manuscript and resubmit it to The Journal of Clinical Investigator, you must resubmit it online as a de novo manuscript where it will be assigned an Associate Editor and expert reviewers. You must be complete all required submission forms and pay the $50 submission fee. No exceptions will be made. ]]^eIjg>a6  
Yours sincerely, jC}2>_#m(  
Associate Editor yJn<S@)VT:  
£¨5£©ÍêÈ«¾Ü¾ø(Reject)¡£×î³£¼û¡£ wFX>y^ 1  
SCIÆÚ¿¯±à¼­²¿³ýÁ˸ø×÷Õ߻ظ´ÒÔÍ⣬ͬʸæËßreviewer±à¼­¶ÔÂÛÎĵÄ×îºó´¦ÀíÒâ¼û¡£  :qe.*\ c  
±à¼­Ð´¸øreviewerÑù¸åÐÅ zz_(*0,Qcr  
Dear Dr. XXX rctGa ,l  
Thank you for reviewing manuscript Cell-07-o555 entitled XXX for Cell. sf5F$  
On behalf of the Editors of Cell, we appreciate the voluntary contribution that each reviewer gives to the Journal. We thank you for your participation in the online review process and hope that we may call upon you again to review future manuscripts. xjK@Q1MJ  
To read the Editors decision on this paper, go to your Reviewer Centre an click on View Decision Letter. p38RgEf  
Sincerely, fIwG9cR  
Editor *)u%KYGr  
2.×î³£¼ûÍ˸åÔ­Òò _k O<|ev  
£¨1£©Ö÷ÌâÔ­Òò£¨Subject£©£º >%1mx\y^  
¨SÄÚÈݲ»ÊÊºÏ¸ÃÆÚ¿¯£¨Not suitable for journal£©¡£ uP NZ^lM  
¨S²»ÊÊʱ£¨Not time£©¡£ 8RaRXnJ  
£¨2£©ÂÛÎÄÄÚÈÝ£¨coverage£©£º M>g% wg7Ah  
¨SÒâÒå²»´ó£¨Questionable significance£©¡£ P5Is#7udN8  
¨S²»¿ÉÐÅ£¨Questionable validity£©¡£ *pj^d><  
¨SÉî¶È²»¹»£¨Too shallow£©¡£ G{]tB w  
¨S¹ýÓÚÏ꾡£¨Too exhaustive£©¡£ /k^!hI"4c  
£¨3£©ÂÛÎij¤¶ÈµÄÔ­Òò£¨Length£©£º -a\[`JHi  
¨SÂÛÎĹý³¤£¨Too long£©¡£ caD)'FSES  
¨SÂÛÎĹý¶Ì£¨Too short£©¡£ He)vl.  
£¨4£©ÂÛÎĵıí´ïÔ­Òò£¨Presentation£©£º _Y _v&  
¨S¿ò¼Ü²»ºÃ£¨Bad organization£©¡£ D7|qFx;]g  
¨S±í´ï²»ÐУ¨Ineffective expression£©¡£ n}L Jt  
¨S²åͼÓÐÎÊÌ⣨Ineffective or unusable illustrations£©¡£ WlW7b.2.  
£¨5£©ÂÛÎĵĸñʽÎÊÌ⣨Failure to follow style guide£©¡£ !(nFq9~~Q  
3.ÈçºÎ´¦Àí±»¾ÜµÄÂÛÎÄ ]o2jS D  
£¨1£©ÒªÀí½â±»SCIÆÚ¿¯¾Ü¸åÊÇÒ»¼þÕý³£µÄÊÂÇ飨70%ÒÔÉϱ»¾Ü£©¡£Òò´Ë£¬Òª±£³ÖÁ¼ºÃÐÄ̬¡£ hmp!|Q[)  
£¨2£©¶ÔÍêÈ«¾Ü¾øµÄÂÛÎÄ£¬±à¼­Í¨³£»á±í´ï²»Ô¸ÔÙ¿´µ½¸ÃÎÄ£¬ÔÙ¼ÄËÍÕâÀàÎÄÕÂÊÇûÓÐÒâÒåµÄ¡£Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ d<_#Q7]I4  
£¨3£©Éó¸åÈËÓÐʱҲ»á·¸´íÎ󣬲»½ö½öÊDZÊÎó£¬Ò²ÓÐרҵ֪ʶÉϵĴíÎó£¬ÒòΪ±à¼­ÈËÕÒµÄÉó¸åÈËδ±ØÊÇÄãÏàͬÁìÓòµÄר¼Ò¡£Èç¹û×÷Õß¶Ô·ñ¶¨µÄÔ­ÒòÓÐÒìÒ飬¿ÉÒÔÏò±à¼­²¿»òÖ÷±àÌá³ö×Ô¼ºµÄÒâ¼û£¬¾ÝÀíÁ¦Õù¡£Ö»Òª×Ô¼ºÊÇÕýÈ·µÄ¾ÍÒª¼á³Ö¡£Ôڻظ´ÖÐίÍñµØ±í´ïÒ»ÏÂÄãµÄÒâ¼û£¬ÂÛÎÄ¿ÉÒÔÖØÐ½øÈëеÄÒ»ÂÖÉó¸å³ÌÐò¡£ÕâÖÖÇé¿öºÜÉÙ¼û¡£³É¹¦µÄ¿ÉÄÜÐԺܵ͡£ G/4~_\YMq  
£¨4£©Èç¹ûÎÄÕ±»¾ÜµÄÔ­ÒòÊÇÒòΪÊý¾Ý»ò·ÖÎöÓÐÑÏÖØÈ±ÏÝ£¬ÕâÖÖÎÄÕ²»·ÁÏÈ·ÅÒ»·Å£¬µÈÕÒµ½¸ü¹ã·ºµÄÖ¤¾ÝÖ§³Ö»òÓÐÁ˸üÃ÷ÎúµÄ½áÂÛºó£¬ÔÙ½«¾­¹ýÐ޸ĵġ°Ð¡±ÎÄÕ¼ĸøÍ¬Ò»SCIÆÚ¿¯£¬±à¼­Í¨³£»á¿¼ÂÇÖØÐÂÊÜÀí¡£ KybrSa  
£¨5£©Èç¹û±»¾ÜÂÛÎIJ»ÊÇÓÉÓÚÎĸåÖеĴíÎ󣬶øÊÇÖØÒªÐÔ»ò´´ÐÂÐÔ²»¹»£¬×÷Õß×Ðϸ¿¼ÂÇÉó¸åÈ˵ÄÒâ¼û²¢ÈÏÕæÐÞ¸ÄÎĸåºó£¬¿ÉÒԼĸøÓ°ÏìÒò×Ó½ÏµÍµÄÆäËûSCI¿¯Îï¡£ qW 2'?B3<  
4.ÈçºÎÐÞ»ØSCIÂÛÎÄ J u"K"  
¸å¼þÍËÐÞ£¨revised manuscript£©¡£¼¸ºõËùÓеľ­Éó²éѧÊõˮƽ´ïµ½³ö°æÒªÇóµÄSCIÂÛÎÄ£¬ÔÚ·¢±íǰ¶¼ÐèÒªÍ˸ø×÷ÕßÐÞ¸ÄÆä±í´ï·½Ê½¼°±à¼­¸ñʽ£¬ÈçѹËõÎÄÕÂÆª·ù¡¢ÖØÐÂÉè¼Æ±í¸ñ¡¢¸ÄÉÆ²åͼÖÊÁ¿¡¢ÏÞÖÆ²»¹æÔòËõд´ÊʹÓõȡ£È»¶øÍ˸ø×÷Õߵĸå¼þ²¢²»´ú±íÎÄÕÂÒѾ­±»½ÓÊÜ¡£Óеĸå¼þ¸Ä¶¯Ò»´Î¼´¿É±»¿¯Îï²ÉÄÉ£¬µ«Ò²ÓеÄÒª·´¸´Ð޸Ķà´Î²ÅÄܱ»Í¨¹ý¡£ÎÄÕÂ×îÖÕ½ÓÊÜÓë·ñÈ¡¾öÓë×÷Õß¶ÔÎÄÕ¹ؼüÐÔÖØÒªÄÚÈݺͱíÊö·½Ê½µÄÐÞ¸ÄÄÜ·ñ´ïµ½Éó¸åÈ˼°±à¼­µÄÒªÇó¡£È»ºóÓ¦¿¼ÂÇÄÜ·ñ»òÔ¸Òâ½ÓÊÜÉó¸åÈË»ò±à¼­µÄÒâ¼û¡£ Bv{DZ?{s  
´ÓÖ÷±à»ò±à¼­µÄ»ØÐźÍÉó¸åÈËÐÞ»áÒâ¼û¿É¿´³öÎÄÕ¼ÓõĿÉÄÜÐÔ¡£Ö÷±àµÄ»ØÐÅ»áÌØ±ðÌáµ½ÄãÎÄÕµĿÆÑ§´´ÐÂÐÔ£»Éó¸åÈ˶ÔÎÄÕÂ×ܵįÀ¼ÛÖлáÌáµ½¶ÔÎÄÕÂÊÇ·ñ¸ÐÐËȤµÈ£»Ðݻ᲻Ҫ²Ö´Ù£¬·´¸´ÔĶÁ¡¢Àí½âÉó¸åÈ˵ÄÎÊÌâ¡£ u#)ARCx,w  
Èç¹û×÷ÕßÔÚ½Óµ½Ö÷±à»ò±à¼­²¿×ªÀ´µÄÉó¸åÈËÒâ¼ûºó£¬¶ÔÆäÆÀ¼ÛÓкܴóÒìÒé»ò²»Ô¸Òâ¸Ä¶¯×Ô¼ºµÄÂÛÎÄ£¬±ã¿ÉÒÔÖ÷¶¯ÒªÇóÍ˸塣ÊÖÐøºÜ¼òµ¥£¬Ö»ÐèÒªÏò±à¼­²¿·¢¸öE-mail¼´¿É£¬»ò×Ô¼ºÉÏÍø³·¸å¡£Èç¹û×÷ÕßÔ­Òâ¸ù¾ÝÉó¸åÈ˵ÄÒâ¼û¸Ä¶¯ÂÛÎÄ£¬ÔòÐèÈ«Ãæ³¹µ×£¬²¢ÇÒ¶ÔÉó¸åÈËÌá³öµÄÒÉÎÊÒªÒ»Ò»×÷´ð¡£ E'+?7ZGWj  
5.¸å¼þÍËÐÞʱעÒâÊÂÏî 4zhg#  
£¨1£©¶ÔÉó¸åÒâ¼ûҪʮ·Ö×ðÖØ£¬¶ÔÓÚÿһÌõÅúÆÀºÍ½¨Ò飬¶¼ÒªÈÏÕæ·ÖÎö¡£ËùÓÐÎÊÌâ±ØÐëÖðÌõ»Ø´ð£¨Response to reviewer¡¯s comments1,2,3£©¡£ a?1Ml>R6P  
£¨2£©¶ÔÐ޻ظåÖÐÒÑÐ޸ĵĵط½Òª¾ßÌå±êÃ÷£¨pages, line£©¡£ m<I>NYfE  
£¨3£©¾¡Á¿Âú×ãÒâ¼ûÖÐÐèÒª²¹³äµÄʵÑé¡£ m5 l,Lxj  
£¨4£©Éó¸åÈËÓÉÓÚ֪ʶÏÞÖÆºÍijÖֳɼû£¬ÉõÖÁѧÊõ¹Ûµã²»Í¬£¬ÅжϴíÎó²¢½¨ÒéÍ˸峣·¢Éú¡£Òª¼«ÆäÉ÷ÖØºÍÈÏÕæµØ»Ø´ð£¬ÓÐÀíÓоݵØÓëÉó¸åÈË̽ÌÖ¡£µ«ÒªÎ¯ÍñµØÀñòµØ±í´ïÄãµÄ¹Ûµã¡£ w^E$R  
ÀýÈ磬 `G "&IQ8.  
[²»ÍƼö]¡°The reviewer¡¯s comments was wrong, ¡­¡± ;!pSYcT,  
[²»ÍƼö]¡°The referee¡¯s idea is bad, but mine is good.¡± R "qt}4m  
[ÍÆ¼ö]¡°The reviewer¡¯s comments is very interesting. However, we found that ¡­¡± |"aop|  
[ÍÆ¼ö]¡°It would be very interesting to see ¡­ .However, ¡­¡± Lq]t6o ]  
[ÍÆ¼ö]¡°The referee has an interesting notion, but the proposed idea is also good, particularly in light of this or that fact.¡± j]'ybpMT"  
£¨5£©²»ÄÜ×öµÄÒ²²»Òª»Ø±Ü£¬ËµÃ÷ºÏÀíÀíÓÉ¡£ sUz,F8G  
£¨6£©Éó¸åÈËÊÇÂÛÎĵĵÚÒ»¶ÁÕߣ¬Èç¹ûËû¶¼Ã»ÓжÁ¶®Äã˵µÄijһ·½Ã棬×÷ÕߵĿ¼ÂÇ×Ô¼ºµÄÎÄÕÂÓÐʲôÎÊÌâÈÃÈ˼Ҳ»¶®£¬·ñÔò·¢±íºóÈçºÎÃæ¶Ô¸ü¶àµÄ¶ÁÕߣ¿ÄãÐè¸ÄµÃ¸üÇå³þ¡£ cP^c}e*;NS  
£¨7£©Èç¹ûÄãµÄÂÛÎÄÓÖ±»¾Ü¾øÊÇÒòΪÓÐÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÓÐºÜºÃµÄÆÀ¼Û£¬µ«ÁíÍâÒ»¸öÉó¸åÈ˶ÔÄãµÄÂÛÎÄÆÀ¼ÛºÜ²î¡£´Ëʱ£¬Èç¹ûÓÐÀíÓÉÈÏΪÉó¸åÈ˲»ºÏÀí¶Ô´ýÄãµÄÂÛÎÄ£¬Äã¿ÉÒÔдПø±à¼­²¿ÒªÇó¸ü»»Éó¸åÈË¡£Èç¹ûÕâλÉó¸åÈËÒ²ÆÀ¼ÛºÜ²î£¬ÄÇô£¬Ó¦¸Ã²¹³äÐ޸ĺó¸ÄͶÆäËûSCIÆÚ¿¯¡£ :wY(</H  
£¨8£©¸ø±à¼­»ØÐÅ£¬¸Ðл¸øÂÛÎÄÌá³öµÄÐÞ¸ÄÒâ¼û£¬²¢Ö¸³ö°´Ð޸Ľ¨ÒéÒÑ×öµÄÐ޸ģ¬Î´×÷Ð޸ĵĵط½ÒªËµÃ÷ÀíÓÉ¡£ |Ng}ZLBM  
6.³£¼ûÎÊÌâ CZDWEM}   
¨SǧÍò²»ÒªÒ»¸å¶àͶ¡£Ò²²»Òª°ÑÒѾ­·¢±íµÄÖÐÎİæµÄÂÛÎĸijÉΪӢÎÄÔÙͶSCIÆÚ¿¯¡£·´Ö®£¬Ò²²»ÐС£µ«ÊÇһƪ»áÒéÂÛÎľ­¹ýÐ޸ĺó¿ÉÒÔÔÚͶSCIÆÚ¿¯¡£ Dio)orc  
¨SÂÛÎı»Ò»¼ÒSCIÆÚ¿¯¾Ü¾øºó²»¾­Ð޸ģ¬ÓּĸøÁíÒ»¼ÒSCIÆÚ¿¯¡£ s(pNg?R  
7.ÂÛÎı»½ÓÊÜ @n^2UJ  
ÐÞ»ØÂÛÎĸåºó£¨´óÔ¼1¸öÔº󣩣¬×÷Õß»áÊÕµ½±à¼­²¿µÄÐÅ£¬Ò»°ãΪ½ÓÊÜͬÒâ·¢±í¡£ #b>D^=NV>)  
SCIÂÛÎı»½ÓÊÜÑù¸åÐÅʾÀý "R^0e Nv$  
Dear Dr. XXX !SdP<{[  
We are pleased to inform you that the PNAS Editorial Board has given final approval of your article for publication. The Editor who conducted the initial review of your manuscript [MS#2007-XXX],will also bo informed of the decision. #k|f%!-Vo  
If you have not done so already, please complete and sign the Copyright Assignment from <http: //www.pnas.org/ misc/ copyright. pdf>. If practical, all authors are not available, the corresponding author may sign on their behalf. The form should be faxed to the PNAS office(202-555555).Proofs for your article will not be sent to you until the copyright form is received in our office. JYrOE "!h  
You will receive reprint order details and an invoice for publication fees with your proofs. Payment of the page charge of $70 per printed page will be assessed from all authors who have funds available for that purpose. Payment by authors of the following additional costs is expected: $325 for each color figure or table and $150 for each replacement or deletion of a color figure or table. Proofs should be returned within 48 hours. JQDS3v=1$  
Sincerely yours, }ws(:I^  
Editor-in-Chief NX8. \Pf#  
ͬʱ£¬×÷ÕßÒ²»áÊܵ½°æÈ¨Ç©×Ö±í¸ñ£¨copyright assignment form£©¡£×÷ÕßÐèÒªÔÚ°æÈ¨Ç©×Ö±í¸ñÉÏÇ©×Öºó£¬ÂÛÎIJÅÄÜ·¢±í¡£Ò»°ãÇé¿öÏ£¬Öйú×÷ÕßÐèÒªÔÚÀ¸Ä¿ºÍµ×²¿Ç©×Ö¾ÍÐС£ md;jj^8zj  

kaobook 2011-08-17 22:44
µÚ22Õ ÈçºÎÐÞ¸ÄSCIÂÛÎĵÄÑù¸å Q|7;Zsd:  
SCIÂÛÎı»½ÓÊܺó£¬×÷Õß²»¾Ã»áÊܵ½ÂÛÎÄÑù¸å£¨proof£©¡£Ò»°ãÅŰæÎªPDFÎĵµ£¬»¹ÓÐTIFFÎĵµ¡£ +\RviF[+  
1.ÂÛÎĵÄÑù¸å <x1,4a~  
ÂÛÎĵÄÑù¸åÐÅʾÀý QeQxz1  
Dear Author Q& vU|y  
We are pleased to inform you that your paper is nearing publication. The page proofs are available at : http://www.spsspitech.com/springer/XXX e#^ vA$d  
The proof shows the paper as it will appear later in print except that: WD|pG;Gq  
-The pages are not numbered but the lines are, to ease reference to any passage to be corrected. {cmV{ 4Yx  
-This proof has been optimized for online presentation. Please note that color figures will appear in color in the online version, but not necessarily in the printed edition. See the comment on the proof as to whether they will be printed in black and white. __i))2  
You can help us facilitate rapid publication by returning the corrected proof of this paper within 2 working days. Please first read about the proof produre to learn how to proceed and also to obtain information about online publication. ZmS ]4WM<  
Thank you very much. We hope you are pleased with the publication. 9^@#Ua  
Sincerely, S+u@ Q}  
Springer 8r.3t\o)X  
2.ÓÃproof correction marks½øÐÐÑù¸åÐÞ¸Ä E+P-)bRa  
Ñù¸å»á¾­³£·¢ÏÖÓм¸´¦´íÎó£¬ÐèÒªÐ޸ġ£Äã¿ÉÒÔÁгöÑù¸åÖÐÒªÐ޸ĵĵط½£¬Ö±½ÓE-mail¸ø±à¼­²¿£¬ËûÃÇ»á°ïÄãÐ޸ĵġ£µ«Ðí¶àÔÓÖ¾ÒªÇó½«ÕýÈ·µÄÎÄ×Ö±êÔÚÑù¸åµÄÁ½±ß£¬¼´Ö±½Ó±ê×¢ÔÚPDFÎļþÉÏ¡£ÕâÊÇÄãÒªÓùú¼ÊͨÓõġ°proof correction marks¡±½øÐбê×¢¡£Ð޸ĺóµÄÑù¸åÖ±½Ó´«Õæ»òÕ߼ĸø±à¼­²¿£¬Ò²¿ÉÒÔɨÃèºó£¬E-mail¸ø±à¼­²¿¡£Ò»°ãÇé¿öÏ£¬SCIÂÛÎĵÄÑù¸åÒªÇóÔÚ24¡ª72СʱÄڼĻء£ BP=<TRp .  
3.Ö±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸Ä h%]  D[g  
ÏÖÔÚÓÐЩSCIÆÚ¿¯ÒªÇóÖ±½ÓÓÃAdobe ReaderÈí¼þÔÚPDFÎļþ½øÐÐÐÞ¸ÄPDFÎļþÊǶÀÁ¢ÐÔµÄÎļþ¡£°üº¬ËùÓÐÊʵ±µÄ¸ñʽ»¯ºÍËùÓÐ×ÖÌ壬¿ÉÒÔÏÔʾÔÚ¼ÆËã»úÆÁÄ»ºÍ´òÓ¡Ö½ÉÏ¡£Òª²é¿´ºÍÐÞ¸ÄÄãµÄÑù¸å£¬ÐèÒªAdobe Reader°æ±¾7£¨»ò¸ü¸ß£©¡£¸ÃÈí¼þ¿ÉÓÃÓÚPC¡¢MacºÍUNIX¼°Æä£¬ÊÇÈ«ÃæÃâ·ÑµÄ£¬²¢¿ÉÒÔ´Óhttp://www.adobe.com/products/acrobat/readstep2.htm ÏÂÔØ¡£ ?zK\!r{  
4.ÈçºÎÓÃAdobe ReaderÈí¼þ½øÐÐÐÞ¸Ä qjH/E6GGg  
£¨1£©´ò¿ªPDFÎļþ£¨open the PDF file£©¡£Òª°ÑPDFÎļþµÄÑù¸å×÷×¢ÊÍ»òÕßÐ޸ģ¬ÏÈ´ò¿ªAdobeÖ÷Òª¹¤¾ßÀ¸¡¾Toolbar¡¿¡£Ò»°ãÀ´Ëµ£¬µ±ÓÃAdobe Reader´ò¿ªPDFÎļþ£¬Ó¦¸Ã×Ô¶¯µØÏÔʾ¡¾Commenting toolbar¡¿¡£Èç¹ûûÓУ¬µã»÷¡¾Tool¡¿£¬Ñ¡¡¾Commenting¡¿£¬È»ºóµã»÷¡¾Commenting toolbar¡¿¡£Èç¹ûÕâЩѡÔñ¶¼²»ÐУ¬ÄÇôÄãµÄAdobe°æ±¾±È°æ±¾7µÍ¡£È»ºó´ò¿ªÄãÒªÐ޸ĵÄPDFÎļþ¡£ !wIrI/P7#  
£¨2£©²åÈëÎÄ×Ö£¨insert text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£½«Êó±êλÖÃÒÆµ½ÐèÒªÐ޸ĵĵط½£¬È»ºó¿ªÊ¼¼üÈëÒªÐ޸ĵÄÎÄ×Ö¡£Í¨¹ýµã»÷ÓÒÉϽǡ¾X¡¿¹Ø±Õ¡¾box¡¿¡£Ò²¿ÉÒÔͨ¹ýµã»÷Êó±êÓÒ¼üÑ¡Ôñ¡¾Delete¡¿À´É¾È¥ÊäÈëµÄÎÄ×Ö¡£ 8[x{]l[  
£¨3£©Ìæ»»ÎÄ×Ö£¨replace text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£È»ºóhighlightÒªÌæ»»µÄÎÄ×Ö£¬½«Êó±êÒÆµ½ÒªÌæ»»µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºóÊäÈëÌæ»»ÎÄ×Ö¡£Èç¹ûÒªÌæ»»Ä³Ð©¸ñʽ»¯µÄÎÄ×Ö£¨ÈçµÈʽ£©£¬Ç븽Îļþ¡£ -NUA  
£¨4£©Ïû³ýÎÄ×Ö£¨remove text£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Text Edits¡¿°´Å¥¡£³¶×§£¨drag over£©Òª±»É¾³ýµÄÎÄ×Ö²¢µã»÷¡£È»ºó°´É¾³ý¼ü¡£ vgN%vw pL  
£¨5£©HighlightÎÄ×Ö/ÆÀ¼Û£¨highlight text/make a comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Highlight¡¿¼ü¡£È»ºóHighlightÏàÓ¦µÄÎÄ×Ö¡£Òª×öÆÀÂÛ£¬Ë«»÷¡¾Highlight¡¿µÄÎÄ×Ö£¬È»ºó¼üÈëÄãµÄcomments¡£ gt!t Du  
£¨6£©¸½¼þ£¨attach a file£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Attach a File¡¿¼ü¡£µã»÷Òª±»Ì滻ͼ£¬ÖƱí»òÕßÎÄ×Ö¡£´°¿Ú½«×Ô¶¯µØ´ò¿ª£¬ÔÊÐí¸½ÓÐÎļþ¡£ V BjA$.  
£¨7£©ÆÀÂÛ£¨leave a note /comment£©¡£µã»÷¡¾Commenting toolbar¡¿Öеġ¾Note Tool¡¿¼ü¡£½«Êó±êÒÆµ½ÏàÓ¦µÄÎÄ×ÖÉϲ¢µã»÷£¬È»ºó¿ªÊ¼¼üÈëÎÄ×Ö¡£µ«²»ÒªÊ¹ÓÃÕâ¸öÌØµã×öÔ­Îı༭¡£ !DXK\,;>  
£¨8£©¸´ÔÄ£¨review£©¡£Òª¸´ÔÄÒÑÓеı䶯£¬µã»÷¡¾Commenting toolbar¡¿Öеġ¾Show¡¿¼ü¡£Ñ¡Ôñ¡¾Show Comments List¡¿¡£ FLQ>,=O  
5.ʵÀý·ÖÎö Ki\J)l  
¹ú¼ÊÉϳ£ÓõÄproof correction mark tw&biLM5T  
Ö÷Òª°üÀ¨Instruction£¬Textual markºÍMargin markÈý²¿·Ö¡£ lGX8kAv?  
Ïà¹ØÍ¼ÎÄ·ûºÅÂÔÈ¥¡£¿ÉÒԲο¼ÍøÖ·Á´½Ó£º http://www.jaggercreative.co.uk/proofingmarks.pdf

kaobook 2011-08-17 22:46
µÚ23Õ SCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ Q6d>tqWhq  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËÆµÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£ v8\pOI}c  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ b\C1qM4  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº URMxCL^"  
¡òººÓïÓ²Òë ]?s^{  
ʾÀýÈçÏ£º z*`nfTw l  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) D3x W?$Z  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿) 0f"la=6  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) qwYq9A$+  
¨SWatch sister(±í½ã) ._(5; PB"  
¡ò ººÓïÖ±Òë m>+ e;5  
ʾÀýÒ» DhT8Kh{  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ '|nAGkA  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ 1_z~<d @?;  
·ÇÓ¢Óïϰ¹ßÐÔ±í´ïʾÀý :YNXS;>)!  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º #w;%{C[D  
°´×ÊÅű² to assign priority according to seniority D>K=D"  
°ÚÍÑÆ¶À§ shake off poverty; lift oneself from poverty /y- 8dgv0a  
°ëÀ­×Ó¹¤³Ì uncompleted project 7?2<W-n  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs !Z%pdqo`.  
±ÆÉÏÁºÉ½ be driven to drastic alternatives XvkFP'%i/  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas pGsu#`t  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency 94L>%{59  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul h F *c  
¶ÀÉú×ÓÅ® the only child in one¡¯s family R9InUX"k  
·´¸¯³«Á® combat corruption and build a clean government E~ 1"Nh  
»§¿Ú²¾ residence booklet %Sw hNn  
=B"^#n ;  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£ 9/6=[)  
1.SCIÂÛÎÄд×÷ʱ̬ nH|7XY9"  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê }RZN3U=  
3.Ó¢Îıêµã·ûºÅ  Kl w9  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ ^(1S`z$  
n<Z1i)  

kaobook 2011-08-17 22:48
µÚ23ÕÂSCIÂÛÎÄÖÐÓ¢Óïд×÷µÄÓïÑÔ¼¼ÇÉ > ubq{'  
ÖÐÎ÷·½ÎÄ»¯µÄ²îÒìµ¼ÖÂÁËÓïÑÔÈÏʶÉϵIJ»Ò»Ö¡£ÖйúѧÕßÔÚSCIÆÚ¿¯ÂÛÎıêÌâÖо­³£»áÓõ½¡°Elementary introduction of ¡­¡±£¨Ç³Ì¸£©¡¢¡°Primary study of ¡­¡±£¨³õ̽£©µÈ×ÔÇ«´Ê£¬¸øÈËÔì³ÉÒ»ÖÖÑо¿²»ÉîµÄ´í¾õ¡£ÕâÖÖÖÐÎ÷ÎÄ»¯²îÒ컹µ¼ÖÂÁËÐí¶àÈËÓÃÓ¢Óïд×÷ʱ£¬Ò²»áÊܵ½ººÓï±í´ïʽµÄÓ°Ï죻¾­³£²ÉÓÃÓ뺺Óï±í´ï·½Ê½ÀàËÆµÄÓ¢Óï¾äÐÍ£¬¶ø²»ÉÆÓÚʹÓõصÀµÄÓ¢Óï¾äÐÍ¡£ "b hK %N;  
ÖµµÃÌá³öµÄÊǺܶàÖйúÇàÄê¿ÆÑÐÈËÔ±ºÍÑо¿ÉúÏÈд³öÂÛÎĵÄÖÐÎĸ壬ÔÙÒë³ÉÓ¢Óï¡£µ«ÊǽðÀ¤ÁÖ½ÌÊÚÈÏΪÂÛÎÄÔÚ׫дʱҪ×ÔʼÖÁÖÕ¶¼ÓÃÓ¢Óïд£¬£¬²»ÒªÏÈдÖÐÎÄÔÚÒë³ÉÓ¢ÎÄ¡£Òª²»È»Ð´³öÀ´µÄÎÄÕ¿ÉÄܾÍÊÇÖйúʽӢÓChinglish£©¡£ a yoC]rE  
½ð½ÌÊÚÈÏΪÖйúʽӢÓïÓ¦·ÖΪÁ½ÖÖÀ´¿´´ý¡£Ò»ÖÖÊÇChineseEnglish£¬Ò»ÖÖÊÇChinaEnglish¡£ÆäÖÐChineseEnglish¾ÍÊÇChinglish£¬ÊÇÓÃÖÐʽµÄÓï·¨ºÍӢʽµÄ´Ê»ã×éºÏ³ÉµÄ£¬ÊôÓÚÓïÑԵIJ»¹æ·¶Ê¹Óᣳ£¼ûChinglishÀàÐÍÓУº 0/)2RmF  
¡òººÓïÓ²Òë {nKw<F2  
ʾÀýÈçÏ£º GI]\  
¨SGood good study, day day up.£¨ºÃºÃѧϰ£¬ÌìÌìÏòÉÏ¡£) 0 %~~IT}U  
¨SWho two who and who?(ÔÛÁ©Ë­¸úË­£¿) T>B'T3or  
¨SGive you some color see see.(¸øÄãµãÑÕÉ«¿´¿´¡£) '.bf88D  
¨SWatch sister(±í½ã) qk<jvha  
`7=$I~`  
ººÓïÖ±Òë 7%  D4  
ʾÀýÒ» ?9\D(V  
¨S¡°¶«Ê©Ð§ò­¡±°´ÕÕ×ÖÃæÒâ˼ֱÒë¹ýÀ´¾Í³ÉΪDongshi imitates Xishi.µ«ÊÇÍâ¹úÈ˾ÍÃ÷°×ÊÇÔõô»ØÊÂÁË¡£ÒªÈÃÍâ¹úÈËÃ÷°×±ØÐë·­Òë³É¡°The ugly imitates the beautiful in such a distorted way that the ugliness of the ugly becomes worse¡±¸üÇ¡µ±¡£ >Q/;0>V  
¨S¡°ÇéÈËÑÛÀï³öÎ÷Ê©¡±²»ÊÇ¡°Xishi is in the eye of the beholder¡±,¶øÊÇ¡°Beauty is in the eye the beholder¡±¡£ \78E>(`'  
·ÇÓ¢Óïϰ¹ßÐÔ±í´ïʾÀý SI!A?34  
ChinaEnglishÖ¸µÄÔòÊÇÓÉÖйúÌØÓеĶ«Î÷£¬ÊÇÔÊÐí´æÔڵġ£ÀýÈ磬20ÊÀ¼Í30Äê´úÖð×Ö·­ÒëµÄ¡°Long time no see¡±£¨ºÜ¾Ã²»¼û£©ÒѾ­½øÈëÓ¢ÓïµÄ±ê×¼´Ê×é¡£ÔÚ±ä³ÉÓ¢ÓïдʵÄÖÐʽӢÓïÖкܶàÊÇÖйú¶ÀÓеĴʻã»ò¸ÅÄî¡£ÈçÈå¼Ò˼Ï루Confucianism£©¡¢ËÄÊ飨FourBooks£©¡¢Îå¾­£¨FiveClassics£©¡¢ÖªÊ¶¾­¼Ã£¨knowledgeeconomy£©¡¢ºÍƽáÈÆð£¨peacefulrising£©µÈ¡£ÒòΪº£Íâ¶ÔÖйú¹Ø×¢µÄ³ÖÐøÉýΣ¬ÕâЩ¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã²»¶Ï³öÏÖÔÚº£Íâ¸÷ÖÖýÌåÉÏ£¬³ÉΪ¹Ì¶¨±í´ï¡£ÆäËû¾ßÓÐÖйúÌØÉ«µÄ´Ê»ã¼ûÈçÏÂʾÀý£º E]mm^i`|  
°´×ÊÅű² to assign priority according to seniority I<#X#_YP  
°ÚÍÑÆ¶À§ shake off poverty; lift oneself from poverty h+W$\T)  
°ëÀ­×Ó¹¤³Ì uncompleted project ^bv^&V&IB  
°àÃÅŪ¸« teach one¡¯s grandma to suck eggs C+TB>~Gv`  
±ÆÉÏÁºÉ½ be driven to drastic alternatives E2dM0r<]  
±ßԶƶÀ§µØÇø outlying poverty-stricken areas vxmX5.  
²»ÕýÖ®·ç bad (harmful) practice; unhealthy tendency ^m#tWb)f  
²ð¶«Ç½²¹Î÷ǽ rob Peter to pay Paul F^.A~{&L  
¶ÀÉú×ÓÅ® the only child in one¡¯s family 6M >@DRZ'|  
·´¸¯³«Á® combat corruption and build a clean government 1Vu#:6%  
»§¿Ú²¾ residence booklet !i"zM}  
u#Ig!7iUu  
×ܶøÑÔÖ®£¬ÔÚSCIÂÛÎÄд×÷ʱ£¬Òª×¢ÒâÓ¢Óï±í´ïµÄÖÐÎ÷·½ÎÄ»¯²îÒì¡£´ËÍ⣬»¹Òª×¢ÒâÒÔϼ¸¸ö·½Ãæ¡£ ^)-[g  
1.SCIÂÛÎÄд×÷ʱ̬ y > =Y  
£¨1£©ÃèÊö×÷Õß×Ô¼ºµÄ¹¤×÷ͨ³£Ê¹Óùýȥʽ£¬ÈçÔÚ¡°Material and Methods¡±ºÍ¡°Results¡±²¿·Ö¡£µ«ÊÇÓÃÏÖÔÚʱ̬ÐðÊö×÷Õß½áÂÛ¡£ w^0hVrws=,  
£¨2£©ÃèÊöËûÈ˵Ť×÷ʱͨ³£Ê¹ÓÃÏÖÔÚʱ»òÏÖÔÚÍê³Éʱ£¬ÔÚ¡°Introduction¡±ÖеÄÎÄÏ׻ع˺͡°Discussion¡±ÖеĴ󲿷֣¨×¢£ºÔÚ¡°Discussion¡±ÖУ¬ÓùýȥʱÃèÊöËûÈ˵Ť×÷²»ÄÜËã´í£©¡£ inaO{ny y  
ÏÂÁÐÇéÀýÍ⣺  tKV,  
¨SÈç¹ûÄ㻳ÒÉËûÈ˵Ť×÷ÊÇ·ñÕýȷʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ TaRPMKk  
¨S×÷Õß×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹Óùýȥʱ¡£ n[Q(q[ULV  
ÀýÈçGreenberg showed that streptomycin inhibits S. nocolor. m#'eDO:  
¨S±í¸ñ»òͼ±í×÷ΪÖ÷Óïʱ£¬Í¨³£Ê¹ÓÃÏÖÔÚʱ¡£ \E?3nQM  
ÀýÈçTable 2 shows the percent of districts in Oklahoma that have individuals identified as filling particular primary positions. $9X +dvu*  
¨SÃèÊö¼ÆËã½á¹ûºÍͳ¼Æ½á¹ûʱʹÓÃÏÖÔÚʱ̬ÐðÊö¡£¼´Ê¹¸Ãʼþ·¢ÉúÔÚ¹ýÈ¥£¬Ò²Ó¦¸ÃʹÓÃÏÖÔÚʱ¡£ N-K/jY  
These values are significantly greater than those of those of the females of the same age, indicating that the males grew more rapidly. 5?^#v  
2.SCIÂÛÎÄÖÐ×îÈÝÒ׳öÏÖµÄÓÃ´Ê 0#WN2f, <:  
£¨1£©¶¯´Ê£¨verbs£©¡¢¶¯Ãû´Ê£*****erund£©ºÍÏÖÔÚ·Ö´Ê£¨present participle£©¡£ÏÖÔڷִʺͶ¯Ãû´ÊÒ»Ñù£¬¶¼ÊÇÔÚ¶¯´ÊβÉϼÓing¹¹³É£»¶ø¹ýÈ¥·Ö´Ê£¨past participle£©ÔòÊÇÔÚ¶¯´ÊβÉϼÓed¡¢en¡¢d¡¢tËù¹¹³É¡£ËäÈ»ÈÝÒ×Çø·Ö£¬µ«ÓÐʱºòÒ²¿ÉÄÜ»ìÏý¡£ c]{}|2 u  
Ò»°ãÀ´Ëµ£¬¿ÉÓö¯´ÊµÄÇé¿öÓ¦¾¡Á¿±ÜÃâʹÓö¯´ÊµÄÃû´ÊÐÎʽ£»ÄÜÓÃÃû´Ê×÷¶¨ÓïµÄ²»ÒªÓö¯Ãû´Ê×÷¶¨ÓÄÜÓÃÐÎÈÝ´Ê×÷¶¨Óï²»ÒªÓÃÃû´Ê×÷¶¨Óï¡£ NF&Sv  
ÓÐЩ¶¯Ãû¼È¿ÉÊǼ°Îﶯ´ÊÒ²¿ÉÒÔÊDz»¼°Îﶯ´Ê£¬Ó¦¸ÃÓÅÏÈʹÓò»¼°Îﶯ´ÊÔì¾ä£¬¶ø²»ÒªÓü°Îﶯ´ÊµÄ±»¶¯Óï̬³É¾ä¡£ [h'u@%N|/  
£¨2£©²»¶¨¹Ú´Ê£¨the indefinite article£©ºÍ¶¨¹Ú´Ê£¨the definite article£©¡£¹Ú´ÊÊÇÐé´Ê£¬±¾Éí²»Äܵ¥¶ÀʹÓã¬Ò²Ã»ÓдÊÒ壬ËüÓÃÔÚÃû´ÎµÄÇ°Ãæ£¬°ïÖúÖ¸Ã÷Ãû´ÊµÄº¬Òå¡£²»¶¨¹Ú´Êa(an)ÓëÊý´ÊoneͬԴ£¬ÊÇ¡°Ò»¸ö¡±µÄÒâ˼¡£aÓÃÓÚ¸¨ÒôÒôËØÇ°£¬¶øanÔòÓÃÓÚÔªÒôÒôËØÇ°¡£¶¨¹Ú´ÊtheÓëָʾ´ú´Êthis¡¢thatͬԴ£¬ÓС°Õ⣨ÄÇ£©¸ö¡±µÄÒâ˼£¬¿ÉÒÔºÍÒ»¸öÃû´ÊÁ¬Óã¬ÓÃÀ´±íʾij¸ö»òij¸öÌØ¶¨µÄÈË»ò¶«Î÷¡£Ó¢ÓïÖе͍¹Ú´ÊÓ÷¨¸´ÔÓ£¬´ÊÒåÖڶ࣬¶øÇÒººÓïÖÐûÓж¨¹Ú´ÊµÄ¸ÅÄÒò´ËÔÚʹÓÃÊÊӦעÒâ¶à·½ÃæÎÊÌâ¡£¶¨¹Ú´ÊÓ÷¨³£¼ûÓÚÏÂÁÐÇé¿ö£º -~]H5er`  
¨SÖ¸ÊÀÉ϶ÀÒ»ÎÞ¶þµÄÊÂÎï¡£ 1b3 a(^^E  
¨SÓÃÔÚµ¥ÊýÃû´ÊÇ°Ãæ£¬ÒÔ´ú±íͬÀàµÄÈË»òÎï¡£µ«µ±Éæ¼°manºÍwomanÕâÁ½¸öÃû´Êʱ£¬Ò»°ã²»±ØÓá°the¡±¡£ f]i"tqoI  
¨SÓÃÔÚÐòÊý´ÊºÍÐÎÈÝ´Ê×î¸ß¼¶¼°ÐÎÈÝ´Êonly¡¢very¡¢someµÈǰ¡£ _ dAyw  
¨SÓ븴ÊýÃû´ÊÁ¬Óã¬Ö¸Õû¸öȺÌå¡£ ],weqs  
¨S±íʾËùÓУ¬Ï൱ÓÚÎïÖ÷´ú´Ê£¬ÓÃÔÚ±íʾÉíÌ岿λµÄÃû´Êǰ¡£ cANt7  
¨SÓÃÔÚijЩÓÐÆÕ±éÃû´Ê¹¹³ÉµÄ¹ú¼ÒÃû³Æ¡¢»ú¹ØÍÅÌåµÈרÓÐÃû´Êǰ¡£ A^,E~Z!x  
¨SÓÃÔÚÊýÄ¿×Öǰ¡£ t) &U'^  
¨SÓÃÔÚÐÎʽµÄ¸´ÊýÃû´Ê֮ǰ£¬±íʾһ¼ÒÈË¡£ uP* kvi:e  
¨SÓÃÔÚ¹ßÓÃÓïÖС£ Odo)h  
ÓÐЩÇé¿öÊDZØÐëÊ¡ÂÔ¹Ú´Ê£º +E</A:|}S  
¨S±íʾ²»ÌØÖ¸µÄ¡¢½Ï³éÏóµÄ¸ÅÄîʱ¿É²»¼Ó¡£ jkL=JAcf~  
¨SĿ¼¡¢±êÌâÖÐͨ³£Ê¡ÂÔ¹Ú´Ê¡£ bh@CtnO  
¨Sͼ¡¢±íµÄÌâÄ¿ÖÐÓÐʱ¿ÉÊ¡ÂÔ¹Ú´Ê¡£ sbmtx/%U  
¨S»¯Ñ§Ò©Æ·¡¢»¯Ñ§ÎïÖÊǰͨ³£²»¼Ó¹Ú´Ê¡£ D U\ytD`u  
¨SͼÖеĺᡢ×Ý×ø±êµÄÃû´Êǰ²»¼Ó¹Ú´Ê¡£ _-C/s p^   
£¨3£©´ú´Ê£¨pronouns£©.´ú´ÊʱÓÃÀ´´úÌæÃû´ÊµÄ´Ê¡£ÔÚSCIÂÛÎÄÖУ¬×î³£ÓõĴú´ÊÊÇ¡°this¡±¡£Òª×¢Òâ´ú´Ê¡°this¡±µÄÓ÷¨¡£Ò»°ãÀ´Ëµ£¬ÌᳫÔÚ¡°this¡±ºóÃæ±ØÐëÁ¬½ÓÃû´Ê£¬ÕâÑù¡°this¡±ËùÖ¸µÄ¶ÔÏó¾Í»á¸ü¼ÓÇå³þ¡£ÀýÈ磺This problem was resolved in update 887742 for Windows XP.  oE+P=  
£¨4£©¸±´Ê£¨adverbs£©¡£Ò»°ãÀ´Ëµ£¬Ðí¶à¸±´ÊÓ¦¸ÃÔÚ¶¯´ÊС×éÖ®ÄÚ¶ø²»ÊÇÔÚ×î³õ»ò×îºóµÄλÖá£ÔÚ·ÇÕýʽӢÓ¸±´Ê³£Î»ÓÚ¾ä×Ó¿ªÊ¼»ò½áβµÄ¾ä×Ó¡£ qob!AU|  
ÀýÈ磺[·ÇÕýʽ]Then the solution was replaced¡£ C7dq=(p&  
[Õýʽ]The solution was then replaced¡£ \1Y|$:T/  
£¨5£©½é´Ê£¨preposition£©¡£½é´ÊÊÇÓÃÀ´±íʾһ¸öÊÂÎïÓëÁíÒ»¸öÊÂÎïÖ®¼ä¹ØÏµµÄÐé´Ê£¬Ëü²»µ¥¶ÀʹÓ㬶ø³£ºÍºóÃæµÄÃû´Ê»ò´ú´Ê¹¹³É½é´Ê¶ÌÓï¡£½é´ÊÌáʾµØ·½£¨where£©£¬Ê±¼ä£¨since, when£©ºÍÈË£¨who, whose£©Ê±Ó¦×¼È·Ê¹Óá£ÀýÈ磺 D>y5&`  
[²»ÍƼö]Since all tumours are visible at bronchoscopy, this is the investigation of choice. bN/8 ~!  
[ÍÆ¼ö]As all tumours are visible at bronchoscopy, this is the investigation of choice. )8C` EPe  
£¨6£©Ãû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ơ£Òª×¢ÒâÃû´ÊµÄµ¥¡¢¸´ÊýºÍÖ÷¡¢Î½ÓïµÄÈ˳ÆÅäºÏ¡£ÀýÈ磺 n$C- ^3 c  
[Îó]The new group of drugs were associated with many adverse reactions. :k_&Zd j,B  
[Õý]The new group of drugs was associated with many adverse reactions. Hl}lxK,]  
£¨7£©Ãû´ÊÐÞÊΣ¨modifiers of noun£©¡£±ÜÃâʹÓó¤ÏµÁÐÐÎÈÝ´Ê»òÃû´ÊÀ´ÐÞÊÎÃû´Ê¡£ \(pwHNSafk  
[ÍÆ¼ö]a modified test of cognitive function K@7%i|H  
[²»ÍƼö] a modified cognitive-function test pL,XHR@Iv  
£¨8£©ÙµÓ¿ÚÓïºÍÍâÀ´Óï¡£²»Ê¹ÓÃÙµÓ¿ÚÓïºÍÍâÀ´Óï×÷ΪÕýʽ±í´ï¡£ÀýÈ磺 1Of(O!  
[·ÇÕýʽ]Retirement is something most of us must face sooner or later. le \f:  
[Õýʽ] Retirement is inevitable. f!kZyD7  
£¨9£©ÂÛÎÄÖеÄÓôÊÓ¦¸Ã±È½ÏÕýʽ¡£²»ÒªÊ¹ÓôʵļòÂÔÐÎʽ£¬Èç¡°don¡¯t¡±£¬¡°can¡¯t¡±ºÍ¡°won¡¯t¡±¡£Ó¦¸Ãдȫ³Æ¡°do not¡±£»¡°can not ¡±ºÍ¡°will not¡±¡£¾ä×ÓÒ²Òª±ÜÃâʹÓá°and so forth¡±¡¢¡°and so on¡±µÈ¡£ Sesdhuy.@  
£¨10£©Êý×Ö¡£Èç¹ûÊý×ÖλÓÚ¾äÊ×£¬Ó¦¸ÃÓÃÓ¢ÎĵÄÍêÕû±í´ï£¬²»Óð¢À­²®Êý×Ö¡£ÀýÈ磺 Z 01A~_  
[²»ÍƼö]¡°30 patients were performed operation.¡± {`D]%eRO  
[ÍÆ¼ö]¡°Thirty patients were performed operation.¡± 9HJYrzf{%  
£¨11£©Ó¢ÓïÓôÊÔ­Ôò£º N~ flao^  
¨SÓÃÊìϤµÄÎÄ×ÖÓÅÓÚǣǿµÄÎÄ×Ö¡£ &j:e<{@  
¨SÓþßÌåÎÄ×ÖÒªÓÅÓÚ³éÏóµÄÎÄ×Ö¡£ -u@ ^P7  
¨SÓõ¥Ò»µÄÎÄ×ÖÓÅÓÚ¶Ý´ÊÎÄ×Ö¡£  j;.P  
¨SÓö̵ÄÎÄ×ÖÒªÓÅÓÚ³¤µÄÎÄ×Ö¡£ }@HgFM"  
¨SÓô¿ÆÓÎÞ»ªµÄÎÄ×ÖÓÅÓÚ¶à×˶à²ÊµÄÎÄѧÐÔÃèÊöÎÄ×Ö¡£ 1|{s8[;8  
3.Ó¢Îıêµã·ûºÅ >s5}pkAv|e  
¡òÖÐÎÄÌØÓеıêµã·ûºÅ !M8_PC*a  
¨S¶ÙºÅ£¨¡¢£©£º¶ÙºÅÔÚººÓïÖÐÆð·Ö¸î¾ä×ÓÖеIJ¢ÁгɷÖ×÷Óã»Ó¢ÓïÖÐûÓжٺţ¬·Ö¸î¾ä×ÓÖеIJ¢ÁгɷֶàÓöººÅ¡£ $\ZWQct  
¨SÊéÃûºÅ£¨¡¶¡·£©£ºÓ¢ÓïûÓÐÊéÃûºÅ£¬ÊéÃû¡¢ÆÚ¿¯ÃûÓÃбÌå»òÏ»®Ïߵȱíʾ¡£ ~T;:Tg*  
¨S¼ä¸ôºÅ£¨.£©£ºººÓïÓмä¸ôºÅ£¬µ«ÊÇÓ¢ÓïÖÐûÓмä¸ôºÅ£¬ÐèÒª¼ä¸ôʱ¶àÓöººÅ¡£ ; +\h$  
¨S×ÅÖØºÅ£ºÓÐʱººÓïÓÃÔÚÎÄ×ÖϵãʵÐÄÔ²±íʾÐèҪǿµ÷µÄ´ÊÓÕâЩʵÐĵã¾ÍÊÇ×ÅÖØºÅ¡£¶øÓ¢ÓïÖÐûÓÐÕâÒ»·ûºÅ£¬ÐèҪǿµ÷ijЩ³É·Öʱ¿É½èÖúÎÄ×ÖбÌå¡¢ºÚÌå×ÖºÍÏ»®ÏߵȶàÖÖ·½·¨¡£ KS8@A/f  
¡òÓ¢ÎÄÌØÓеıêµã·ûºÅ -ZE YzZqY  
¨SбÏߺšªforward slash(/):Ö÷Òª¹¦ÄÜÊÇ·Ö¸ô×÷Óᣠ~T H4='4W3  
¨SƲºÅ¡ªapostrophe£¨£¬£©:¹¹³ÉÃû´ÊËùÓиñ£»±íʾ´Ê¡¢×Öĸ¡¢ÊýÂëµÈµÄ¸´ÊýÐÎʽ£¬»¹±íʾһ¸ö»ò¼¸¸ö×ÖĸºÍÊý×ÖµÄÊ¡ÂÔ£¬È磺I¡¯ve got it¡£ P-B5-Nz  
¨SÁ¬×ֺšªhyphen£¨--£©£ºÖ÷ÒªÓÃÓÚijЩǰ׺£¨È磺self-¡¢ex-ºÍall-£©¹¹³É¸´ºÏ´Ê¡£ 6qDt 6uB  
¡òººÓ¢¹²Óе«ÐÎʽ²»Í¬µÄ±êµã·ûºÅ JE}VRMNr  
¨SÖÐÎĵľäºÅ£¨periods£©ÊÇ¡°Ô²È¦¡±£¨¡££©£¬¶øÓ¢ÎÄÖÐÊǸöʵµã£¨.£©¡£ /4(HVua  
¨SÓ¢Óï¾äÖеÄÊ¡ÂԺţ¨ellipsis£©ÊÇÈý¸öµã£¨¡­£©£¬Èç¹ûÊ¡ÂÔºÅÔÚ¾äÄ©¼ÓÉϾäºÅ¾ÍÊÇËĸöµã£¨ ¡­ .£©£¬Î»Öö¼ÔÚÐеף»ÖÐÎĵÄÊ¡ÂÔºÅΪÁù¸öµã£¨¡­¡­£©£¬¾ÓÓÚÐÐÖС£ 8a*&,W  
¨SÓ¢ÓïµÄÆÆÕۺţ¨dash£©ÊÇ£¨-£©£¬¶øÖÐÎÄÊÇ£¨¡ª¡ª£© )!0}<_2  
4.SCIÂÛÎÄÖоä×ӺͶÎÂäÉÏÏÂÁ¬¹áÓëÂß¼­ K W&muD  
£¨1£©SCIÂÛÎÄÖоä×ÓÁ¬¹áÓëÂß¼­£º´ÓÓïÑÔÄÚ²¿À´Ëµ£¬Óï¾ä»ò¶ÎÂä¶¼ÊÇһЩÒâÒåÏà¹ØµÄ¾ä×Óͨ¹ýÒ»¶¨µÄ³Ð½ÓÊֶκϺõÂß¼­µÄ×éÖ¯ÆðÀ´µÄÓïÒåÕûÌ塣ͨ¹ýÒ»×éÒâÒåÏà¹ØµÄ¾ä×Ó²»Í¨¹ýÒ»¶¨µÄתÕÛ´Ê»òÁ¬½Ó´ÊºÏºõÂß¼­µÄÁªÏµÆðÀ´£¬Õâ×é¾ä×Ó¾ÍÄÑÒÔ¹¹³ÉƪÕ¡£Á¬½Ó´ÊÊÇÖ¸ÔÚÂÛÎÄÖÐÓÃÀ´ËµÃ÷ÉÏϾä»òǰºó¾äÁ½¸öÒâ˼֮¼ä¹ØÏµµÄ´Ê»ò´Ê×é¡£Á¬½Ó´Êͨ³£ÓÃÓÚ¿ªÆª£¬Òý³öÀ©Õ¹¾ä£»Ò²¿ÉÓÃÓÚ¾äÖУ¬ÓÈÆäÊÇÓÃÓڽϳ¤µÄ¸´ÔÓ¾ä×ÓÖУ¬ÒÔ×÷ΪÉÏÏÂÎĵÄŦ´ø£»»¹¿ÉÓÃÓÚÎÄÄ©»ò¶ÎÄ©£¬ÓÃÓÚ×ܽáÉÏÎÄ»ò½áÊø±¾¶ÎÄÚÈÝ¡£ÓÐÁËÊʵ±µÄתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾äÓë¾äÖ®¼äÂöÂçÇåÎú¡¢ÌõÀí×ÔÈ»£¬°ïÖú¶ÁÕßÀí½âÂÛÎĵÄ˼·¡£³£¼ûµÄתÕ۴ʺÍÁ¬½Ó´Ê¿ÉÒÔÓÃÀ´±íʾ£º L|WrdT D;  
¨SƽÐлòµÝ½ø¹ØÏµ >bWpj8K v  
and; furthermore; s``a{ HZ  
also; in addition(to); HXT"&c|  
as well(as); likewise; HTQTDbhV^  
at the same time; moreover; G~y:ZEnN[  
besides; similarly; .+S%hT,v6i  
both ¡­ and ¡­ ; still; q`mxN!1[  
¨SתÕÛ¹ØÏµ Vj4 h#NN$  
although; otherwise; IT:WiMDQ}  
but; to the opposite; - c>Vw&1  
however; while; gpyio1V>  
nevertheless; yet; } O+xs3Uv  
on the contrary H0&wn#);6R  
¨SÄ¿µÄ»òÒò¹û¹ØÏµ (b~l.@xh  
as; since; ASov/<D_q  
as a result; so; {HY3E}YJL  
because(of); so¡­that ¡­; KWDH 35  
consequently; such¡­that¡­; ?,7!kTRH  
due to; therefore; ? ch?q~e)  
for; thus; syLdm3d|  
now that; P9m  
¨S¾ÙÀý¹ØÏµ !X: TieyVu  
For example; for another; kjPf%*3  
For instance; such as; rb@[ Edj  
For one thing; z59;Qk  
¨S²ã´Î¡¢Ë³Ðò¹ØÏµ v/xlb&Xx  
first, second, third, last O)V;na  
firstly, secondly, thirdly, finally(²»ÍƼö) 0kCo0{+n  
the first, the second, the third, the last kF'9@*?J  
in the first place , in the second place , in the third place ,lastly _)<5c!  
to begin with , then , furthermore, finally SVwxK/Fci  
to start with, next, in addition, finally +}at#%1@  
first and foremost, besides, last but not least Ga9iPv  
most important of all, moreover , finally >QJDO ]~V  
on the one hand, on the other hand(ÊÊÓÃÓÚÁ½µãµÄÇé¿ö) o=9 4H7@  
¨S½âÊÍ˵Ã÷¹ØÏµ£º CLZ j=J2  
in other words 03)irq%l;  
that is Zs}h>$E5_B  
¨S¹éÄÉ¡¢×ܽ᣺ !XjZt  
as a result; on the whole; "LDNkw'  
briefly; to sum up; a!6r&<s=E  
in a word ; in summary; h&i(K fv*  
in brief; collectively; %!-t7K^mFq  
in short; taken together  * ;Q#UH  
ÕýÈ·´îÅäתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­ÐÔÇ¿¡£ q("l?'  
£¨2£©SCIÂÛÎÄÖжÎÂä²¼¾ÖµÄÕûÌåÂß¼­£º¾­³£ÎÒÃÇÒªÐðÊöÒ»¸öÎÊÌâµÄ¼¸¸ö·½Ãæ¡£ÕâÖÖÇé¿öÏ£¬Ò»¶¨Òª×¢Òâ¶ÎÂäÖ®¼äµÄÂß¼­½á¹¹¡£°ÑÄãµÄÏë·¨°´ÕÕÂß¼­Ë³Ðò×éÖ¯£¬»òÕßÖÁÉÙÓ¦°´ÖÈÐòÅÅÁУ¬Ê¹¸÷¶ÎÂäÓлúµØÁ¬½ÓÔÚÒ»Æð¡£ C$q -WoTM(  
³ý´ËÖ®Í⣬»¹Òª×¢Òâ¾ä×ÓÖ®¼äÁ¬¹áÓëÂß¼­¡£×ܶøÑÔÖ®£¬ÓúÃתÕ۴ʺÍÁ¬½Ó´ÊÄÜʹ¾ä×ÓÁ¬¹áÓëÂß¼­¡¢ÎÄÕ²ã´ÎÇå³þ¡¢Òâ˼Ã÷È·¡£ c)Ef]E\  

kaobook 2011-08-17 22:49
µÚ24ÕÂSCIÂÛÎĵÄд×÷Ô­Ôò GCQOjqiR  
1.SCIÂÛÎĵÄд×÷ÓïÑÔ±í´ï×ÜÌåÔ­Ôò S.iUi S"  
£¨1£©ÕýÈ·£¨correctness£©£ºÑ¡ÔñÕýÈ·´Ê»ò´Ê×é¡£ c|m?f  
£¨2£©Çå³þ£¨clarity£©£º¿ÆÑ§ÂÛÎĵÄд×÷ÍêÈ«²»Í¬ÓÚÎÄÒÕ×÷Æ·£¬ÒªÇó¾«È·¡¢Çå³þºÍºÁ²»º¬ºý¡£ 0Z((cI\J  
±ÜÃâË×ÓïºÍÄѶ®µÄ»°Ê¾Àý d72( g$F  
¨SAs already state |@b|Q,  
¨SIt has been found that z,C>Rh9Id  
¨SIt has long been known that Yx. t+a-  
¨SIt is interesting to note that b!SIs*  
¨SIt is worth mentioning at this point 26_PFHQu4  
¨SIt may be said that |%X_<Cpk  
¨SIt was demonstrated that )('{q}JxV  
£¨3£©¼ò½à£¨concision£©£ºÎÄ×ÖÒª¼ò½à£¬É¾·±´Ó¼ò¡£ @$QtY(a  
ʾÀý },5LrX`L  
¡°There is ample evidence indicating that smoking is a risk factor for cancer¡±Ó¦¸Ã¼ò»¯Îª¡°Smoking is a risk factor for cancer¡±¡£ >i1wB!gc8  
Óüò½à´Ê¡¢¶Ì¾ä×ÓÀ´±í´ïʾÀý y fS  
¨Sa majority of = most r 3T#Nv  
¨Sat the present time = now }LIf]Y K  
¨Sgive rise to = cause }?GeU Xhy  
¨Sin some cease = sometimes /xA`VyHO  
¨Sis defined as = is 2I4G=jM[  
¨Sit is believed that = I think k8.,id  
¨Son the basis of = by <C*%N;F5R  
¨Spooled together = pooled 6l>016 x  
¨Ssubsequent to = after 5FNf)F   
¨Swith the result that = so that cz>`$Zz  
È¥µô¶àÓàµÄ´Ê£¬ÀýÈç {\!@ k\__  
[δÐÞ¸Ä]We plan additional studies in the future in order to confirm previous experiments where replicate determinations consistently showed the pool sizes to essentially increase. 'aZAWY d  
[Ð޸ĺó]We plan studies to confirm experiments where replicate determinations showed an increase in pool size. !.{{QwZ  
[ÔÙÐÞ¸Ä] We plan to confirm the experiments showing an increase in pool size. FRE${~Xd  
£¨4£©ÍêÕûÐÔºÍÂß¼­ÐÔ£¨completion and logic£©¡£Ð´ÂÛÎľÍÏñ½²¹ÊÊ£¬²»½öҪעÒâ¾ä×ÓÍêÕû£¬ÂÛÊö¡°¹ÊÊ¡±Ò²ÒªÍêÕû¡£ÌرðҪעÒâÂß¼­ÐÔ±í´ï¡°¹ÊÊ¡±¡£ q*>|EJR^Rw  
(5)Ò»ÖÂÐÔ£¨consistency£©¡£ f7]C1!]  
2.Ìá¸ßÂÛÎÄд×÷ÄÜÁ¦µÄ;¾¶ v[ y|E;B  
£¨1£©¶à¶Á¡£Ñ§Ï°ÈκÎÓïÑÔ¶¼ÐèÒª´óÁ¿ÔĶÁ¡£Ñ§Ï°Ó¢ÓïÒ²ÐèÒª´óÁ¿ÔĶÁ¡£Èç¹ûҪ׫д¸ßˮƽÂÛÎÄ£¬Æä¹Ø¼üµÄÊǶÁºÜ¶àÎÄÏס£Õâ¸öµÀÀíºÜ¼òµ¥£¬µ«²»ÉÙѧÕßȴδ±ØÍêÈ«Ã÷°×¡£Ê±Ï£¬ºÜ¶àÈ˶¼ÈÈÖÔÓÚ×öÌâÄ¿£¬ÒÔΪÕâÊÇѧϰӢÓïµÄÕýȷ;¾¶¡£½á¹û×öµÄÁ·Ï°²áÒ»±¾ÓÖÒ»±¾£¬ÊÔÌâ×öÁËÒ»Ì×ÓÖÒ»Ì×£¬×öµÃÍ·»èÑÛ»¨£¬ÐËȤȫÎÞ£¬Ó¢Óïˮƽȴ²¢Ã»ÓÐʵÖÊÐÔÌá¸ß¡£ÔÚÔĶÁʱ£¬ÒªÓÃÓ¢Óï˼¿¼£¬²»±Ø°ÑÓ¢ÎÄ·­Òë³ÉÖÐÎÄ£¬·ñÔò½«´ó´óµØ½µµÍÔĶÁËÙ¶È£¬´Ó¶øÓ°Ïì¶ÔÔĶÁ²ÄÁϵÄÈ«ÃæÀí½â¡£½¨ÒéÈÏÕæµØÑжÁÓ°ÏìÒò×ӸߵĹúÍâÎÄÏ×£¬×îºÃÓ°ÏìÒò×Ó´óÓÚ5ÒÔÉÏ¡£Ðí¶à¿Æ¼¼ÈËÔ±²»ÉÆÓÚ±í´ï×Ô¼ºµÄ¿ÆÑгɹû£¬Ö÷ÒªÊÇÕë¶Ô±¾ÁìÓòÖªÊ¶ÕÆÎյıȽÏÉÙ¡£ÒªÌرðÖØÊÓÂÛÎĵıí´ï£¬Ðû´«×Ô¼º£¨sell yourself£©¡£ÒªËµÃ÷ÂÛÎĵÄÖØÒªÐÔ£¬¾ÍÐèÒª¶à¶ÁÎÄÏס£ dI8y}EbE~  
£¨2£©¶àд¡£¾ÍÊÇÒª×Ô¼º¶¯ÊÖд×÷¡£ÓÉÓÚSCIÂÛÎĵÄд×÷ÎÊÌⲻͬÓÚÆäËüÎÄÕµÄд×÷£¬¸ü²»Í¬ÓÚÎÄÒÕд×÷£¬ËûÔÚд×÷¸ñʽ¡¢±í´ï·½Ê½ºÍÒªÇóÉ϶¼ÓÐ×Ô¼ºµÄÌØµã¡£ ~hA;ji|I  
£¨3£©¶à¸Ä¡£Îĸå³õ¸åÍê³ÉÖ®ºó£¬Òª°´ÕÕSCIÂÛÎĵÄд×÷ÒªÇó·´¸´Ð޸ġ£ W&k2z,|  
¨S¿ò¼Ü·½ÃæµÄ·´¸´Ð޸ġ£×öµ½¾«µñϸ×Á¡¢¾«²ÊºÏÀí¡£°üÀ¨£º I03 45Hc  
¡¤ÂÛÎÄÖ÷Ìâ¡¢Â۾ݺÍÂÛÖ¤·½·¨ÊÇ·ñ¿ÆÑ§£» G|]39/OO3{  
¡¤¶ÔÎÄÕµĽṹ¡¢ÓïÑÔÒª×ÐÏ¸ÍÆÇ㬶àÓàµÄÄÚÈݹû¶Ïɾ³ý¡£ w.0]>/C  
¨SÄÚÈÝ·½ÃæµÄÐÞ¸ÄÓëУºË y {1p #  
¡¤ÄÚÈݵÄÔö²¹¡¢É¾³ýºÍµ÷Õû¡£ Rh#TR"  
¡¤ÌáÁ¶¡£Ê¹ÎÄÕ´ﵽÎÄ×Ö¼òÁ·£¬ÓôÊ׼ȷ£¬ÄÚÈݾ«´â¡£ }NJ? .Y  
¡¤Ð£ºË¡£¶ÔԭʼÊý¾Ý£¬ÔËËã¹ý³ÌºÍ×îºó½á¹û£¬¶¼Òª½øÐÐÈÏÕæµÄУºË£¬ÓÈÆäÊǶÔÊýѧʽµÄÍÆµ¼ÒªÈÏÕæÉóºË£¬¿´ÆäÊÇ·ñ´æÔÚ´íÎó¡£ MU&P+Wr  
¨SÐÎʽ·½ÃæµÄÐ޸ģº ]+0I8eerd  
¡¤ÂÛÎĸñʽÊÇ·ñ·ûºÏSCIÆÚ¿¯¹æ¶¨µÄд×÷¸ñʽ¡£ uO`YA]  
¡¤ÓÃ×ÖÊÇ·ñÕýÈ·¡£ GwVSRI:[N  
¡¤¼ÆÁ¿µ¥Î»ÊÇ·ñ·ûºÏ·¨¶¨¼ÆÁ¿µ¥Î»¡£ V0WFh=CM@  
¡¤±êµã·ûºÅ¼°¸÷ÖÖÈ˹¤ÓïÑÔ·ûºÅµÄʹÓÃÓëÊéдÊÇ·ñÕýÈ·¡¢Çå³þ¡£ n\y%5J+  
3.дSCIÂÛÎÄ»¹Òª¿¼Âǵã u kKp,1xz  
£¨1£©ÔÙдSCIÂÛÎÄ֮ǰ£¬Ó¦¸Ã¼ì²éÊÇ·ñ±ðÈËÒѾ­Ð´ÁËÀàËÆµÄÎÄÕ¡£ r5?qz<WW~  
£¨2£©Ë¼Â·µÄ´´ÐÂÐÔ¡£ \TBY)_[ {  
£¨3£©ÂÛÎĵÄÄÚÈÝÒªÕæÊµ¡¢ÕýÈ·¡£ÕâÒ»µãÊǺÜÖØÒªµÄ£¬²»ÅªÐé×÷¼ÙÊÇÁ¼ºÃµÄ¿ÆÑ§µÀµÂ¡£ rj].bGQ,+  
£¨4£©ÎªÊ¹ÎÄÕÂÇå³þ£¬µÚÒ»´ÎÌá³ö¸ÅÄîʱ£¬ÒªÒÔÀ¨ºÅ¸ø³ö½ÏÏêϸµÄ½âÊÍ¡£ jlZW!$ Iq  
£¨5£©ÂÛÎĵÄд·¨Ò»¶¨ÒªÍ»³öÖØµã¡£ ]jS+ItL@  
£¨6£©ÓÅ»¯Ó¢Óï¡£

kaobook 2011-08-17 22:51
¸½Â¼ ³£ÓüìË÷ÍøÖ· $_l@k=  
1.ISIÖ÷Ò³ ?(!$vqS`f(  
http://www.isinet.com ue$\ i=jw  
2.Web of Knoeledge fdN-Zq@'  
http://www.isiwebofknowledge.com >b |l6 #%  
3.Journal Citation Report ~/h P6*  
http://scientific.thomson.com/product/jcr v. ,C"^W  
4.SCIÎÄÏ×¼ìË÷½çÃæ ]`y4n=L.  
http://isiknowledge.com d;(L@9HH D  
5.EIÖ÷Ò³ j+J)S1  
http://www.ei.org TjlKy  
6.ElsevierϵÁÐÆÚ¿¯ >)U 7$<&b  
http://www.sciencedirect.com ^C@uP9g  
http://elsevier.lib.tsinghua.edu.cn !/['wv@  
http://elsevier.lib.sjtu.edu.cn E'&UWD h  
7.IEEE(ÃÀ¹úµçÆøµç×Ó¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ ~|pVz/s|G  
http://www.ieee.org/web/publications/journmag/index.html M&y!w   
8.IEEE»áÒéÂÛÎÄ xK0VWi  
http://www.ieee.org/web/publications/confproc/index.html 'sY>(D*CQ  
9.ACM(ÃÀ¹ú¼ÆËã»úЭ»á)ÂÛÎÄ #* S0d1  
http://www.acm.org/pubs W UdKj  
10.ASME(ÃÀ¹ú»úе¹¤³ÌʦЭ»á)ÆÚ¿¯ÂÛÎÄ .F?yt5{5No  
http://www.asme.org/Publications/Journals/View_Journals_Online.cfm }vxb, [#  
11.NIH(ÃÀ¹úÈ«¹úÎÀÉúÑо¿Ëù) 1?)<*[  
http://www.nih.gov  #d*mG =  
12.ҽѧË÷Òý /[GOs*{zB  
http://www.pubmed.gov |VlAt#E  
13.Academic Press (Y'rEc#H&z  
http://www.idealibrary.com |I7P 0JqP  
14.kluwer jY:(Tv3~  
http://kluwer.calis.edu.cn eP' e_E  
15.springer dj?.Hc7od  
http://link.springer-ny.com H<%7aOwO2  
16.Öйú¿ÆÑ§ÔÚÏß }%y_Lc L  
http://china.sciencemag.org 3oxQ[. o  
17.Öйú¿ÆÑ§ÔºÑо¿ËùͼÊé¹ÝÊÕ²Ø GfJm&'U&  
http://www.las.ac.cn/subpage/subframe_detail.jsp?Sub-FrameID=1003 1F/`*z  
@p|[7'  
ÔÙ´ÎÏòÂÃÃÀ»ªÒáѧÕß½ðÀ¤ÁÖ½ÌÊÚÖÂÒÔ³ç¸ßµÄ¾´Ò⣬¸ÐлËûΪ¹ã´óÖйúѧÕß·¢±íSCIÂÛÎÄËù×÷µÄ·îÏ×£¡ E` XUK,b  
EiP_V&\  
¾´Àñ£¡ .+ai dWd  

chqu 2011-11-15 21:25
лл·ÖÏí

mengliuhe 2011-11-16 01:55
ºÃÂ鷳Ŷ

xielei0409 2011-11-16 03:09
²»´íµÄÎÄÕ£¡£¡

chqu 2011-11-21 11:08
·Ç³£Ïêϸ£¬Ð»Ð»

haoyl123 2012-01-09 01:35
ѧϰһͨ£¬¸Ð¾õÊǾÞÂé·³µ½¶«¶«

2013Ä꿼²© 2012-05-08 13:47
лл¥Ö÷

2013Ä꿼²© 2012-05-18 18:03
лл¥Ö÷£¬¿¼²©£¬µ¼Ê¦ºÜ¿´ÖÐÎÄÕ£¿

y691935503 2012-05-25 15:14
¶àл

lunwen365 2014-10-06 10:53
SCI£¬Ïë±Ø´ó¼Ò¶¼ÄܱíÏÖ³ö¶úÊìÄÜÏêµÄÑù×Ó£¬ËüÊÇÃÀ¹ú¡¶¿ÆÑ§ÒýÎÄË÷Òý¡·µÄÓ¢Îļò³Æ£¬´´¿¯ÓÚ1961Ä꣬ËüÊǸù¾ÝÏÖ´úÇ鱨ѧ¼Ò¼Ó·Æ¶ûµÂ(Engene Garfield) 19 5 3ÄêÌá³öµÄÒýÎÄ˼Ïë¶ø´´Á¢µÄ¡£ lsY5QE:Qrp  
       SCIÊÇÒ»²¿¹ú¼ÊÐԵļìË÷¿¯Î°üÀ¨ÓУº×ÔÈ»¿ÆÑ§¡¢ÉúÎҽѧ¡¢Å©Òµ¡¢¼¼ÊõºÍÐÐΪ¿ÆÑ§µÈ£¬Ö÷Òª²àÖØ»ù´¡¿ÆÑ§¡£ ,U],Wu)  
SCIÑ¡ÔñÆÚ¿¯±È½Ï¿ÆÑ§£¬ËüÔËÓÃÒýÎÄÊý¾Ý·ÖÎöºÍͬÐÐÆÀ¹ÀÏà½áºÏµÄ·½·¨£¬³ä·Ö¿¼ÂÇÁËÆÚ¿¯µÄѧÊõ¼ÛÖµ£¬ÔÚÑ¡ÓÃµÄ 3 400ÓàÖÖÆÚ¿¯Àï°üº¬Á˹ú¼ÊÉϽÏÎªÖØÒªµÄÆÚ¿¯¡£ËüËùÔñÈ¡µÄ80ÍòÌõÂÛÎÄ£¬¿ÉÒÔ˵ÊǼ¯¸÷ѧ¿ÆÖ®¾«ÝÍ¡£SCI¼ìË÷ϵͳÀúÀ´³ÉΪÊÀ½çѧÊõ½çÃÜÇÐ×¢ÊÓµÄÖÐÐÄ£¬ÕùÏà½ÇÖðµÄ½¹µã£¬ÊÀ½ç¹«ÈϵÄÎÄÏ×ͳ¼ÆÔ´¡£ 1f~un b\Gg  
       È»£¬SCI¾ÍÆä±¾Éí¶øÑÔ£¬×îÖØÒªµÄ¹¦ÄÜÊǰïÖú¿Æ¼¼ÈËÔ±»ñÈ¡×îÐèÒªµÄÎÄÏ×ÐÅÏ¢¡£ÕâÒ²ÊDZ༭¸Ã²¿Ë÷ÒýµÄÖ÷ÒªÒâͼ¡£ opte)=]J  
       SCI×î´óµÄÓŵãÊÇÒýÎŦÄÜ£¬ÔÚÕâÀï¶ÁÕßÄÜºÜ¿ìµØÁ˽⵽ijһ×÷ÕßµÄijƪÂÛÎÄÊÇ·ñ±»ËûÈËÒýÓùý£¬Í¨¹ýÒýÎÄ´ÎÊý¿ÉÒÔÁ˽âijһѧ¿ÆµÄ·¢Õ¹¹ý³Ì¡£Í¬Ê±£¬SCIÒ²¾ßÓз´Ó³¿Æ¼¼ÂÛÎÄÖÊÁ¿ºÍѧÊõˮƽµÄ¹¦ÄÜ¡£ Ga.a"\F.V  
asj^K|.z  
QI=",vma u  
ϲѶ´«À´¹úÄÚÊ×¼ÒÓµÓÐ×Ô¼ºSCI SSCI ¶ÀÁ¢ÔËÓª×ÊÖÊ×Éѯ¹«Ë¾ fk#SD "iJ  
          Ò»¡¢SCI SSCI ´Óҵǰ¾°£º y''`73U"  
ÎÒÃǵÄÓÅÊÆÊÇ ¡¢Ä¿Ç°¹úÄÚÄÜÏñÎÒÃÇÕâÑù²Ù×÷SCI/SSCIÊDZȽÏÉٵģ¬ÎÒÃÇÓÐ×Ô¼ºSCI/SSCIÆÚ¿¯×ÊÔ´ÒÔ¼°ºÍºÜ¶à¹ú¼ÊSCI/SSCIÔÓÖ¾´ï³ÉÕ½ÂÔºÏ×÷µ¥Î»£¬ÌØÆ¸ÇëÁ˹ú¼ÊÖªÃûѧÕßר¼Ò×öѧÊõÖ¸µ¼£¬ÆÀ¹À ¡¢ÈóÉ«¡¢ ÐÞ¸Ä ¡¢ÍƼö·¢±í¡¢¼Û¸ñµÍ¡¢²ã´Î¸ß¡¢ÔÚ¹úÄÚ 211 ¡¢985¡¢´óÖÐרԺУ¿ÆÑÐÔºËù¡¢¼°Ïؼ¶ÒÔÉÏÒ½ÔºÓкܴóµÄÐèÇó¡£¹úÄÚ¸÷´óѧҽԺ¿ÆÑÐÔºËù¶¼°ÑSCI SSCIÆÚ¿¯ÂÛÎÄÁÐΪ×î¸ß¼¶±ðµÄѧÊõ³É¾Í¡£ÕâЩÊÇĿǰ¹ú¼ÊÖ÷Á÷ÆÀ¼Û»úÖÆ¡£ nI|jUD +y  
ÀýÈç ¹þÒ½´óϵÁе¥Î»¾ùÒªÇó·¢±íSCI¼ìË÷ÂÛÎÄΪְ³ÆÆÀ¶¨µÄÓÐЧÂÛÎÄ¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×ÓСÓÚ1£¬Ôò±ØÐëͬʱÓÐÁ½ÆªÒÔÉϱ±´óºËÐÄÂÛÎIJÅÄܲÎÓëÖ°³ÆÆÀ¶¨¡£Èç¹û·¢±íSCIµÄÓ°ÏìÒò×Ó´óÓÚ1£¬Ôòһƪ¼´¿É¡£ÕâÖ»ÊÇÀýÍâ±íÏÖ£¬¹úÄÚÖ÷Á÷ԺУ²»ÏÞÖÆÓ°ÏìÒò×Ó£¬ÓÈÆäÊǶþ±¾ Èý±¾ ְҵԺУ¾Í¸ü²»ÒªÇóÓ°ÏìÒò×ÓÁË£¬ÉõÖÁºÜ¶àµ¥Î»»¹¸ø¸ß¶î½±Àø£¬×÷ÕßÒ»¾ÙÊýµÃ¡£ ,K+K`"Oy  
ÀýÈç½­ËÕ»´°²ÊÐÈËÃñÒ½Ôº ·¢±íһƪSCI ҽѧÎÄÕ½±ÀøÎåÍò »¹ÔÚµ±µØ»´°²ÈÕ±¨¿¯µÇÕû°æ±íÑĿǰ¶øÑÔSCI SSCIÔÚ¹úÄÚ»¹ÊǾø¶ÔÊÜ»¶Ó­µÄ¡£ %^2LTK(P  
           ¶þ¡¢ ÐÐÒµ¸Å¿ö ;pBSGr 9  
Ŀǰ£¬¹úÄÚÆÚ¿¯ÖÊÁ¿ÐÐÒµ½ÏÂÒ£¬¼Ù¿¯¡¢ÀÄ¿¯µ½´¦¶¼ÊÇ£¬Õý¹æ¿¯ÎïÒ²¶¼´ò²Á±ßÇò£¬ÒÔÖÂ×·Çó¾­¼ÃÀûÒæ£¬ÂÛÎÄÖÊÁ¿¡¢Ñ§Êõˮƽ ¡¢ÖðÄêϽµ¡¢ºËÐÄÆÚ¿¯ÓÉÓÚ¹ØÏµ¸åÌ«¶à ÖÊÁ¿ÁîÈ˵£ÓÇ£¬¹úÄÚÏÖÔڸ߶ËÖ÷Á÷ԺУ¿ÆÑÐÔºËù ¶¼Ïò¹ú¼Ê¿´Æë Óùú¼Ê¿ÆÑ§±ê×¼£¬Ñ§ÊõÆÀ¼Û»úÖÆÎª×¼ ¡£¹úÄÚ¿¯ÎïÂÒÏó»¹»á³ÖÐø3-5Äê»ò¸ü¶Ì£¬ÓÉÓÚÊܹú¼ÒÕþ²ßÓ°Ïì£¬ËæÊ±¶¼Óм±É²³µÎ£ÏÕ¡£¹ú¼Ê¿¯ÎïSCI SSCI ²»ÊÜÕþ²ßÏÞÖÆÓ°Ïì¡¢²»ÊÜÖ°³Æ ¡¢Ñ§Àú¡¢ ѧλ¡¢¿ÉÒÔÓÀÔ¶³¤ÆÚºÏ×÷¡£ËùÒÔÎÒÃÇץסÆõ»úÓ­ÈжøÉÏ £¬Ç°¾°²»¿ÉÏÞÁ¿ ¡£Í¬Ö¾Ãǹ²Ãã¡£ \n6#D7OV  
~>k<I:BtrT  
deQ0)A 4g  
»¶Ó­Ë÷È¡Ïêϸ×ÊÁÏ QQ:1046245582ÓÊÏ䣺wuk223@163.com  18611667875 СÎâ X4Q ? ]{  


²é¿´ÍêÕû°æ±¾: [-- ʲôÊÇSCIÆÚ¿¯ --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us